Clinical Implications of Treacher Collins Syndrome by Plomp, R.G. (Raul)
Clinical Implications 
of Treacher Collins 
Syndrome
raul galeano plomp
Clinical Im
plications of Treacher Collins Syndrom
e  
raul galeano plom
p

Clinical implications of Treacher Collins syndrome
Raul Galeano Plomp
This study was supported by the Nuts-Ohra Foundation, the Hoofdzaak Foundation,
the Dutch Society for Plastic Surgery, Erasmus University Rotterdam, ABN AMRO, 
ChipSoft, and Mölnlycke Healthcare.
Layout: Optima Grafische Communicatie (www.ogc.nl)
Printed: Optima Grafische Communicatie (www.ogc.nl)
ISBN: 978-94-6169-672-4
All figures are printed with permission.
© Raul G. Plomp, 2015
All rights reserved. No part of this publication may be reproduced or transmitted in any 
form by any means, without permission of the author.
 5 
Clinical	  Implications	  of	  Treacher	  Collins	  Syndrome	  
Klinische	  implicaties	  van	  het	  Treacher	  Collins	  syndroom	  
	  
	  
	  
	  
Proefschrift	  
	  
ter	  verkrijging	  van	  de	  graad	  van	  doctor	  aan	  de	  
Erasmus	  Universiteit	  Rotterdam	  
op	  gezag	  van	  de	  
rector	  magnificus	  
Prof.dr.	  H.A.P.	  Pols	  
en	  volgens	  besluit	  van	  het	  College	  voor	  Promoties.	  
	  
De	  openbare	  verdediging	  zal	  plaatsvinden	  op	  
woensdag	  20	  mei	  2015	  om	  15.30	  uur	  
	  
door	  
	  
Raul	  Galeano	  Plomp	  
geboren	  te	  Bogotá,	  Colombia	  
	  
	  
	  
	  
	  
	  
	  
	  
	  
	  
	  
Promotiecommissie
Promotor:
Prof.dr. I.M.J. Mathijssen
Overige leden:
Prof.dr. E.B. Wolvius
Prof.dr. J. Passchier
Prof.dr. H.A.M. Marres
Copromotoren:
Dr. S.L. Versnel
Dr. K.F.M. Joosten
Paranimfen:
Drs. N. Ayez
Drs. H.M. ter Wal

TABLE OF CONTENTS
General Introduction
Chapter I General introduction of the thesis 11
Obstructive Sleep Apnea
Chapter II Obstructive sleep apnea in Treacher Collins syndrome: 
prevalence, severity and cause
29
Chapter III Screening for obstructive sleep apnea in Treacher Collins 
syndrome
43
Chapter IV Is there an effect of obstructive sleep apnea syndrome on 
oxidative stress and inflammatory parameters in patients 
with craniofacial anomalies?
57
Long-Term Results of Treatment
Chapter V Long-term assessment of facial features and functions 
needing more attention in treatment of Treacher Collins 
syndrome
75
Chapter VI Long-term psychological functioning of adults with severe 
congenital facial disfigurement
95
The Nose: Endonasal and External Nasal Deformity and Satisfaction 
with Function and Appearance
Chapter VII Nasal sequelae of Treacher Collins syndrome 113
General Discussion: Evidence-based Medicine, the Treatment of 
Treacher Collins Syndrome
Chapter VIII Treacher Collins syndrome: a systematic review on evidence-
based treatment and recommendations
135
Summary
Chapter IX English and Dutch summary of the thesis: clinical 
implications of Treacher Collins syndrome
165
Appendices Gratitude/ dankwoord
List of publications
PhD Portfolio
About the author
182
185
186
189

GENERAL 
INTRODUCTION

Chapter I 
General introduction 
of the thesis

General introduction 13
1
BACkGROuND
Treacher Collins syndrome (OMIM 154500) is a rare congenital craniofacial condition.1 
The incidence of Treacher Collins syndrome is nowadays estimated at 1 in 50,000.2-3 
Based on this, every year approximately 4-5 patients are born with this syndrome in the 
Netherlands.
Treacher Collins syndrome has several eponyms, for example it is also known as 
Franceschetti-Zwahlen-Klein syndrome or Berry syndrome. George Andreas Berry in 
1889 first described an abortive form with colobomata of the lower eyelids. In 1900 
Treacher Collins presented two similar cases and described their features (Figure  1).4 
Forty-four years later in 1944 Franceschetti and Zwahlen and later Franceschetti and 
Klein published a review with phenotypic features and designated it “mandibulofacial 
dysostosis”.5 In addition, later on Fazen described in 1967 10 affected persons in four 
Figure 1. Illustration from the original report in 1900 of what is now called Treacher Collins syndrome. 
14 Chapter I
generations.1 Nowadays “Treacher Collins syndrome” (TCS) is the most used eponym for 
this congenital craniofacial syndrome.
Edward Treacher Collins
Edward Treacher Collins (1862-1932) was a British ophthalmologist (Figure  2). Collins 
went to university college London and started in 1879 at Middlesex Hospital where he 
received his medical degree in 1883. For 48 years Collins worked as a faculty member in 
the Moorfields Eye Hospital. Collins contributed considerably to the ophthalmological 
community in that time.6 One of his most important works is "The anatomy and pathol-
ogy of the eye" published in 1900.7
Genetics
TCS is a mandibulofacial dysostosis syndrome with overlapping phenotypic facial clinical 
features syndromes with Miller syndrome (OMIM 263750) and Nager syndrome (OMIM 
154400), distinguished by postaxial and preaxial deficiencies in the limbs respectively. 
Craniofacial microsomia (OMIM 164210) can resemble TCS phenotypic facial features, 
but these features are found mostly unilateral and in addition to craniofacial anomalies, 
there may be cardiac, vertrebral and central nervous system defects. Phenotypic facial 
features of TCS could be part of the Robin sequence (OMIM 261800). Until now three 
genes have been found responsible for the occurrence of the phenotypic features defin-
ing TCS. The inheritance of TCS is autosomal dominant. Mutations in TCOF1 (78-93%) and 
in a smaller subset of TCS patients in POLR1D and POLR1C (8%) are found responsible 
for the resulting phenotype.8-11 Sixty percent of the mutations are de novo in the TCOF1 
Figure 2. Edward Treacher Collins. 
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gene.12 Over 100 distinct mutations are identified.3, 13 However, there still remain patients 
resembling the phenotype in whom no mutations within one of these three genes are 
detected, and thus the diagnosis TCS is only based on clinical features in these patients.
It is hypothesized that TCOF1 (5q32-33.1) encodes Treacle, a protein which expression 
is crucial for craniofacial development via survival and migration of craniofacial neural 
crest cells resulting in first and second branchial arch cartilage, connective tissue, bone 
and nervous structures hypoplasia.13-15 In addition, recently TCOF1 is identified as a DNA 
damage response factor that suppresses inappropriate ribosomal DNA transcription 
and maintains genomic integrity after DNA damage.16 The POLR1D gene (13q12.2) 
codes for three exons and POLR1C gene (6p21.1) codes for nine exons both contributing 
to subunits of RNA polymerase I and III. A reduction in functional polymerase I and III 
results in inadequate quantities of mature ribosomes in the neuroepithelium and neural 
crest cells leading to activation of cell death pathways and subsequent hypoplasias.10
Clinical features
TCS has a broad phenotypic variability, varying from very mild (mostly periorbital soft 
tissue) deformities which might be hard to detect for clinicians not particularly familiar 
with these condition, to severe deformities like colobomata of the lower eyelids, refrac-
tive errors, down slanting of the palpebral fissures, malar hypoplasia, microtia, middle 
ear deformities, choanal atresia, palatal cleft and mandibular hypoplasia (Figure 3).1, 17 
Even a case with arhinia and anotia is described.18 Until now there are no correlations 
found between the genetic cause and the severity of the phenotypic clinical features. It 
is assumed that men and women are affected equally.
Figure 3. Variable expression of the phenotypic clinical features of Treacher Collins syndrome ranging from 
mild to more severe (left to right).
16 Chapter I
Prenatal diagnosis
Mid-trimester prenatal diagnosis is possible through a two-dimensional or three-
dimensional ultrasonography identifying the presence of for example micrognathia 
and low-set ears.19-20 However, one can suppose that very mild forms of TCS might be 
undetected during regular ultrasonography screening.
Grading systems
Two subjective grading systems have been described until now to grade TCS. Hayashi et 
al described a scoring system with eight criteria and each criteria was assigned several 
categories.21 The eight criteria are: deformity of the malar bone, deformity of the lower 
eyelid, deformity of the mandible, deformity of the ear, palatal cleft, nasal root, other de-
formities and the presence of a TCOF1 mutation. The second is the O.M.E.N.S. classifica-
tion, as initially proposed for craniofacial microsomia. The acronym indicates five major 
features: orbital distortion, mandibular hypoplasia, ear anomaly, nerve involvement and 
soft tissue involvement.22 Although these classification systems illustrate the variety and 
severity of the deformities, these classifications have never resulted in any structured 
(surgical) approach or treatment; therefore they are rarely used in clinical practice.
CLINICAL IMPLICATIONS OF TREAChER COLLINS SyNDROME
upper airway
TCS is mostly known for the esthetic sequelae, however, functional problems are consid-
ered a major issue as well. A known condition which may be present in craniofacial syn-
dromes in general, is obstructive sleep apnea (OSA). OSA is characterized by breathing 
cessation (apneas) or reduction (hypopneas) as a result of complete or partial upper air-
way obstruction. The gold standard for diagnosis of OSA is the poly(somno)graphy used 
in hospital settings or ambulatory measurements at home. For screening on OSA alter-
native tools might be used for the diagnosis but cannot substitute polysomnography.23 
They may be used in low resource settings. Two questionnaires are frequently used in 
children and adults; in children the Brouillette score (validated in children) and in adults 
the Epworth Sleepiness scale (validated in adults).24-26 However, the Brouillette score has 
a poor sensitivity and specificity for the prediction of polysomnography results.23 Based 
on the current literature, the prevalence of OSA in TCS is estimated between 25- 95%.27-28 
In for example syndromic craniosynostosis the prevalence of OSA is determined to be 
68%.29 In that patient category, the Brouillette score could not differentiate between 
OSA and non OSA.30 Also in TCS it is unknown whether questionnaires are accurate for 
the diagnosis OSA.
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The mechanism underlying OSA in TCS is attributed to mandibular hypoplasia to-
gether with a posterior tongue collapse. This can narrow the upper airway at the level of 
the oro/hypopharynx significantly resulting in sometimes severe OSA. However, instead 
of an one level origin, some studies report obstructions at more than one level.28, 31-33 
Airway problems can be so severe that they can result in peri- or postnatal early death 
through fatal airway compromise. In children with OSA there might be an increased 
prevalence of abnormalities which reflect associated morbidity. Central nervous or car-
diovascular system morbidity, growth failure or enuresis should be recognised. Central 
nervous abnormalities include excessive daytime sleepiness, increased frequency of 
inattention/hyperactivity symptoms, increased prevalence of cognitive deficits and in-
creased frequency of behavioral disorders.34-35 Morbidity from the cardiovascular system 
may be reflected in elevated blood, increased risk of pulmonary hypertension and cor 
pulmonale. Moreover, OSA is associated with oxidative stress and systemic inflamma-
tion.36 Cytokines are released including interleukin 1, interleukin 6, tumor necrosis factor 
α and C-reactive protein. These proinflammatory proteins can induce oxidative stress, 
systemic inflammation and sleepiness.37-41 Through these pathways OSA can lead to ath-
erosclerosis and vascular dysfunction.42 So far these comorbidities in the cardiovascular 
system have not been described in children and adults with craniofacial syndromes.
The ear, hearing and speech
Around 93-96% of the TCS patients suffer from a certain degree of unilateral or bilateral 
conductive hearing loss.43-45 In addition, around 50% suffer from a certain degree of 
communication problem.46 A variety of complex middle ear deformities (hypoplastic, 
ankylosed or missing ossicles) contribute to a conductive hearing loss. Hypoplasia of the 
mastoid and mastoid antrum, absence of the external auditory canal or even absence of 
the middle ear and epitympanic space are noted and could further impede conductive 
hearing. There are limited options for surgical reconstruction. However, hearing rehabili-
tation through a bone anchored hearing aid is an option for these patients.43, 47-49 There is 
limited evidence for patients' experience of success of hearing rehabilitation. The inner 
ear is assumed to be usually normal.50 The degree of hearing impairment may correlate 
with the external ear deformity as scored with the auricle four category system of cra-
niofacial microsomia.45, 51 This suggests that a correlation exists between the severity of 
the deformity of the pinna and external auditory canal and the middle ear deformities.
The eye, eyelashes and lacrimal system
Periorbital soft tissue defects are one of the cardinal facial features of TCS. The identifiable 
“down slanting” of the eyelids are almost always present. Although the syndrome was 
named after an ophthalmologist, (intra-)ocular deformations are seldom mentioned. An 
assortment of ocular conditions can be found in TCS: vision loss (37%), amblyopia (33%), 
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significant refractive errors (58-86%), anisometropia, bilateral absence of the inferior lac-
rimal puncta (36%) or cilia (50%), regular astigmatism (36%) and absent lateral canthal 
tendon (64%).17, 52 In addition, corneal drying through colobomata can give irritation of 
the globe. Regarding these topics very limited evidence can be found in literature.
Growth, feeding and swallowing
In craniofacial syndromes feeding difficulties and growth failure are described which 
are often related to OSA. In TCS, also swallowing dysfunctioning can occur.46 Patients 
reported eating difficulties up to 68% and dry mucosa in 42%.46 A reduced jaw opening 
(63%), malocclusion (94%) and a narrow hypopharynx are the basis of the anatomic lim-
ited normal feeding route.46 Dysplasia and even aplasia of the parotid gland can occur 
with or without a detectable orifice of Stenson's duct.53 It is unknown how often these 
functional impairments lead to growth failure in TCS.
The nose
On the level of the midface, one of the less prominent deformities can be found: the nose. 
Current treatment overviews seldom describe nasal reconstruction or considerations 
of other (endonasal) treatment of the nose.11, 45, 54-55 However, it is known that choanal 
atresia occurs now and then in TCS.45 This can cause significant nasal obstruction. The ex-
ternal nose can be deformed as well. Although the height and width are mostly optimal, 
the nose is often protruded proximally with a wide nasal root.56 Moreover, the clinical 
picture suggests a dorsal hump deformity.11, 45, 54-55 Evidence considering reconstructive 
nasal surgery or patients' experience is currently lacking.
Psychosocial factors
The effect of the congenital craniofacial anomalies of TCS patients on their psychosocial 
functioning, has not been investigated well.57 It is known that stress and avoidance 
behavior can be elicited by stigmatization and insecurity about experiencing nega-
tive reactions of others.58-59 In addition patients with congenital facial deformities may 
have an impeded social functioning.60-61 The exact coping mechanisms or long-term 
psychological functioning, however, is unknown in TCS. No recent studies suggest a 
lower average level of intelligence in TCS patients, compared to the normal population. 
Concerning self-esteem only in one study it was shown that surgical improvements of 
facial appearance may have positive influence on self-esteem and adaptive functioning 
in TCS on the short-term postoperatively.62
Craniofacial reconstruction and the multidisciplinary approach
Since it's multidisciplinary character of the syndrome various specialists should be 
involved in the diagnosis and treatment. Plastic and reconstructive surgeons, oral- and 
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maxillofacial surgeons, clinical geneticist, pediatricians and otorhinolaryngologists are 
involved to a certain extent. The rarity of the syndrome together with the variety of the 
phenotypic expression makes the multidisciplinary staged surgical treatment compli-
cated. No "standard" procedure or protocol exists. Many ways of surgical reconstruction 
have been published by experts in craniofacial surgery; they published mainly their own 
experience and opinions.45, 54-55, 63-68 Generally, the main targets are the periorbital soft 
tissue, hypoplastic maxilla and mandible. Options for zygoma, orbital floor and lower 
rim are free grafts or pedicled flaps.69-70 Techniques described for correcting midface 
hypoplasia are the Le Fort I and II, rib grafts, malar osteotomies with or without onlay 
grafts or lipofilling.66, 71-72 The retrognatic mandible is often distracted for esthetic and 
functional indications, for example to overcome severe airway compromise and/or 
tracheotomy and to ameliorate feeding.73-75
OuTLINE AND AIMS OF ThE ThESIS
The range of functional and esthetic problems patients with TCS exhibit during life, the 
diversity of (and multiple stage) surgeries and psychological sequelae may be extensive. 
In contrast, craniofacial research is limited and with low levels of evidence. The limited 
research is probably due to the rarity, the relatively "low impact" these craniofacial syn-
dromes have in our society and lack of centralization of these conditions in craniofacial 
centers.
Even for relatively "severe" conditions like OSA very limited evidence has been pro-
vided for its' exact occurrence and cause in TCS. Although it is known that OSA occurs 
in TCS, until now, the exact prevalence, cause and severity of OSA have been unknown; 
therefore we try to determine these entities in chapter II of the thesis.
Alternatives for polysomnography to diagnose OSA in TCS patients may be the use of 
a specific questionnaire for children and adults, which are discussed in chapter III.
As OSA is associated with oxidative stress and systemic inflammation, this may intro-
duce cardiovascular disease. In a group of children and adults with craniofacial anoma-
lies and with and without OSA (including patients with TCS) parameters of oxidative 
stress and inflammation were investigated and described in chapter IV.
Multiple craniofacial surgeries at a relatively young age are performed in TCS. One 
of the main goals for surgery is satisfaction with facial appearance. But how does the 
surgical treatment succeed for specific facial features and functioning of the face on the 
long term? Are patients satisfied in the end? Is there still a wish for further treatment? 
The deficits of facial functions and esthetics as experienced by TCS patients compared 
with controls are discussed in chapter V.
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It may be plausible that patients with congenital craniofacial deformities can experi-
ence psychological issues, which alter or impede daily functioning. Chapter VI assesses 
the impact of congenital craniofacial deformities on the long-term psychological func-
tioning. Satisfaction with facial appearance, objective severity, fear of negative appear-
ance evaluation and self-esteem are compared with a control group and a group with a 
traumatically acquired facial deformity.
In chapter VII a relatively unknown feature of TCS is investigated into more extent, the 
nose. Clinical picture suggested a beaked nose and a possible cause of OSA might be 
present at the level of the nose. Moreover, as less attention has been paid to the nose, it 
is questionable whether TCS patients are indeed satisfied with functions and esthetics 
of the nose? Therefore, external and endonasal deformity and satisfaction with nasal 
functioning and appearance are determined in TCS.
No reviews or guidelines are available on evidence-based treatment for the multidisci-
plinary approach in TCS. In order to provide a basis for future research and to assist phy-
sicians in their clinical decision-making Chapter VIII (i.e. also the general discussion of 
the thesis) aimed to provide an evidence-based review of multidisciplinary treatment of 
TCS based on levels of evidence and supported with graded recommendations.
In conclusion, this thesis aims to answer four clinical questions in TCS:
1) To determine the prevalence, severity, cause and screening of OSA and potential 
effects of OSA on oxidative stress and inflammation (chapter II, III and IV)
2) To determine which facial features, functions and psychosocial aspects need more 
attention during surgical treatment on the long-term (chapter V and VI)
3) To determine external and endonasal deformity, and satisfaction with nasal func-
tioning and appearance (Chapter VII)
4) To provide an evidence-based review of multi-disciplinary treatment of TCS based 
on levels of evidence and supported with graded recommendations (Chapter VIII)
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ABSTRACT
This cohort study in 35 patients (13 children) evaluates the prevalence, severity and 
anatomical cause of obstructive sleep apnea syndrome (OSAS) in patients with Treacher 
Collins syndrome.
Ambulatory polysomnography was performed cross-sectionally to determine OSAS 
prevalence and severity. All upper airway related surgical interventions were evaluated 
retrospectively. In 11 patients, sleep endoscopy, and flexible and rigid endoscopy were 
applied to determine the level of anatomical obstruction of the upper airway.
The overall prevalence of OSAS in Treacher Collins patients was 46% (54% in children 
and 41% in adults). Thirty-eight upper airway related surgical interventions were per-
formed in 17 patients. Examination of the upper airway revealed various anatomical 
levels of obstruction, from the nasal septum to the trachea. Most significant obstruction 
was found at the level of the oro/hypopharynx.
OSAS in Treacher Collins patients is an important problem so all patients should be 
screened for OSAS by polysomnography. Endoscopy of the upper airway was helpful 
in determining the level of obstruction. Surgical treatment at one level will not resolve 
OSAS in most patients because OSAS in Treacher Collins has a multilevel origin. Non-
invasive ventilation (continuous positive airway pressure or bilevel positive airway 
pressure) or tracheotomy should be considered as treatment a modality.
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INTRODuCTION
Treacher Collins syndrome (TCS) is a rare congenital craniofacial condition. Its deformi-
ties can range from a slight defect of the cilia to severe defects such as micrognatia and 
zygomaticotemporomaxillary dysostosis. Mandibular hypoplasia, choanal atresia, un-
derdevelopment of the auricles, a downslant of the eyelids, coloboma of the eyelids and 
hypoplasia of the zygomatic bone and lateral orbital wall are common features of this 
condition.1 TCS is an autosomal dominant disorder with an incidence of 1 in 50,000 live 
births. In more than 60% of cases there is no previous family history and the condition is 
thought to arise as the result of a de novo mutation. TCS is mainly caused by mutations 
in the TCOF1 gene, located on chromosome 5, which encodes a low complexity, serine/
alanine-rich, nucleolar phosphoprotein known as treacle. Deletions, insertions, splicing, 
and missense and nonsense mutations in the TCOF1 gene cause TCS, however altera-
tions in the POLR1D and POLR1C genes have been demonstrated to cause TCS.2 Patients 
with craniofacial syndromes, such as Pierre Robin sequence, Apert, Crouzon and Pfeiffer 
syndrome, frequently suffer from obstructive sleep apnea syndrome (OSAS).3-4
The main factors that lead to OSAS in craniofacial syndromes appear to be midface 
and/or mandibular hypoplasia. Mandibular hypoplasia may result in a posterior collapse 
of the tongue base and a decreased oropharyngeal airway.5 Leaving OSAS untreated 
may result in major physical and functional impairment due to the disturbed sleep 
patterns. TCS is a syndrome in which mandibular hypoplasia is a frequent finding, but 
only a few studies suggest that TCS may be accompanied by sleep apnea.6-10 All these 
latter studies are case reports, with the exception of the study by Sher et al. published in 
1986.10 These authors found a prevalence of 25% in a small group of TCS patients using 
OSAS criteria that differ from the current standards; they did not differentiate between 
paediatric and adult TCS patients.
It is important to establish the prevalence and severity of OSAS in TCS patients be-
cause of its potential long-term physical and functional effects; but this knowledge is 
currently lacking. The present study determined these factors in a large group of TCS 
patients, taking into account all respiratory related interventions that these patients had 
undergone.
MATERIALS AND METhODS
This cohort study comprised a cross-sectional and a retrospective parts and was con-
ducted in a population diagnosed with TCS and treated by the multidisciplinary cranio-
facial team of the Erasmus MC since 1975 (over 36-years). All patients were eligible for 
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inclusion if they were diagnosed with TCS within that period. The research protocol was 
approved by the Ethical Committee of the Erasmus MC (MEC-2008-402).
Patients were contacted by mail or approached personally at a regular appointment in 
our outpatient clinic. They had to decide whether to participate within month. Patients 
were contacted at home by telephone if they had not responded to the mail within that 
period.
Between January 2007 and November 2009 all included patients underwent a nightly 
ambulatory polysomnography (PSG) for clinical and/or research purposes. Patients were 
divided into a paediatric group and an adult group based on their age at the time of the 
PSG; there was no overlap between the two groups. With the use of a paediatric and an 
adult group (cutoff at age ≥18 years) the authors were able to determine the proportion 
of patients suffering from OSAS in both groups separately. PSG was carried out with 
the Embletta Portable Diagnostic System and analyzed with Somnologica for Embletta 
software 3.3 ENU (Medcare Flaga, Reykjavik, Iceland).11 Cardiorespiratory variables were 
measured in the clinical or home setting. Respiratory variables measured were nasal 
airflow, chest and abdominal wall motion, snoring, oxygen saturation, and oximeter 
pulse waveform. The minimal total registration time was 6 hours. Analysis of the PSG 
was expressed in the apnea-hypopnea index (AHI) and the oxygenation-desaturation 
index (ODI). AHI was defined by the number of obstructive apneas and hypopneas per 
hour. ODI was defined by the number of desaturations (≥ 4% decrease with respect to 
the baseline oxygen saturation during 10 s) per hour. An obstructive apnea was defined 
as a cessation of airflow referred to baseline airflow signal, during at least 10 s or less 
if followed by desaturation. A hypopnea was defined as a reduction in airflow of 50% 
referred to baseline airflow signal, during at least 10 s or less if followed by desaturation.
For children the obstructive-AHI (OAHI) was used. Central apneas were not included. An 
OAHI score <1 was considered to be normal for children, 1-5 was defined as mild OSAS, 
5-24 as moderate OSAS, and a score >24 as severe OSAS.12-13 The duration of obstructive 
apnea and hypopnea was defined as "longer than two breaths".11 ODI scores were taken 
into account, but not for diagnostic differentiation between grades of severity of OSAS 
in children.
For adults, the current OSAS guideline standards for adults were used.14-15 OSAS was 
diagnosed when AHI fell outside the normal limit (AHI >5). An AHI of 5-15 was defined 
as mild OSAS, 15-30 as moderate OSAS, and an AHI > 30 was defined as severe OSAS.
Regarding upper airway surgery, a retrospective chart review was performed on 
upper-airway-related surgery in all patients. Surgery performed in other medical centers 
was also taken into account. All available PSGs and presence of a tracheotomy or use of 
continuous positive airway pressure (CPAP) for severe OSAS were taken into account. 
Types of surgeries were categorized according to the level of the upper airway.
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Regarding sleep endoscopy and level of obstruction in TCS with OSAS, data on drug-
induced sleep endoscopy were taken into account for patients suffering from severe 
OSAS to assess the anatomical site of obstruction during sleep. The jaw-thrust maneuver 
was applied to check whether the obstruction could be alleviated. If available, results 
from flexible and rigid endoscopy were taken into account. Plain lateral skull radiographs 
for cephalometric analysis were taken to determine the severity of the mandibular/
maxillary hypoplasia.
Statistical analysis
All statistics concern descriptive numerical and categorical data. Measured values are 
reported as mean ± 1 standard deviation (SD) or median (range), as appropriate. Out-
comes of PSGs are expressed as median and interquartile range. Analyses were made 
using SPSS 17.0 for Windows (SPSS, Inc., Chicago, IL, USA).
RESuLTS
Population
From 1974 through 2010, 58 patients were diagnosed with TCS. In this period four 
patients died: three suffered from severe OSAS, two deaths were not related to OSAS, 
and the cause of death was unknown for one patient. The death of one patient was 
related to OSAS because of asphyxiation due to frequent aspiration. Of the 54 patients, 
19 did not participate due to emigration (one patient), lack of correct personal details 
(three patients), unwillingness to participate (14 patients), and loss to follow-up (one 
patient). At least two patients who refused to participate suffered from severe OSAS 
(one tracheotomy, and one used CPAP). Another patient who was lost to follow-up was 
known to have a tracheotomy for severe OSAS.
Thirty-five of the 54 patients (65%) were included in this study. At time of the inclusion 
this group comprised 13 children (five boys) and 22 adults (10 males). Median age of the 
paediatric group was 12 years (range 0-17 years) and for the adult group, 37 years (range 
20-60 years). The median body mass index of the adult group was 20.7 (15.2-29.4), and 
was 17.4 (11.0-20.5) in the paediatric group.
Polysomnography
A PSG was performed in 12 children and showed OSAS in six of them. No PSG was 
performed in one child who required instant treatment (tracheotomy) for severe OSAS; 
because temporary closure of the cannula caused immediate breathing problems, 
decannulation was impossible. This patient was therefore classified as having severe 
OSAS without undergoing a formal assessment. Seven of the 13 children (54%) had 
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OSAS: one mild, five moderate and one severe (Table 1). Five of the 13 children (38%) 
had undergone airway treatment prior to these measurements.
A PSG was performed in all 22 adults; OSAS was diagnosed in nine (41%). Mild OSAS 
was diagnosed in three patients and severe OSAS in six patients (Table 1). Of these 22 
adults, 12 had undergone airway treatment (55%) prior to these measurements.
upper airway surgical procedures in TCS
In 17 (49%) of the 35 TCS patients 38 interventions related to the upper airway were 
performed. Figure 1 shows the schematic follow-up process.
A tracheotomy was performed in two of the newborn infants because of severe upper 
airway obstruction. One of these patients has now reached adulthood and has been 
successfully decannulated.
Nasal surgery was performed in three patients (two in childhood) aged five, 17 and 49 
years at the time of intervention. Two patients suffered from severe OSAS preoperatively. 
In the adult patient the distinct septum deviation was surgically corrected, resulting in 
a reduction of apneas of 224 to 3 per/h during the night (Fig. 1: no.7) (Table 2: no.7). In 
one paediatric patient (with severe OSAS preoperatively), surgery for choanal atresia at 
five years of age resulted in moderate OSAS postoperatively.
Maxillary surgery was performed in seven patients (six in childhood): age range 15-20 
years at time of intervention. In five patients a Le Fort I osteotomy advancement was 
performed, in one patient with internal distraction. Preoperatively, three patients were 
diagnosed with severe OSAS and two of them showed no OSAS after a Le Fort I procedure. 
Indications for Le Fort I procedure were improvement of occlusion and orthognathic 
correction following mandibular surgery. A surgically assisted rapid maxillary expansion 
Table 1. Cross-sectional polysomnography outcomes in paediatric and adult TCS patients (n=35)
Prevalence No OSAS Mild OSAS Moderate 
OSAS
Severe OSAS Total
TCS children (n=13) 46% (6/13) 8% (1/13) 38% (5/13) 8% (1/13)* 54% (7/13)**
Median OAHI (interquartile range) n/a 0.9 (-) 5.4 (5.2-11.0) -
Median ODI (interquartile range) n/a 1.9 (-) 8.3 (0.3-20.2) -
TCS adults (n=22) 59% (13/22) 14% (3/22) 0% (0/22) 27% (6/22) 41% (9/22)**
Median AHI (interquartile range) n/a 9.0 (9.0-14.0) - 55.0 (54.0-111)
Median ODI (interquartile range) n/a 4.0 (2.0-6.0) - 28.5 (14.5-38.75)
Total (n=35) 54% (19/35) 11% (4/35) 14% (5/35) 20% (7/35) 46% (16/35)**
n/a = not applicable
*No PSG was performed in one child who required instant treatment (tracheotomy) for severe OSAS. Be-
cause temporary closure of the cannula immediately caused severe breathing problems this patient was 
classified as having severe OSAS, without undergoing formal assessment.
**Twelve of the 22 adults and 5 of the 13 children underwent airway surgery prior to the PSG.
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Figure 1. Schematic follow-up of TCS patients: time at polysomnography, severity of OSAS, all forms of 
invasive or non-invasive airway treatment, endoscopies and X-rays are presented together with the ob-
struction levels.
Symbols used:
® OSAS diagnostic evaluation moment
| Surgical intervention
¯ Obstruction level evaluation moment
Abbreviations:
MDO: Mandibular distraction osteogenesis
MRD: Mandibular repositioning device
PSG: Polysomnography
SARME: Surgically assisted rapid maxillary expansion
TMD: Transmandibular distractor
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(SARME) was performed in four of seven patients (two in childhood), combined with a 
Le Fort I in two patients.
In eight patients (two in childhood) a genioplasty was performed. Three of these 
eight patients suffered from severe OSAS: age range 13-56 years at time of interven-
tion. A genioplasty was the only surgical intervention applied in five patients to correct 
mandibular hypoplasia. Three of these eight patients suffered from severe OSAS. The 
genioplasty did not result in a reduction of OSAS severity in any of the patients.
In six patients (five in childhood) a mandibular distraction osteogenesis was performed 
for their micrognatia: age range 1-20 years at time of intervention. Preoperatively, four 
patients suffered from severe OSAS, one from moderate OSAS and one was unknown. 
Postoperatively, two patients still suffered from severe OSAS, one patient from moder-
ate OSAS and three showed no OSAS. The patient with preoperative moderate OSAS 
showed no obstructions postoperatively (Fig. 1 no. 4). In two of the three patients the 
Table 2. Levels of obstruction found in the upper respiratory tract in 10 patients with Treacher Collins syn-
drome
Levels of obstruction in the upper respiratory tract including the diagnostic tools used
including the diagnostic tools used
Level of obstruction
Paediatric cases Adult cases
No.1 No. 2 No. 3 No. 5 No. 7 No. 8 No. 9 No. 10 No. 11 No. 12
Nasopharynx
Choana Rigid Flex
Septum Flex Flex
Nasopharynx* Rigid
Maxilla X-ray X-ray X-ray
Adenoid Flex
Oropharynx
Palate Sleep
Oro/hypopharynx Flex Sleep Flex
Glossoptosis Flex Sleep Sleep Sleep
Hypoplastic mandible X-ray X-ray X-ray
Laryngopharynx
Pharynx* Rigid Flex Flex Sleep
Epiglottis Sleep
Larynx Flex Rigid Flex Flex
Trachea Rigid
* not further specified
Case numbers correspond with figure 1. Only detected levels of obstruction are reported. Case no. 4 had no 
upper airway obstruction on endoscopy.
X-ray = cephalometric X-ray; Flex = flexible endoscopy; SleeP = sleep endoscopy; Rigid = rigid endoscopy.
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postoperative absence of OSAS was not attributable solely to the mandibular surgery 
because a Le Fort I was also performed, in one child following a SARME.
In three patients (all in childhood) a transversal mandibular distraction osteogenesis 
was performed: age range 15-17 years at time of intervention. These procedures were 
combined with a SARME. Preoperatively, two patients suffered from severe OSAS which 
resolved after surgery. Postoperative OSAS results were not attributable solely to these 
interventions, because a SARME was also performed in these two patients.
In one patient an adenoidectomy was performed at five years of age, and in another 
patient an adenotonsillectomy was performed at three years of age. Both patients suf-
fered from severe OSAS and used CPAP. Postoperatively, one had no OSAS and one had 
moderate OSAS (AHI 19.8). Postoperative OSAS results were not attributable solely to 
this intervention, because a mandibular distraction osteogenesis was also performed in 
these two patients.
Endoscopy of the upper airway was performed in 11 patients: sleep endoscopy in six 
(age range 3-60 years, five in adulthood), flexible endoscopy in six (age range 3-19 years, 
one in adulthood), and rigid endoscopy in two patients (both in childhood, age range 
0-9 years). In seven of 11 patients cephalometric X-rays were analysed. Upper airway 
obstructions were found in 10 of the 11 patients. Table 2 presents the results of these 
investigations (only detected obstruction levels are reported).
DISCuSSION
This cohort study shows that OSAS is frequently present in patients with TCS. The preva-
lence of OSAS was 41% in adults and 54% in paediatric patients. The overall prevalence 
of OSAS (46%) is high compared with the prevalence in healthy children and adults, but 
almost the same as in patients with syndromic craniosynostosis.16 The present popula-
tion tends to be more prone to severe OSAS (20% overall prevalence of severe OSAS) 
compared with severe OSAS in syndromic craniosynostosis (4-12.5%).4, 11, 17-20 Remark-
ably, in four of six adults diagnosed with severe OSAS, OSAS was not recognized as such 
prior to this study. There may have been a discrepancy between the severity of airway 
obstruction and complaints may have existed in these patients, which might have led to 
underdetection of OSAS. Bearing in mind that 38% of the children and 55% of the adults 
had undergone upper airway related surgery at the time of the cross-sectional measure-
ment, this probably resulted in an underestimation of the initial prevalence and severity. 
Despite these surgeries this study shows that the proportion of patients suffering from 
OSAS is high and similar in children and adults.
Endoscopy showed various levels of obstruction from nose to trachea, including 
obstruction due to the nasal septum and choanal atresia, obstruction at the maxilla, 
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narrowing at the level of the nasopharynx/laryngopharynx, posterior collapse of the 
tongue base, and tracheal malformation. In almost all patients a combination of one of 
these levels of obstruction was found.
One study reported pharyngeal narrowing in all 11 TCS patients using endoscopy; 
in most of these patients narrowing was throughout the entire vertical pharyngeal 
height.21 In that study, the authors found a typically anteroinferiorly displaced hyoid 
bone. In addition to the present results, these findings imply that OSAS has a complex 
multiple level origin in TCS. Overall there is a contrast with syndromic craniosynostosis, 
in which midface hypoplasia with collapse of the pharyngeal wall and obstructions at 
the level of the nasopharynx are generally considered to be the major cause of obstruc-
tion.19
Treatment of OSAS at one level may not resolve OSAS because OSAS is caused by 
obstruction at multiple levels. In this study, OSAS persisted in two patients after exten-
sive surgical airway treatment (Fig. 1, case nos. 3 and 10), and improved dramatically in 
two (case nos. 2 and 4). Concerning surgery at the nasopharynx level in TCS patients, it 
is useful to examine the nasal cavity because nasal surgery can reduce the airway ob-
struction.22-23 This is shown by one of present patients (Fig. 1 case no. 7): a nasal septum 
correction caused a significant reduction in OSAS. In the authors' opinion, the value of 
a genioplasty to improve airway obstruction remains doubtful, given the disappointing 
results in three patients (Fig. 1 case nos. 10, 11, 20).
The authors hypothesise that maxillary advancement (Le Fort I) may be indicated. In 
two cases (Fig.  1 case nos. 5 and 20) this intervention seemed to resolve OSAS com-
pletely, but there are no reliable pre- and postoperative PSG data to prove it.
Most interventions can be effective in resolving airway obstruction, but may fail in 
TCS due to its multilevel origin in these patients. Therefore, prior to surgical treatment of 
OSAS, the exact levels of obstruction need to be taken into consideration.
A limitation of this study is that determination of the level of obstruction was not 
standardized; different ways of endoscopy were used, sometimes retrospectively. We 
did not use 3D CT scans to measure airway volumes, although this would have allowed 
more precise measurement.
In most patients the preoperative severity of OSAS is unknown. Therefore, our conclu-
sions with regard to surgical treatment were limited to the cases in which preoperative 
and postoperative OSAS severities were known.
This cross-sectional cohort study shows that OSAS in TCS patients is an important 
problem in childhood and adulthood. Owing to the potential long-term untreated ef-
fects of OSAS all new TCS patients need to be screened for OSAS with PSG. The authors 
suggest annual screening for OSAS during the first few years of life. Endoscopy of the 
upper airway is helpful to determine the level of obstruction. Because OSAS in TCS has 
a multilevel origin, in most of the patients surgical treatment at one level is unlikely to 
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resolve OSAS. Therefore non-invasive ventilation, such as CPAP or bilevel positive airway 
pressure or a tracheotomy should be considered as treatment modality.
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ABSTRACT
Objectives/hypothesis This study evaluated the accuracy of established obstructive 
sleep apnea syndrome (OSAS) questionnaires based on presenting symptoms and com-
plaints as screening tools for OSAS in Treacher Collins syndrome (TCS).
Study design Cross-sectional cohort study.
Methods In 35 TCS patients (13 children, 22 adults) in whom diagnostic polysomno-
graphic results on OSAS were available, the Brouillette score was evaluated in children 
and the Epworth Sleepiness Scale in adults.
Results The total Brouillette score showed a sensitivity of 50%, specificity of 71%, posi-
tive and negative predictive value of 60% and 63%, respectively. The answer “no” to the 
question whether a child snored could rule out OSAS in children and showed positive 
and negative predictive values of 55% and 100%, respectively.
The Epworth Sleepiness Scale showed a sensitivity of 0%, specificity of 92%, positive 
and negative predictive values of 0% and 57%, respectively. A positive answer to the 
question of whether a person falls asleep while sitting and talking to someone (some-
times or more) was able to predict OSAS in adults. This question showed positive and 
negative predictive values of 100% and 72%, respectively.
Conclusions This cross-sectional cohort study shows that the Brouillette score and the 
Epworth Sleepiness Scale are of minimal usefulness in TCS. Diagnosis of OSAS based 
solely on complaints is not reliable, probably due to habituation. Therefore, for a good 
evaluation and optimal multidisciplinary treatment of this chronic disease in TCS, all 
newly referred pediatric and adult TCS patients should be screened for OSAS at least 
once with a polysomnography.
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INTRODuCTION
Treacher Collins syndrome (TCS) is a rare congenital craniofacial syndrome. Deformi-
ties can range from minor defects in the periorbital region to a full clinical presentation 
which is characterized by defects such as mandibular hypoplasia and hypoplasia/aplasia 
of zygoma, microtia and middle-ear deformities.1 TCS is an autosomal dominant disor-
der of craniofacial development with an incidence of 1 in 50,000 live births.2 In more 
than 60% of cases there is no previous family history and the condition is thought to 
arise as the result of a de novo mutation. Loss-of-function mutations are generally found 
in the TCOF1 gene; however alterations in the POLR1D and POLR1C genes have been 
demonstrated to cause TCS as well.3-4
Patients with craniofacial syndromes frequently suffer from obstructive sleep apnea 
syndrome (OSAS). OSAS is characterized by breathing cessation (apneas) or reduction 
(hypopneas) as a result of complete or partial upper airway obstruction. This disorder 
is one of the most frequent forms of sleep-disordered breathing, associated with major 
physical and functional impairment due to the disturbed sleep patterns.5 OSAS is a 
frequent finding in TCS.6-9 Severities range from mild to severe in pediatric and adult TCS 
patients, of which a considerable number suffered from severe OSAS.
Definitive diagnosis and grading of OSAS requires polysomnography (PSG), which is 
considered the gold standard for diagnosis. Normally, diagnosis is often supported by 
symptoms like snoring and excessive sleepiness in adults.10-11 In children, symptoms can 
be apneas, snoring and increased respiratory effort which can lead to failure to thrive, 
recurrent respiratory infections, feeding difficulties, and disturbed cognitive functions 
such as attention deficit and impaired concentration and memory.12 However, symp-
toms as presented often remain unrecognized in patients with OSAS.13
Because the presence of symptoms/complaints in a normal population can be 
suggestive for OSAS and supports the diagnosis, it is important to know whether it is 
possible to predict OSAS in patients with TCS with two validated questionnaires used 
for screening for OSAS.11, 14-16 Currently, no scientific evidence is available regarding 
screening for OSAS in TCS either with PSG or validated questionnaires. Given the high 
prevalence of OSAS in TCS, it is essential to clarify whether symptoms/complaints of 
OSAS are of diagnostic value.
Therefore, the present study aimed to: 1) determine whether it is possible to predict 
OSAS with two validated OSAS questionnaires, 2) explore differences in outcomes of 
these questionnaires (symptoms), and 3) determine the frequency of different symp-
toms. To establish this, the same TCS cohort was investigated in which we established 
the prevalence and severity of OSAS with the gold standard (i.e., PSG).
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MATERIALS AND METhODS
Patient selection
We conducted a cross-sectional cohort study to establish the complaints associated with 
OSAS in a population diagnosed with TCS. Patients were included if they were diagnosed 
with TCS and treated by the multidisciplinary craniofacial team of the Erasmus MC.
The group was divided into pediatric and adult patients (cutoff at age ≥18 years). The 
study was approved by the Ethical Committee of the Erasmus MC (MEC-2008-402).
Polysomnography
A clear objective diagnosis of OSAS through PSG was available for 35 TCS patients (13 
children, 22 adults) (Table 1). Current guideline standards were used for the diagnosis of 
OSAS for children according to the consensus.10, 17-19
For children the obstructive Apnea-Hypopnea Index (AHI) was used. Central apneas 
were not included. An obstructive AHI score > 1 was defined as mild OSAS. An AHI ≥ 5 
and < 24 was defined as moderate OSAS, and a score ≥ 24 as severe OSAS.
For adults, the diagnosis of OSAS was according to the Adult OSA Task Force of the 
American Academy of Sleep Medicine.20-21 OSAS was defined as mild for AHI ≥ 5 and < 15, 
moderate for AHI ≥ 15 and ≤ 30, and severe for AHI > 30 per hour.
Questionnaires
Pediatric questionnaire
Brouillette et al. developed an OSAS score to predict the presence of OSAS with a 
high sensitivity in normal children. To make a clear inventory of the complaints associ-
ated with OSAS in this cohort we used the Brouillette score for pediatric patients.22 The 
parents of these children answered the questions.
The Brouillette score is calculated using the following formula: 1.42 D + 1.41 A + 0.71 
S – 3.83. Where D stands for difficulty in breathing and S for snoring, using different scores 
for the frequency of the complaint (never = 0, sometimes = 1, often = 2, always = 3); A 
Table 1. Prevalence of obstructive sleep apnea in children and adults with Treacher Collins syndrome (TCS) 
based on polysomnography (n=35)
Prevalence
Mild OSAS Moderate OSAS Severe OSAS Total
% (No.) % (No.) % (No.) % (No.)
TCS children (n=13) 8 (1/13) 38 (5/13) 8 (1/13)* 54 (7/13)
TCS adults (n=22) 14 (3/22) 0 (0/22) 27 (6/22) 41 (9/22)
Total (n=35) 11 (4/35) 14 (5/35) 20 (7/35) 46 (16/35)
* One patient received immediate treatment for severe airway obstruction, therefore no polysomnography 
prior to treatment was available.
OSAS = obstructive sleep apnea syndrome; TCS = Treacher Collins syndrome
Screening for obstructive sleep apnea in Treacher Collins syndrome 47
3
stands for apnea and is scored 0 if apnea does not occur and scored 1 if it does. A Brouil-
lette score below –1 is defined as no OSAS, between –1 and 3.5 as suggestive for OSAS 
and greater than 3.5 as OSAS.22
Children were divided into an OSAS group and a non-OSAS group based on the PSG 
results.
Adult questionnaire
Daytime sleepiness was assessed using the Epworth Sleepiness Scale. The Epworth 
Sleepiness Scale provides a rapid and quantifiable assessment of subjective sleepiness 
as cardinal daily symptom of OSAS.11, 23 Adults were asked “How likely are you to doze off 
or fall asleep in the following situations?” in eight different situations. The following situ-
ations were described according to the Epworth Sleepiness Scale: 1) sitting and reading, 
2) watching television, 3) sitting inactive in a public place (for instance, a theater or 
meeting), 4) as a passenger in a car for an hour without a break, 5) lying down to rest in 
the afternoon when circumstances permit, 6) sitting and talking to someone, 7) sitting 
quietly after a lunch without alcohol, 8) in a car, while stopped for a few minutes in traffic. 
The total score of the Epworth Sleepiness Scale is the sum of the responses to the eight 
individual items and ranges from 0 to 24. Values ≥ 10 indicate significant sleepiness and 
a relation with OSAS and prompts further evaluation; values ≥ 16 indicate a high level 
of daytime sleepiness. Adults were divided into an OSAS group and a non-OSAS group.
Statistical analysis
Accuracy of the questionnaires was determined by using contingency tables to calcu-
late the sensitivity, specificity, positive predictive value (PPV) and negative predictive 
value (NPV) of total scores and separate items of the questionnaires, as appropriate. To 
calculate the above-mentioned values a cutoff ≥ -1 was used (suggestive for OSAS) in 
the total Brouillette score. A cutoff ≥ 1 was used per question in the Epworth Sleepiness 
Scale. A cutoff ≥ 10 was used for the total score in this questionnaire.
The unpaired t test with equal variances with two-tailed significance was used to 
compare differences in mean scores in all questionnaires between the OSAS group and 
the non-OSAS group. The Bonferroni correction for significance for multiple testing was 
used in all questionnaires. A P-value  ≤  0.05 was defined as significant. Analyses were 
performed using SPSS 17.0 for Windows (SPSS, Inc., Chicago, IL, USA).
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RESuLTS
Population
In the period 1974 through 2010, 58 patients were diagnosed with TCS. Of these four 
died, and 19 did not participate due to emigration (one patient), lack of correct personal 
details (three patients), unwillingness to participate (14 patients) and loss to follow-up 
(one patient). Of the 54 patients, 35 (65%) were included in the present study. Of these 
35 patients, 34 underwent PSG. In one patient no PSG was performed due to severe 
airway problems which necessitated immediate tracheotomy; therefore this patient was 
considered to have severe OSAS.
All patients filled out the questionnaires on the same day that the PSG was performed. 
This cohort comprised 13 children (five boys) and 22 adults (10 males). Median age of 
the pediatric group was 12 years (range, 0-17 years), and median age of the adult group 
was 37 (range, 20-60 years).
Questionnaires
Pediatric questionnaire
Parents of all 13 pediatric TCS patients filled out the Brouillette score. Although children 
with OSAS scored higher than children in the non-OSAS group, the difference was 
not significant (0.42 vs. -1.81, P = 0.094) (Table 2). The total Brouillette score showed a 
low sensitivity (50%), specificity (71%), and a low PPV and NPV (60% and 63%, respec-
tively). The most frequent complaint in children was snoring. PPV of the three separate 
Table 2. Brouillette score and separate items as tools for predicting obstructive sleep apnea syndrome in 
children with Treacher Collins syndrome (n=13)
Brouillette score and 
separate items
OSAS (n=6)
Non-OSAS (n=7)
OSAS
Mean (SD)
Non-OSAS
Mean (SD) P value
Se
% (No.)
Sp
% (No.)
PPV
% (No.)
NPV
% (No.)
Difficulty in breathing + 1.33 (1.37) 0.29 (0.49) - 67 (4/6) 71 (5/7) 67 (4/6) 71 (5/7)
Apnea + 0.67 (0.52) 0.29 (0.49) - 67 (4/6) 71 (5/7) 67 (4/6) 71 (5/7)
Snoring + 2.00 (0.89) 1.14 (0.90) - 100 (6/6) 29 (2/7) 55 (6/11) 100 (2/2)
Total Brouillette score > -1 - - - 50 (3/6) 71 (5/7) 60 (3/5) 63 (5/8)
Total Brouillette score 0.42 (2.62) -1.81 (1.76) 0.094 - - - -
OSAS = obstructive sleep apnea syndrome
SD = standard deviation
Se = sensitivity
Sp = specificity
PPV = positive predictive value
NPV = negative predictive value
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symptoms as used in this questionnaire ranged from 55% to 67%, of which snoring 
scored lowest. Specificity of snoring was low (29%) but showed the best NPV (100%).
Adult questionnaire
All 22 adults who underwent a PSG completed the full Epworth Sleepiness Scale. The mean 
scores of the OSAS and non-OSAS groups on the total Epworth Sleepiness Scale showed 
no significant difference (4.2 vs. 4.7, P = 0.729) (Table 3). The total score of the Epworth 
Sleepiness Scale showed a sensitivity, PPV and NPV of 0%, 0% and 57%, respectively.
When taking the severe OSAS group separately (as a subset) and comparing the mean 
total scores of the total Epworth Sleepiness Scale of the severe OSAS group with the non-
OSAS group again, no significant difference was found (4.3 vs. 4.7, P = 0.824). The question 
concerning whether a person was falling asleep while sitting and talking to someone 
showed the best PPV and NPV (100% and 72%, respectively); the score on this question 
showed a significant difference between the OSAS group and the non-OSAS group (0.4 
vs. 0.0, P = 0.035). The other question showing a significant difference was sitting quietly 
after a lunch without alcohol, which was scored higher in the non-OSAS group (0.1 vs. 0.6, 
P = 0.028).
DISCuSSION
The results of this cross-sectional cohort study show that the Epworth Sleepiness Scale 
and the Brouillette score are not useful in predicting OSAS in adults and children with 
TCS. The lack of differences between the severity of symptoms/complaints in the OSAS 
group and the non-OSAS group resulted in low values of sensitivity, PPV and NPV, and of 
the total scores of these two questionnaires.
Whereas the sensitivity of the Brouillette score in normal healthy children with OSAS 
is reported to be around 89%, in the present study the sensitivity was very low.22, 24 This 
might be because the most frequently scored complaint was snoring in children with 
TCS. The total score of this screening tool probably failed in our population because 
nearly all of the children in the present study snored.
Although the snoring question was not specific, the NPV of this question was high 
(100%) indicating that the answer “yes” to this question was not helpful, whereas the 
answer “no” was able to rule out OSAS in children.
The fact that almost all children snored is in accordance with a study in children with 
syndromic craniosynostosis in which 77% of the children reported to snore; therefore, 
this item could not be used to discriminate between OSAS and non-OSAS.25 That same 
study found that asking parents whether the child has difficulty (or not) in breathing 
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during sleep can exclude the presence of clinically significant OSAS.25 For this particular 
question we found a low sensitivity of 67% and an NPV of 71%.
Considering the low predictive values of the total score, the Brouillette score missed 
around 40% of the OSAS cases in children, based on the cutoff values as used in that 
score.
Currently, the most widely used self-reporting scale for excessive daytime sleepiness 
is the Epworth Sleepiness Scale as subjective screening for OSAS in normal healthy 
patients. However, we found that this scale has no sensitivity and no PPV (both 0%) to 
detect OSAS. Two items of the Epworth Sleepiness Scale showed a significant difference 
between the OSAS group and the non-OSAS group. Of these items, the question as to 
whether a person falls asleep while sitting and talking to someone (sometimes or more) 
showed the best PPV (100%). Although a positive answer to this question indicates the 
presence of OSAS, a negative answer did not rule out OSAS. Of all the eight questions, 
this latter question implies the most extreme daytime sleepiness and suggests hyper-
somnolence may still be a symptom of OSAS in our population. However, we think this 
is to a lesser overall degree than expected in a normal OSAS population, because all our 
total sleepiness scores were relatively low.
Surprisingly, the second significant item falling asleep while sitting quietly after a 
lunch without alcohol scored significantly higher in the non-OSAS group (showing very 
low PPV and NPV) and is therefore not useful for screening.
A possible explanation for the fact that the Epworth Sleepiness Scale in adult TCS 
patients is not discriminative for OSAS is that the patients are accustomed to these 
symptoms, probably having experienced them from birth. Furthermore, we have to bear 
in mind that the questionnaires were not filled in due to referral to a specialist because 
of complaints, but because we requested them to do so.
Limitations
Due to the relatively small study population the results of this study should be inter-
preted with caution.
CONCLuSION
This cross-sectional cohort study shows that the Epworth Sleepiness Scale and the 
Brouillette score are of minimal usefulness in TCS. A negative answer to the question 
snoring can rule out OSAS in children; however, although this question is helpful the 
PSG is still required as it is the only reliable screening tool. A diagnosis of OSAS based 
solely on complaints is not reliable, probably due to habituation. Therefore, for a good 
evaluation and optimal multidisciplinary treatment of this chronic disease in TCS, all 
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newly referred pediatric and adult TCS patients should be screened for OSAS at least 
once with PSG.
Future research should focus on the impact on the quality of life of these OSAS-related 
symptoms/complaints, rather than using these as a screening method for TCS.
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ABSTRACT
This prospective, cross-sectional cohort study included ambulant sleep study data to 
assess OSAS in patients with syndromic craniosynostosis and Treacher Collins syndrome. 
Laboratory analyses were performed including malondialdehyde, tumor necrosis factor 
α (TNF-α) , interleukin 6 and high-sensitivity C-reactive protein.
Forty-eight patients were included; 11 were adults; 37 were children. The patients' 
body mass indexes were normal, with a median (SD) of 0.7 (-1.82 to 2.48) in children 
and 20.5 (15.2  –  29.4) in adults. Obstructive sleep apnea syndrome was diagnosed in 
23 of 48 patients. It was mild (median obstructive apnea-hypopnea index (oAHI): 2.3; 
oxygenation-desaturation index (ODI), 0.9) in 16 patients and moderate/severe in sev-
enpatients (median oAHI, 10.8; ODI, 5.0). Neither oxidative stress nor inflammation had 
a correlation with the oAHI and ODI. Only TNF-α was found significantly higher in both 
the OSAS and non-OSAS groups compared with the reference values (median 15.1 pg/
mL and 12.3 pg/mL vs. 4.05 (0.0 - 8.1 pg/mL), P < 0.001 and P < 0.001, respectively).
Based on our findings we conclude that (mainly mild) OSAS, oxidative stress, as well as 
high-sensitivity C-reactive protein and interleukin 6 levels are not abnormal in the day 
time in a population of nonobese patients with a craniofacial anomaly. The increased 
level of TNF-α cannot be explained by OSAS. Future research should focus on mapping 
chronobiologic changes for further interpretation of the results.
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INTRODuCTION
Obstructive sleep apnea syndrome (OSAS) is highly prevalent in patients with craniofa-
cial anomalies. In most craniofacial anomalies, a genetic cause is known or suspected, 
including gene mutations in RUNX2, FGFR, TWIST, ALX3, MSX2 and TCOF1.1-5 This results in 
for example craniosynostosis and Treacher Collins syndrome, which is associated with a 
46% to 72% prevalence of OSAS owing to the anomalies of the development of the face 
and airway (Figure 1).6-9
OSAS is associated with hypoxia reoxygenation,10 which resembles ischemia reperfu-
sion. Together with recurrent arousals and changes in thoracic pressure, it may lead to 
a variety of responses including increased oxidative stress and systemic inflammatory 
responses.10-19 Oxidative stress is induced by the production of reactive oxygen species, 
hydrogen peroxide, and reactive nitrogen species and can be detected by measuring 
plasma levels of malondialdehyde (MDA) indicating the presence of oxidative stress-
induced lipid peroxidation. Consequently, apoptosis of endothelial cells and neurons 
may occur which induces cardiovascular comorbidity10, 13 and central nervous system 
dysfunction.19 It may also activate inflammatory pathways,10, 19 for example, by means of 
Figure 1: Causes and consequences of obstructive sleep apnea syndrome in craniofacial anomalies.
* Where MDA = malondialdehyde; TNF-α = tumor necrosis factor alfa; IL-6 = interleukine 6; hCRP = high 
sensitivity C-reactive protein
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up-regulation of the transcription factor nuclear factor κB.15 Cytokines are produced and 
released, including interleukin 1 (IL-1), interleukin 6, tumor necrosis factor α (TNF-α), and 
acute phase reactants such as C-reactive protein. These proinflammatory proteins can 
induce oxidative stress, and day-time sleepiness.13, 18
Previous research has shown that the levels of oxidative stress and the proinflamma-
tory proteins show a correlation with the severity of OSAS in both adults and children 
(Figure  1).12, 14, 16, 18, 20 We are the first to study to what extent OSAS exhibits oxidative 
stress and inflammation in patients who have a congenital, craniofacial anomaly.
MATERIALS AND METhODS
Participants
A prospective, cross-sectional cohort study was conducted at the Dutch Craniofacial 
Center from 2007 to 2011. The study was approved by the ethics committee of our 
institution (METC Erasmus MC MEC-2005-273 and MEC-2008-402). All children with syn-
dromic craniosynostosis and children and adults with Treacher Collins syndrome were 
diagnosed and/or underwent treatment at the Dutch Craniofacial Center. They were in-
vited to participate by means of written informed consent. Diagnosis of craniosynostosis 
was based on genetic analysis, including Apert syndrome, Crouzon/Pfeiffer syndrome, 
Muenke syndrome, and Saethre Chotzen syndrome. If no genetic mutation was found, 
the patients were classified as having “complex” craniosynostosis. Treacher Collins syn-
drome was mainly diagnosed clinically. After inclusion of a total of 94 patients, analyses 
were performed on a fixed number of 48 randomly selected patients (51%).
Sleep study
Overnight sleep respiratory recordings were captured using the Embletta Portable Diag-
nostic system and analyzed with Somnologica for Embletta software 3.3 ENU (Medcare 
Flaga, Reykjavik, Iceland).21 The following summary statistics, abnormalities and sleep 
data were analyzed by visual inspection.22 Apneas were scored if 80% of flow or greater 
was reduced during for the length of two breaths in children22 and for at least 10 seconds 
in adults. Apneas associated with ≥4% reduction in SpO2 from baseline were all included 
regardless of duration in all patients. Hypopnea was identified when flow was reduced 
50% or greater in the presence of thoracic and abdominal breathing movement.23 Hy-
popneas were only included if a subsequent reduction in SpO2 of 4% or greater from 
baseline occurred.
The summary statistics from the night sleep study included the apnea-hypopnea 
index (AHI), where the total number of obstructive as well as central and mixed apneas 
and pathologic hypopneas were indexed to the duration of sleep (i.e., episodes per hour 
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of sleep). This statistic was broken down into a combined obstructive and mixed apnea 
and pathologic hypopnea index (oAHI). A hemoglobin oxygenation-desaturation index 
(ODI) was calculated as the number of desaturations (≥4% from baseline) per hour of 
sleep time.
The severity of OSAS in children was graded as mild if the oAHI was 1 or greater and 
less than 5, moderate if the oAHI was 5 or greater and less than 25, and severe if the 
oAHI was 25 or greater.22-24 For adults, OSAS was defined as mild if AHI was 5 or greater 
and less than 15, moderate if AHI was 15 or greater and 30 or less, and severe if AHI was 
greater than 30 per hour.25-26
Blood samples
Daytime blood samples were collected during surgical procedures related to the cranio-
facial abnormality in children and at the outpatient department in adults. Laboratory 
analyses including Malondialdehyde (MDA), Tumor Necrosis Factor alfa (TNF-α), Inter-
leukin 6 (IL-6) and high sensitivity C-reactive protein (hCRP).
1. As a biomarker for oxidative stress malondialdehyde (MDA) was measured in plasma 
on a Waters Quattro Premier XE® Liquid Chromatography (LC) – Tandem Mass Spec-
trometry (MS/MS) system.
	 •	 MDA	in	plasma	was	first	deconjugated	by	alkaline	hydrolysis	and	subsequently	
quantitatively analyzed with LC-Electron Spray Ionisation (ESI)-MS/MS, using 
D2-MDA as an internal standard. The reference range in healthy individuals was 
4.6 - 9.4 µmol/L.
2. Inflammatory status was analyzed using TNF-α, IL-6 and hCRP determinations. They 
were run on the Immulite® Immunoassay System for which serum or heparinised 
plasma was used.
	 •	 TNF-α	was	analyzed	using	an	immunometric	assay.	The	range	varied	from	non-
detectable to 8.1 pg/mL in healthy individuals and the analytical sensitivity is 1.7 
pg/mL.
	 •	 IL-6	was	tested	with	a	solid-phase,	enzyme-labelled,	chemi-luminescent	sequen-
tial immunometric assay. The range varied from nondetectable to 5.9 pg/mL in 
healthy individuals and the analytical sensitivity is 2.0 pg/mL.
	 •	 hCRP	was	analyzed	using	an	immunometric	assay.	The	97.5th percentile was 11.0 
mg/L in healthy individuals and the analytical sensitivity is 0.1 mg/L.
Statistical analysis
Data are presented as median (range). Non parametric statistical tests were applied for 
all analyses. The Mann-Whitney U test and the one sample Wilcoxon signed rank test 
were applied for calculating differences between groups and testing of laboratory val-
ues against reference values, respectively. The Chi-squared test was used for differences 
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between gender. Correlations were calculated with the Spearman's test. All tests applied 
were two-sided and the significance level was set to 5%. Analyses were made in SPSS 
20.0 for Windows (SPSS, Inc., Chicago, IL, USA).
RESuLTS
A total of 48 patients were included (Table 1). This group consisted of 34 (71%) patients 
with craniosynostosis and 14 (29%) patients with Treacher Collins syndrome. Eleven 
were adults, median age 29.2 years (18.6  –  59.2), 37 were children, median age 9.2 
years (0.4 - 17.2). OSAS was diagnosed in 23/48 patients. It was mild (median oAHI: 2.3; 
ODI: 0.9) in 16 patients and moderate/severe in 7 patients (median oAHI: 10.8; ODI: 5.0) 
(Table 2.). The other patients (25/48, 52%) did not have OSAS (Table 1).
Table 1. Demographic characteristics.
OSAS (n=23) Non OSAS (n=25) Total (n=48)
Diagnosis
Syndromic craniosynostosis 18 16 34
Apert 5 4 9
Crouzon / Pfeiffer 6 8 14
Muenke 2 1 3
Saethre Chotzen 2 3 5
Complex 3 0 3
Treacher Collins syndrome 5 9 14
Age median (range) yrs 9.8 (0-59) 12.0 (1-50) 11.4 (0-59)
Sex
Male 10 14 24
Female 13 11 24
BMI
Children (n = 37) 0.70 (-1.82 - 2.30) 0.67 (-1.10 - 2.48) 0.7 (-1.82 - 2.48)
Adults (n = 11) 21.3 (15.2 - 25.5) 20.0 (15.7 - 29.4) 20.5 (15.2 – 29.4)
Availability laboratory results
MDA 23/23 (100%) 25/25 (100%) 48/48 (100%)
TNF-α 19/23 (83%) 20/25 (80%) 39/48 (81%)
IL-6 20/23 (87%) 20/25 (80%) 40/48 (83%)
hCRP 19/23 (83%) 20/25 (80%) 39/48 (81%)
Age (P = 0.14) and the distribution of sex (P = 0.39) was not different between patients with and without 
obstructive sleep apnea syndrome (OSAS). Body mass index was not different between patients with OSAS 
and without OSAS (Children U = 161.5; Z = -0.29; P-value = 0.78) (Adults U = 10.0; Z = -0.11; P = 1.00)
Where BMI = Body Mass Index in kg/m2;  MDA = Malondialdehyde; TNF-α = Tumor Necrosis Factor alfa; IL-6 
Interleukin 6; hCRP = high sensitivity C-reactive protein.
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The patients' BMI was normal with a median SD of 0.7 (-1.82 - 2.48) in children and 
a median BMI of 20.5 (15.2 – 29.4) in adults. BMI was not higher in patients with OSAS 
as compared to those without (children U = 161.5; Z = -0.29; P = 0.78) (adults U = 10.0; 
Z = -0.11; P = 1.00)
Oxidative stress did not have a correlation with the oAHI and ODI (Figures 2 and 3).
There were no statistically significant differences when comparing the OSAS group 
and the non-OSAS group, not even when only comparing patients with moderate to 
severe OSAS to those without OSAS (Table 2). MDA levels were not higher when testing 
OSAS patients against the reference values (median 6.6 µmol/L vs. 7.0 (4.6 - 9.4 µmol/L), 
P = 0.648).
Inflammatory parameters did not have a corlaon with the oAHI and ODI (Figures 2 and 
3). There were no statistically significant differences when comparing the OSAS group 
and the non-OSAS group, not even when comparing patients with moderate to severe 
OSAS to those without OSAS (Table 2).
IL-6 values were not higher when testing OSAS patients against the reference values 
(median 3.47 vs. 2.95 pg/mL (0.0 - 5.9 pg/mL), P = 0.167). hCRP values even were signifi-
Figure 2: Correlation of MDA, TNF-α, IL-6 and hCRP with the oAHI.
Where MDA = Malondialdehyde (pink; reference 4.6 to 9.4 µmol/L); TNF-α = Tumor necrosis factor alfa (blue; 
reference 0.0 to 8.1 pg/mL); IL-6 = Interleukine-6 (green; reference 0.0 to 5.9 pg/mL); hCRP = high sensitivity 
C-reactive protein (purple; reference 0.0 to 11.0 mg/L); oAHI = Obstructive Apnea-Hypopnea-Index.
Both scales are presented as a logarithm of the original values. Correlation MDA (r=0.18, =0.24). Correlation 
TNF-α (r=0.069. P=0.69). Correlation IL-6 (r=-0.17, P=0.33). Correlation hCRP (r=0.063, P=0.72).
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cantly lower in OSAS patients compared to reference values (median 0.54 vs. 5.5 mg/L 
(0.0 - 11.0 mg/L), P < 0.001).
TNF-α was found significantly higher in both the OSAS group and non-OSAS group 
compared to the reference values ((median 15.1 pg/mL and 12.3 pg/mL vs. 4.05 (0.0 - 8.1 
pg/mL), P < 0.001 and P < 0.001 respectively)). It was higher than reference values in 90% 
(26/29) of all patients with syndromic craniosynostosis and in 70% (7/10) of patients 
with Treacher Collins syndrome.
DISCuSSION
OSAS is highly prevalent in patients with craniofacial anomalies. It was never studied 
before to what extent it results in oxidative stress or systemic inflammation in these 
subjects with mild OSAS and without obesity.
Oxidative stress and its role in OSAS has increasingly prompted attention. To mea-
sure cellular damage, we used MDA as a marker which increases after degradation of 
the cellular membrane due to lipid peroxidation. Our results suggest that mild OSAS 
in non-obese patients does not induce daytime oxidative stress. A previous study27 in 
Figure 3: Correlation of MDA, TNF-α, IL-6 and hCRP with the ODI.
Where MDA = Malondialdehyde (pink; reference 4.6 to 9.4 µmol/L); TNF-α = Tumor necrosis factor alfa (blue; 
reference 0.0 to 8.1 pg/mL); IL-6 = Interleukine-6 (green; reference 0.0 to 5.9 pg/mL); hCRP = high sensitivity 
C-reactive protein (purple; reference 0.0 to 11.0 mg/L); ODI = Oxygenation Desaturation-Index. Both scales 
are presented as a logarithm of the original values. Correlation MDA (r=0.14 P=0.36). Correlation TNF-α (r=-
0.070. P=0.67). Correlation IL-6 (r=-0.27, P=0.097). Correlation hCRP (r=0.079, P=0.63).
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adults with severe OSAS (mean AHI 59 ± 5) measured increased values of thiobarbi-
turic acid-reactive substance (TBARS), which also reflects lipid peroxidation. The level 
of TBARS improved after CPAP treatment.27 Isoprostane, which is another measure for 
lipid peroxidation, was also found to be higher in moderate to severe OSAS (AHI >15) 
compared to mild OSAS (AHI 5 – 15) and no OSAS (AHI < 5) in adults.28 However, it was 
also significantly higher in smoking subjects29 and in obese subjects without OSAS as 
compared to lean subjects.28 On the contrary, lipid peroxidation was tested negative 
in other populations with different degrees of OSAS in both obese adult patients30 and 
children.31
Concerning inflammation, we found that IL-6 and hCRP were within the thresholds for 
normality; TNF-α levels were slightly increased independent of OSAS. None of the three 
markers for inflammation had a correlation with the severity of OSAS. Systemic inflam-
mation as indicated by hCRP has been reported before in pediatric OSAS32 but extensive 
analyses by Larkin and co-workers demonstrated that hCRP levels are only correlated 
with OSAS in case of AHI greater than 5.33 Other studies however have demonstrated 
an increased inflammatory state in patients with OSAS. The levels of hCRP and IL-6 were 
increased in adult patients with OSAS.34 It was also found that adults with OSAS (mean 
AHI 52.3) had an increased TNF-α level as compared to adults without OSAS (AHI 9.0).35 
Extrapolation of these data and comparison to ours is difficult since their patients with-
out OSAS have more abnormalities in sleep studies and more extensive co-morbidity.
It was of great interest to demonstrate increases in TNF-α-levels. Since they were un-
related to the respiratory parameters, OSAS is an improbable causal factor for increased 
TNF-α. It is also unlikely that the increased TNF-α-levels are due to systemic inflamma-
tion, since the other inflammatory markers were not found abnormal. Moreover, the 
majority of our population was paediatric and lean, excluding the major burdens of 
comorbidity. It is of clinical relevance however that TNF-α-levels were increased since 
prolonged exposure to low concentrations of TNF-α levels may result in cachexia.36 It 
was also previously found that TNF-α has sleep-enhancing potency, whereas for ex-
ample IL-6 does not.37-38 Physiologically, there is a circadian rhythm of TNF-α release with 
a nocturnal peak.  In patients with OSAS, this nocturnal peak may virtually disappear 
and an additional daytime peak may develop.37 Previous studies that addressed oxida-
tive stress and inflammation as a result of OSAS mainly drew blood samples in the early 
morning27-28, 30-31, 34-35 but because of  altered chronobiology day-time increases in both 
oxidative stress determinants and hCRP have also been observed.39-40
Because the increased TNF-α levels were unrelated to OSAS in our population, we ex-
plored the circadian expression of the genes associated with the craniofacial anomalies 
in the Circa database (Circadian Expression Profiles, National Heart Lung and Blood In-
stitute, U.S. Department of Health & Human Services). As compared to wild-type animals 
who have a normal function of the suprachiasmatic nucleus (or the "core clock"), it was 
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found that clock-mutant mice with TWIST, MSX2, FGFR2 or TCOF1 gene mutations reveal 
a cyclic pattern of end-organ metabolism with an inverted circadian rhythm. Hence, it 
might be possible that chronobiology is altered due to the genetic origin of the cranio-
facial anomalies. Dysfunction of the circadian core clock has not only been linked to 
OSAS, but also to mood disturbances and some psychiatric diseases.41
Increased TNF-α-levels have been previously linked to TWIST mutation (Saethre-
Chotzen syndrome1-2) and MSX2 mutation (Boston-type craniosynostosis3).4-5 It has been 
proposed that TNF-α, by means of inhibition of alkaline phosphatase, alters the path-
ways of osteoblast and osteoclast differentiation and apoptosis42-43 and therefore would 
be a cause of synostosis. On the contrary an increase in alkaline phosphatase was found 
in patients with Apert syndrome (as a result of a mutation in the fibroblast growth factor 
receptor 2 (FGFR 2) gene44; the gene that may also be affected in Crouzon or Pfeiffer 
syndrome45). To our knowledge, there has been no report on anomalies in TNF-α levels 
associated with Treacher Collins syndrome (TCOF1, POLR1D nor POLR1C genes46-47).
All together, possible explanations for the lack of evidence linking OSAS to oxidative 
stress and hCRP and IL-6 increases may reside in 1) a low overall severity of severe OSAS 
and 2) the absence of co-morbidities such as obesity. Increased TNF-α levels may be the 
result of an altered circadian rhythm, which is more likely to be present as a result of 
the genetic mutations rather than OSAS. It raises many additional questions for future 
research, including the need for laboratory studies with wild-type and mutant animal 
models regarding the previously mentioned genes. To conclude on the effect of OSAS 
on oxidative stress and inflammation, we first need to map the chronobiologic changes 
that come with the genetic mutations over at least 24 hours. Generally, (mild) OSAS 
was not associated with increased oxidative stress and systemic inflammatory day-time 
responses in a non-obese population with craniofacial anomalies.
68 Chapter IV
REFERENCES
 1.  el Ghouzzi V, Le Merrer M, Perrin-Schmitt F, et al. Mutations of the TWIST gene in the Saethre-
Chotzen syndrome. Nat Genet 1997: 15: 42-6.
 2.  Howard TD, Paznekas WA, Green ED, et al. Mutations in TWIST, a basic helix-loop-helix transcrip-
tion factor, in Saethre-Chotzen syndrome. Nat Genet 1997: 15: 36-41.
 3.  Jabs EW, Muller U, Li X, et al. A mutation in the homeodomain of the human MSX2 gene in a family 
affected with autosomal dominant craniosynostosis. Cell 1993: 75: 443-50.
 4.  Lee HL, Yi T, Woo KM, et al. Msx2 mediates the inhibitory action of TNF-alpha on osteoblast dif-
ferentiation. Exp Mol Med 2010: 42: 437-45.
 5.  Yousfi M, Lasmoles F, Lomri A, Delannoy P, Marie PJ. Increased bone formation and decreased 
osteocalcin expression induced by reduced Twist dosage in Saethre-Chotzen syndrome. J Clin 
Invest 2001: 107: 1153-61.
 6.  Plomp RG, Bredero-Boelhouwer HH, Joosten KF, et al. Obstructive sleep apnoea in Treacher Col-
lins syndrome: prevalence, severity and cause. Int J Oral Maxillofac Surg 2012: 41: 696-701.
 7.  Plomp RG, Joosten KF, Wolvius EB, et al. Screening for obstructive sleep apnea in Treacher-Collins 
syndrome. Laryngoscope 2012: 122: 930-4.
 8.  Al-Saleh S, Riekstins A, Forrest CR, et al. Sleep-related disordered breathing in children with 
syndromic craniosynostosis. J Craniomaxillofac Surg 2011: 39: 153-7.
 9.  de Jong T, Bannink N, Bredero-Boelhouwer HH, et al. Long-term functional outcome in 167 pa-
tients with syndromic craniosynostosis; defining a syndrome-specific risk profile. J Plast Reconstr 
Aesthet Surg 2010: 63: 1635-41.
 10.  Gozal D. Sleep, sleep disorders and inflammation in children. Sleep Med 2009: 10 Suppl 1: S12-6.
 11.  Amin RS, Carroll JL, Jeffries JL, et al. Twenty-four-hour ambulatory blood pressure in children with 
sleep-disordered breathing. Am J Respir Crit Care Med 2004: 169: 950-6.
 12.  Biltagi MA, Maguid MA, Ghafar MA, Farid E. Correlation of 8-isoprostane, interleukin-6 and cardiac 
functions with clinical score in childhood obstructive sleep apnoea. Acta Paediatr 2008: 97: 1397-
405.
 13.  Gozal D, Crabtree VM, Sans Capdevila O, Witcher LA, Kheirandish-Gozal L. C-reactive protein, 
obstructive sleep apnea, and cognitive dysfunction in school-aged children. Am J Respir Crit Care 
Med 2007: 176: 188-93.
 14.  Kheirandish-Gozal L, Capdevila OS, Tauman R, Gozal D. Plasma C-reactive protein in nonobese 
children with obstructive sleep apnea before and after adenotonsillectomy. J Clin Sleep Med 
2006: 2: 301-4.
 15.  Lavie L, Dyugovskaya L, Polyakov A. Biology of peripheral blood cells in obstructive sleep ap-
nea—the tip of the iceberg. Arch Physiol Biochem 2008: 114: 244-54.
 16.  Li AM, Chan MH, Yin J, et al. C-reactive protein in children with obstructive sleep apnea and the 
effects of treatment. Pediatr Pulmonol 2008: 43: 34-40.
 17.  Tam CS, Wong M, McBain R, Bailey S, Waters KA. Inflammatory measures in children with obstruc-
tive sleep apnoea. J Paediatr Child Health 2006: 42: 277-82.
 18.  Tauman R, Ivanenko A, O'Brien LM, Gozal D. Plasma C-reactive protein levels among children with 
sleep-disordered breathing. Pediatrics 2004: 113: e564-9.
 19.  Kim J, Hakim F, Kheirandish-Gozal L, Gozal D. Inflammatory pathways in children with insufficient 
or disordered sleep. Respir Physiol Neurobiol 2011: 178: 465-74.
 20.  Tauman R, O'Brien LM, Gozal D. Hypoxemia and obesity modulate plasma C-reactive protein and 
interleukin-6 levels in sleep-disordered breathing. Sleep Breath 2007: 11: 77-84.
Obstructive sleep apnea, oxidative stress and inflammatory parameters in craniofacial anomalies 69
4
 21.  Bannink N, Mathijssen IM, Joosten KF. Use of ambulatory polysomnography in children with 
syndromic craniosynostosis. J Craniofac Surg 2010: 21: 1365-8.
 22.  Ward SL, Marcus CL. Obstructive sleep apnea in infants and young children. J Clin Neurophysiol 
1996: 13: 198-207.
 23.  Guilleminault C, Lee JH, Chan A. Pediatric obstructive sleep apnea syndrome. Arch Pediatr Ado-
lesc Med 2005: 159: 775-85.
 24.  Goroza E, Sagy M, Sagy N, Bock K. Severity assessment of obstructive sleep apnea syndrome 
(OSAS) in pediatric patients. Clin Pediatr (Phila) 2009: 48: 528-33.
 25.  AASMTF. Sleep-related breathing disorders in adults: recommendations for syndrome definition 
and measurement techniques in clinical research. The Report of an American Academy of Sleep 
Medicine Task Force. Sleep 1999: 22: 667-89.
 26.  Epstein LJ, Kristo D, Strollo PJ, Jr., et al. Clinical guideline for the evaluation, management and 
long-term care of obstructive sleep apnea in adults. J Clin Sleep Med 2009: 5: 263-76.
 27.  Barcelo A, Miralles C, Barbe F, et al. Abnormal lipid peroxidation in patients with sleep apnoea. Eur 
Respir J 2000: 16: 644-7.
 28.  Minoguchi K, Yokoe T, Tanaka A, et al. Association between lipid peroxidation and inflammation 
in obstructive sleep apnoea. Eur Respir J 2006: 28: 378-85.
 29.  Simiakakis M, Kapsimalis F, Chaligiannis E, et al. Lack of Effect of Sleep Apnea on Oxidative Stress 
in Obstructive Sleep Apnea Syndrome (OSAS) Patients. PLoS One 2012: 7: e39172.
 30.  Alzoghaibi MA, Bahammam AS. Lipid peroxides, superoxide dismutase and circulating IL-8 and 
GCP-2 in patients with severe obstructive sleep apnea: a pilot study. Sleep Breath 2005: 9: 119-26.
 31.  Montgomery-Downs HE, Krishna J, Roberts LJ, 2nd, Gozal D. Urinary F2-isoprostane metabolite 
levels in children with sleep-disordered breathing. Sleep Breath 2006: 10: 211-5.
 32.  Goldbart AD, Tal A. Inflammation and sleep disordered breathing in children: a state-of-the-art 
review. Pediatr Pulmonol 2008: 43: 1151-60.
 33.  Larkin EK, Rosen CL, Kirchner HL, et al. Variation of C-reactive protein levels in adolescents: as-
sociation with sleep-disordered breathing and sleep duration. Circulation 2005: 111: 1978-84.
 34.  Yokoe T, Minoguchi K, Matsuo H, et al. Elevated levels of C-reactive protein and interleukin-6 
in patients with obstructive sleep apnea syndrome are decreased by nasal continuous positive 
airway pressure. Circulation 2003: 107: 1129-34.
 35.  Kobayashi K, Nishimura Y, Shimada T, et al. Effect of continuous positive airway pressure on 
soluble CD40 ligand in patients with obstructive sleep apnea syndrome. Chest 2006: 129: 632-7.
 36.  Fry M. Essential Biochemistry for Medicine. Wiley-Blackwell, 2011.
 37.  Entzian P, Linnemann K, Schlaak M, Zabel P. Obstructive sleep apnea syndrome and circadian 
rhythms of hormones and cytokines. Am J Respir Crit Care Med 1996: 153: 1080-6.
 38.  Krueger JM, Walter J, Dinarello CA, Wolff SM, Chedid L. Sleep-promoting effects of endogenous 
pyrogen (interleukin-1). Am J Physiol 1984: 246: R994-9.
 39.  Jordan W, Cohrs S, Degner D, et al. Evaluation of oxidative stress measurements in obstructive 
sleep apnea syndrome. J Neural Transm 2006: 113: 239-54.
 40.  Mills PJ, Natarajan L, von Kanel R, Ancoli-Israel S, Dimsdale JE. Diurnal variability of C-reactive 
protein in obstructive sleep apnea. Sleep Breath 2009: 13: 415-20.
 41.  Burioka N, Koyanagi S, Endo M, et al. Clock gene dysfunction in patients with obstructive sleep 
apnoea syndrome. Eur Respir J 2008: 32: 105-12.
 42.  Jimi E, Akiyama S, Tsurukai T, et al. Osteoclast differentiation factor acts as a multifunctional 
regulator in murine osteoclast differentiation and function. J Immunol 1999: 163: 434-42.
70 Chapter IV
 43.  Sampaio EP, Sarno EN, Galilly R, Cohn ZA, Kaplan G. Thalidomide selectively inhibits tumor necro-
sis factor alpha production by stimulated human monocytes. J Exp Med 1991: 173: 699-703.
 44.  Lomri A, Lemonnier J, Hott M, et al. Increased calvaria cell differentiation and bone matrix forma-
tion induced by fibroblast growth factor receptor 2 mutations in Apert syndrome. J Clin Invest 
1998: 101: 1310-7.
 45.  Kan SH, Elanko N, Johnson D, et al. Genomic screening of fibroblast growth-factor receptor 2 
reveals a wide spectrum of mutations in patients with syndromic craniosynostosis. Am J Hum 
Genet 2002: 70: 472-86.
 46.  Dixon MJ, Dixon J, Houseal T, et al. Narrowing the position of the Treacher Collins syndrome locus 
to a small interval between three new microsatellite markers at 5q32-33.1. Am J Hum Genet 1993: 
52: 907-14.
 47.  Dauwerse JG, Dixon J, Seland S, et al. Mutations in genes encoding subunits of RNA polymerases 
I and III cause Treacher Collins syndrome. Nat Genet 2011: 43: 20-2.


LONG-TERM RESULTS 
OF TREATMENT

Chapter V 
Long-term assessment of 
facial features and functions 
needing more attention 
in treatment of Treacher 
Collins syndrome
Raul G. Plomp
Sarah L. Versnel
Manouk J.S. van Lieshout
René M.L. Poublon
Irene M.J. Mathijssen
J Plast Reconstr Aesthet Surg. 2013 Aug;66(8):e217-26.
76 Chapter V
SuMMARy
Aim This study aimed to determine which facial features and functions need more at-
tention during surgical treatment of Treacher Collins syndrome (TCS) on the long term.
Method A cross-sectional cohort study was conducted to compare 23 TCS patients with 
206 controls (all  ≥18 years) regarding satisfaction with their face. The adjusted Body 
Cathexis Scale was used to determine satisfaction with the appearance of the different 
facial features and functions. Wishes for further treatment of these items were ques-
tioned. For each patient an overview was made of all facial operations performed, the 
affected facial features and the objective severity of the facial deformities.
Results Patients were least satisfied with the appearance of the ears, facial profile and 
eyelids, and with the functions hearing and nasal patency (P < 0.001). Residual defor-
mity of the reconstructed facial areas remained a problem in mainly the orbital area. 
The desire for further treatment and dissatisfaction was high in the operated patients, 
predominantly for eyelids reconstructions. Another significant wish was for improve-
ment of hearing.
Conclusion In patients with TCS, functional deficits of the face are shown to be as impor-
tant as the facial appearance. Particularly nasal patency and hearing are frequently im-
paired and require routine screening and treatment from intake onwards. Furthermore, 
correction of ear deformities and midface hypoplasia should be offered and performed 
more frequently. Residual deformity and dissatisfaction remains a problem, especially in 
reconstructed eyelids.
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INTRODuCTION
Treacher Collins syndrome (TCS) is an inherited autosomal dominant craniofacial dis-
order which affects about 1 in 50,000 live births.1 The phenotype of TCS encompasses 
a variety of craniofacial deformities (from mild to severe) which can affect all facial fea-
tures. The typical deformities occur bilaterally and include micrognatia, anti-mongoloid 
slant, coloboma of the eyelids and hypoplasia of the zygomatic bones.2 Complicated ear 
malformations such as meatal atresia (up to 36%) and microtia are frequently reported, 
as are absent, rudimentary or malformed parts of the ossicular chain,3-4 Together, these 
malformations result in a conductive hearing loss, possibly present in about 50% of the 
patients.5-6
From birth onwards, TCS patients frequently undergo surgery to create a more "nor-
mal" appearance and to improve facial functions. In their early years, treatment often 
focuses on respiratory management of problems associated with TCS, such as obstruc-
tive sleep apnea, speech and feeding problems, and significant lagophthalmus that may 
threaten the cornea.7-8 At a later stage, corrections of (peri)orbital area and orthognatic 
surgery are performed.8-14 Due to the multiple affected facial features and functions, and 
the variable presentation, treatment is complex and management has to be made on an 
individual basis.
It is generally assumed that reconstructive craniofacial surgery can ameliorate satis-
faction with facial appearance.15 However, a systematic review on satisfaction studies in 
plastic surgery revealed that, especially studies in craniofacial surgery, were underex-
posed (only 8% representing 14 of all 178 studies found).16-19 Studies on craniofacial sur-
gery in TCS consist mainly of expert opinions, case series or retrospective cohort studies 
with a limited number of cases.8, 11-12 Some present an overview (i.e. narrative reviews) on 
(surgical) treatment; however, because these are not systematic and are opinion based, 
they suffer from the same limitations as an expert opinion.9-10, 13-14
As a result, data on long-term outcomes of treatment in TCS are scarce. Only one de-
scriptive study based on six patients, and another study exploring short-term follow-up 
in 1987, were found;20-21 also, both those studies addressed psychosocial adjustment 
only. Furthermore, earlier studies had no control group and lacked a sufficient level of 
evidence (using patient-based outcome measures) to improve available evidence on 
TCS.20, 22-23 Therefore, it remains largely unknown whether affected facial features and 
functions have been sufficiently treated in the long term. As assessing outcome goals 
for patients with a complex and variable assortment of affected facial features and func-
tions can be difficult, the patient's own satisfaction with facial appearance and functions 
is considered a reliable outcome measure.19, 24
The present study aimed to determine which facial features and functions need more 
attention during treatment by: 1) assessing how satisfied TCS adults are with different 
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facial features and functions on the long term, also in comparison with a non-facially 
disfigured control group, and 2) establishing the patient's wish for further surgical treat-
ment of certain facial features and functions at an adult age, and the objective severity 
of residual deformity.
PATIENTS AND METhODS
Patient selection
A cross-sectional cohort study was conducted with a TCS group and a control group. Pa-
tients in the TCS group were included if they were aged ≥18 years, diagnosed with TCS, 
and had been treated by the craniofacial team of the Erasmus University Medical Center 
in the period 1975 through 2010. A control group (also aged  ≥18 years) consisted of 
patients without any physical disfigurement randomly selected from the waiting rooms 
of five general practitioner practices in Rotterdam. Exclusion criteria in both groups 
were: mental retardation, blindness or insufficient ability to speak/understand Dutch. 
The research protocol was approved by the Medical Ethical Committee of the Erasmus 
MC (MEC-2008-402).
Satisfaction with facial appearance and functioning
The adjusted Body Cathexis Scale (BCS; 37 items, figure 1) was used because this ques-
tionnaire contains more specific facial features than the original BCS (46 items) which 
comprised more features concerning the whole body.25 Satisfaction with features of 
the body and their function was scored on a 5-point Likert scale (1=very dissatisfied, 
2=dissatisfied, 3=neutral, 4=satisfied, 5=very satisfied). Of the 37 items, 24 dealt with 
physical appearance of which 14 items represented facial appearance; the remaining 
13 items dealt with facial functioning. The adjusted BCS was piloted and showed good 
internal consistency and reliability for facial appearance, facial function, body and total 
BCS scores.18
Facial reconstructive surgery
An overview was made of all types of reconstructive procedures performed in the TCS 
patients. Different types of procedures were classified for different facial regions, and 
dichotomized into having been performed or not. A comparison was made of the fre-
quency of dissatisfaction between operated and non-operated patients for the top five 
most dissatisfying facial features and functions, as rated by the patients.
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Adjusted Body Cathexis Scale
This questionnaire contains questions about how satisfied you are with the following features and functions of 
the body. Please encircle the level of satisfaction.
Continue to encircle whether you would consider a medical treatment or not
Would you like to change it with 
a medical treatment?
1 Hair 1 2 3 4 5 yes no
2 Smelling 1 2 3 4 5 yes no
3 Lower extremity (legs, knees, feet) 1 2 3 4 5 yes no
4 Sensibility nose (pain when touching) 1 2 3 4 5 yes no
5 Height 1 2 3 4 5 yes no
6 Cheeks 1 2 3 4 5 yes no
7 Mouth 1 2 3 4 5 yes no
8 Lower part trunk (hips, buttocks, genitalia) 1 2 3 4 5 yes no
9 Smiling 1 2 3 4 5 yes no
10 Nose 1 2 3 4 5 yes no
11 Closure of the eyelids 1 2 3 4 5 yes no
12 Eyebrows 1 2 3 4 5 yes no
13 Face (in total) 1 2 3 4 5 yes no
14 Facial profile 1 2 3 4 5 yes no
15 Vision 1 2 3 4 5 yes no
16 Neck 1 2 3 4 5 yes no
17 Middle part trunk (belly, waist) 1 2 3 4 5 yes no
18 Lacrimal function 1 2 3 4 5 yes no
19 Facial skin 1 2 3 4 5 yes no
20 Teeth 1 2 3 4 5 yes no
21 Forehead 1 2 3 4 5 yes no
22 Hearing 1 2 3 4 5 yes no
23 Shape of head 1 2 3 4 5 yes no
24 Ears 1 2 3 4 5 yes no
25 Weight 1 2 3 4 5 yes no
26 Lips 1 2 3 4 5 yes no
27 Elevating eyebrows 1 2 3 4 5 yes no
28 Upper part trunk (shoulders, breasts, chest) 1 2 3 4 5 yes no
29 Eyelids 1 2 3 4 5 yes no
30 Chewing 1 2 3 4 5 yes no
31 Chin 1 2 3 4 5 yes no
32 Taste 1 2 3 4 5 yes no
33 Upper extremities (arms, wrists, hands) 1 2 3 4 5 yes no
34 Smell of breath 1 2 3 4 5 yes no
35 Nasal patency 1 2 3 4 5 yes no
36 Eyes 1 2 3 4 5 yes no
37 Speech 1 2 3 4 5 yes no
1 = very dissatisfied
2 = dissatisfied
3 = neutral
4 = satisfied
5 = very satisfied
Figure 1. Adjusted Body Cathexis Scale
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Affected facial features
Three medical doctors (SLV, RGP, RMLP), all familiar with congenital craniofacial diseases, 
scored independently whether facial features were affected in each patient. This was 
done for 14 facial features, based on standardized photographs of the patients. In addi-
tion, a validated objective scoring list for severity of facial deformities was scored based 
on standardized recent (postoperative) photographs.26
Desire for further treatment
For all items in the BCS, the patient was questioned regarding their wish for further 
treatment.
Statistical analysis
The unpaired t-test was used to analyse differences in age between the two groups. For 
categorical data the Fisher exact test and the Chi-squared test were used (as appropriate). 
Measured values are reported as mean ± 1 standard deviation (SD) or median (range) as 
appropriate. Multivariate analysis of covariance (MANCOVA) was conducted to compare 
means between the cohorts with adjustment for age, gender and educational level. The 
Pearson correlation coefficient was used for the correlation between satisfaction and 
the scored objective severity of the facial deformity. All statistical tests were two-tailed 
with P≤0.05 as statistically significant. Analyses were performed with Statistical Package 
for the Social Sciences (SPSS) 17.0 for Windows (SPSS, Inc., Chicago, IL, USA).
RESuLTS
Population and demographic characteristics
In the period 1975 through 2010, 58 patients were diagnosed with TCS. In this period 
four patients died (two adults). Of the 54 remaining patients, 33 were aged ≥ 18 years. 
Ten patients did not participate: nine due to unwillingness and one was lost to follow-up. 
Finally, 23 (10 males) adults (70%) participated in the present study. The control group 
comprised 206 adults. A significant difference in age was found between the TCS group 
and the control group (Table 1).
Satisfaction with facial appearance
Of the 14 facial features, 10 were scored significantly lower in the TCS group versus 
the control group (Table  2). In the TCS cohort, mean scores showed that the top five 
items providing least satisfaction were "ears", "facial profile", "eyelids" "chin" and "teeth" 
(Table 2); patients were satisfied with the appearance of the nose.
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Satisfaction with facial functioning
Regarding facial functioning, a significant difference was found in 9/13 items between 
the TCS and control group (Table 3). In the TCS group, the top five BCS items providing 
the most dissatisfaction were "hearing", "nasal patency", "tearing of the eyes", "smelling" 
Table 1. Demographic characteristics of the study participants.
TCS (n=23) Control group (n=206) P-value for differences 
between the groups% Mean (SD) % Mean (SD)
Age (years) 34.57 (13.57) 43.57 (17.08) 0.048
Gender (%) 0.657
Male 43.5% 38.3%
Female 56.5% 61.7%
Education level (%) 0.256
Primary school 42.8% 25.5%
High school 33.4% 51.5%
Post graduation 23.8% 23.0%
* Categorical data for gender, education and marital status are displayed as frequency counts.
Table 2. Satisfaction with facial features in Treacher Collins syndrome (TCS) and wish for further treatment: 
outcomes of the adjusted Body Cathexis Scale
Body Cathexis Scale (1-5)
Facial features
Satisfaction with 
facial features
TCS group  
(n=23)
Satisfaction with 
facial features
Control group 
(n=206)
Differences 
between TCS and 
control group
Wish for further 
treatment in all 
TCS patients
Mean (SD) Mean (SD) P-value % (n)
Face (overall) 2.87 (0.92) 3.88 (0.69) < 0.001 39% (9/23)
1.* Ears 2.78 (1.20) 4.00 (0.67) < 0.001 22% (5/23)
2. Facial profile 2.87 (0.97) 3.77 (0.80) < 0.001 30% (7/23)
3. Eyelids 3.00 (1.07) 3.72 (0.94) < 0.001 35%(8/23)
4. Chin 3.13 (1.01) 3.95 (0.62) < 0.001 17% (4/23)
5. Teeth 3.17 (1.03) 3.59 (0.90) 0.035 17% (4/23)
6. Shape of head 3.26 (0.92) 3.93 (0.66) < 0.001 9% (2/23)
7. Cheeks 3.52 (0.95) 3.98 (0.67) 0.001 13% (3/23)
8. Facial skin 3.57 (0.84) 3.65 (0.94) 0.468 0% (0/23)
9. Lips 3.57 (0.73) 3.97 (0.65) 0.001 4% (1/23)
10. Nose 3.61 (0.84) 3.82 (0.80) 0.141 13% (3/23)
11. Neck 3.61 (0.99) 3.90 (0.73) 0.007 9% (2/23)
12. Eyebrows 3.87 (0.69) 3.89 (0.80) 0.399 0% (4/23)
13. Forehead 3.87 (0.55) 3.96 (0.59) 0.268 0% (0/23)
Multivariate analysis was applied with adjustment for age, gender and education level.
* Items of Body Cathexis Scale ranked ascending from least to most satisfied in Treacher Collins syndrome
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and "closure of eyelids". All these five items had a P value <0.001, except for "tearing of 
the eyes" (P = 0.012). (Table 3).
Facial reconstructive surgery
Ten reconstructive surgical procedures addressed the top five most dissatisfying facial 
"features" and five procedures addressed the most dissatisfying facial "functions" 
(Table 4). Median number of reconstructive surgeries was 3 (range 0-7), and age at "time 
of operation" ranged from 0-57 years. Most of the operations were performed for recon-
struction of the eyelids; 11 of the 22 (50%) affected patients had one or more surgical 
corrections for eyelids. The two most frequently performed surgical procedures were 
lateral canthopexias, and autologous bone grafts in the zygomatic region. A total of 19 
patients had an ear deformity, but only five patients (26%) underwent a correction of the 
external ear with an autologous reconstruction (three) or epithesis (two). Rhinoplasties 
were limited to two of 14 patients with an affected nose (14%); one had a nasal hump 
reduction and the other a cartilage graft for restoring tip projection with lateral oste-
otomies of the nasal bones. An otorhinolaryngologist was consulted in seven patients 
for screening/treatment of ear and hearing problems. Placement of a bone-anchored 
hearing aid (BAHA) was performed six times. Other otorhinolaryngological therapies 
Table 3. Satisfaction with facial functioning and wish for further treatment in Treacher Collins syndrome 
(TCS): outcomes of the adjusted Body Cathexis Scale
Body Cathexis Scale (1-5)
Facial functioning
Satisfaction with 
facial functioning 
TCS group
(n=23)
Satisfaction with 
facial functioning 
Control group 
(n=206)
Differences 
between TCS and 
control groups
Wish for further 
treatment in TCS
Mean (SD) Mean (SD) P value % (n)
1.* Hearing 2.68 (1.04) 3.84 (0.86) < 0.001 35% (8/23)
2. Nasal patency 3.00 (1.00) 3.76 (0.83) < 0.001 26% (6/23)
3. Lacrimal function 3.39 (0.89) 3.73 (0.90) 0.012 4% (1/23)
4. Smelling 3.48 (0.95) 4.08 (0.75) < 0.001 9% (2/23)
5. Closure of eyelids 3.52 (0.67) 4.09 (0.64) < 0.001 17% (4/23)
6. Chewing 3.55 (0.80) 3.94 (0.75) 0.009 13% (3/23)
7. Speech 3.55 (1.10) 4.08 (0.59) < 0.001 13% (3/23)
8. Smell of breath 3.57 (0.73) 3.73 (0.79) 0.200 13% (3/23)
9. Elevating eyebrows 3.65 (0.71) 4.02 (0.60) 0.001 0% (0/23)
10. Vision 3.65 (0.89) 3.53 (1.05) 0.935 22% (5/23)
11. Sensibility nose 3.78 (0.95) 3.94 (0.75) 0.277 0% (0/23)
12. Smiling 3.78 (0.85) 4.14 (0.63) 0.005 4% (1/23)
13. Taste 4.04 (0.64) 4.16 (0.55) 0.144 0% (0/23)
Multivariate analysis was applied with adjustment for age, gender and education level.
* Items ordered ascending from least to most satisfied in Treacher Collins syndrome
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concerned septoplasties (three), sleep endoscopies (two), speech therapy (one), tympa-
noplasty (one) and tracheotomy (one). Ophthalmological consultations concerned: viral 
conjunctivitis, problems with closure of eyelids based on cicatricial entropion/orbicular 
muscle paralysis and cataract.
Affected facial features
In TCS the median number of affected facial features was 9 (4-13). Overall, the most frequent-
ly affected facial features were eyelids (96%), facial profile (87%) and ears (83%)(Figure 2).
Figure 2. Facial features affected in adult patients with Treacher Collins syndrome (n=23).
Drawing of a patient with Treacher Collins syndrome. Frequency (%) and number (n) of patients affected in 
specific facial features are shown.
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 Postoperatively, the orbital zone was found to be the most "severely" affected compared 
to the other facial zones (Table 5). No correlation was found between a patient's satis-
faction of the total face and the residual objective severity of the deformity (r =-0.186 
P=0.396; Table 5).
Wish for further treatment
In the "non-operated affected" patients the average wish for further treatment of the 
four most dissatisfying facial features (teeth excluded) was 25% (range 13-35%) (Ta-
ble 4). Wish for further treatment in the "operated" patients was highest for the feature 
"eyelids" (5/11 after lateral canthopexia, and 4/6 after lower eyelid reconstruction). In 
the "non-operated" group, for "hearing" and "nasal patency" the percentage of those 
desiring for further treatment was 29% (5/17) and 16% (3/20), respectively.
DISCuSSION
This cohort study shows that long-term satisfaction with facial appearance is significant-
ly lower in TCS for the ears, facial profile and eyelids compared with the control group. 
Satisfaction with facial functioning is also significantly lower for hearing, nasal patency, 
lacrimal function and smelling. In the long-term, residual deformity is a significant prob-
lem in patients who underwent reconstructive surgery to address these facial features. 
A large proportion of the operated patients remains dissatisfied, while the desire for 
correction in the remaining patients was not sufficiently addressed.
Table 5. Objective severity of facial deformity in Treacher Collins patients on the long-term
Objective severity of facial deformity
Zones (range scores) † Long-term  
postoperative score
Mean (SD)
Correlation with satisfaction  
with total facial appearance
r (P-value)
Zone of the forehead (0-6) 0.88 (0.68) -
Zone of the nose (0-17) 2.01 (1.06) -
Zone of the orbits (0-31) 7.36 (2.73) -
Zone of the maxilla (0-4) 3.12 (0.83) -
Zone of the mouth (0-17) 0.48 (0.94) -
Zone of the mandible (0-5) 1.51 (1.02) -
Total score (0-80) 15.36 (5.03) -0.186 (0.396)
† Outcomes of three independent raters
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Satisfaction with facial appearance and functioning
Upper face
In overviews, treatment of the deformities of eyelids is well addressed.8-10, 14 In the pres-
ent study, TCS patients underwent repeated lateral canthopexias and/or lower eyelid 
reconstructions mainly with lateral pedicled myocutaneous transposition flaps of upper 
eyelid. Patients' dissatisfaction with the eyelids and their considerable wish for further 
treatment is not surprising when considering the severity of the residual deformity 
in the orbital zone. The soft-tissue deficiencies of the lower eyelid, hypoplasia of the 
zygoma, and dystopia of lateral canthi, result in a complex aesthetic and functional 
deficit in the orbital zone. To correct a lower eyelid, many aspects have to be taken into 
account, such as the position, mobility, tone, "volume" and continuity of the lower 
eyelid. However, also the presence of eyelashes, scars and contour deformities influence 
the aesthetic appearance. Unfortunately no single surgical procedure can address all 
these aesthetic aspects at one time and some aspects are difficult to correct. In addition, 
periorbital ossal deformities are difficult to correct at a young age and should preferably 
be treated when the face has matured.27-28 However, soft tissue can be improved locally 
by lipofilling. Concerning eye-related function, patients were least satisfied with lacrimal 
function and closure of the eyelids. Scarring, possible congenital orbicular muscle and 
infraorbital rim deficiencies, together with the too low position, can result in diminished 
mobility and closure of the eyelids. Drainage of tears is impaired for the same reasons, 
but also due to possible deformities of the lacrimal system, inferiorly displaced lateral 
canthi, and reduced blinking function of the lower eyelid.8, 29 However, details on lacri-
mal dysfunction in TCS are currently lacking. Moreover, vision loss and/or affected ocular 
structures are not well described; however, patients in our study were not particularly 
dissatisfied with this function. Interestingly, some studies report that vision loss might 
occur in about 37% of patients, and amblyopia and significant refractive errors in up to 
33% and 17%, respectively.30-31
Midface
The ears were frequently affected and patients were aesthetically least satisfied with it. 
Relatively few surgical interventions were performed in this area. Some overviews on 
the treatment of TCS do not mention external ear reconstruction in detail or do not suffi-
ciently emphasize the importance of these interventions.8-9 Only Posnick et al. described 
this procedure more extensively and advocated reconstruction at age 6 years.14, 32
Hearing scored the lowest in "functional" satisfaction. Only six patients received a 
BAHA at a relatively old age (range 9-54 years). Some overviews adequately discuss 
hearing problems.8, 10, 14 However, our results show that hearing rehabilitation requires 
more attention. A structural referral to an otorhinolaryngologist is indicated for 
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screening. Hearing rehabilitation must be undertaken as early as possible to initiate 
adequate language development in young children and to improve their integration 
within society. To achieve this, reconstruction of the external auditory canal or middle 
ear malformations in selected cases can be performed. Middle ear reconstruction may 
result in improved hearing, but was found insufficient to make a BAHA unnecessary.33 In 
addition, a recent study on conductive hearing loss in TCS showed that BAHA implanta-
tion can be accomplished with a very low rate of complications and with significant 
gain in hearing (39 dB on average).34 After gain of function, an (phased) external ear 
reconstruction can begin.
Our TCS patients were also dissatisfied with the feature "facial profile". Treatment of 
facial profile is addressed in Le Fort I, rhinoplasties and genioplasties. Patients were 
relatively satisfied after a mandibular advancement and Le Fort I osteotomy. Generally, 
more attention is paid to mandibular surgery. As a result, midface surgery is relatively 
underexposed in TCS; however, a Le Fort I osteotomy together with a mandibular ad-
vancement can significantly improve facial profile (and dental occlusion). Therefore, 
more attention should be paid to screening for maxillary hypoplasia, and a Le Fort I 
osteotomy should be considered more often.
Surprisingly, patients were not dissatisfied with nasal appearance and the overall wish 
for further treatment was only 2/14, despite the nose being frequently affected (61%). 
Nasal reconstruction is seldom (or not) mentioned in literature reviews.8, 11-12 However, 
Posnick et al. did describe nasal reconstruction10, 14 and suggested to perform a rhino-
plasty that includes osteotomies with in-fracture, reduction of the skeletal and carti-
laginous dorsal hump and removal of cephalic portions of the lower laterals and septal 
cartilage graft, to improve tip projection. In our opinion, nasal reconstruction should be 
offered if other deformities have been satisfactorily treated and after orthognatic and 
endonasal procedures have been performed.
Our TCS patients were significantly less satisfied with nasal patency and (probably due 
to the lower patency) with smelling. Endonasal surgery (septoplasty) was performed in 
only three patients. However, 6/20 of the "non-operated" patients were dissatisfied with 
nasal patency; this suggests an intrinsic nasal obstruction in patients with TCS. In addi-
tion, intrinsic nasal problems can have a causal relation with obstructive sleep apnea 
which is frequently present in TCS.7, 35 Earlier overviews do not mention problems with 
nasal functioning.8, 10-12, 14 This underlines the importance of a structural referral to an 
otorhinolaryngologist for complementary nasal investigation and treatment.8 Primarily 
restoring olfactory function is difficult to achieve, but nasal patency due to obstructions 
can be surgically ameliorated and may improve olfactory functions by means of a better 
passage through septoplasty.36-37
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Lower face
Before restoring chin protrusion, functional problems (like obstructive sleep apnea due 
to mandibular hypoplasia) should be excluded. Priority should be given to mandibular 
advancement instead of genioplasty in case of oro-/hypopharyngeal obstruction.7 In 
addition, instead of genioplasty, our patients were also satisfied with the chin after a 
mandibular distraction osteogenesis, and wish for further treatment was low.
One study found an improvement of facial appearance as rated by the TCS patients 
themselves in the short term postoperatively after periorbital reconstructions and 
mandibular advancement.20 However, there was no differentiation regarding specific 
facial features, and it remained unclear which surgical procedures were performed and 
whether they resulted in higher satisfaction. Our long-term results show that patients 
are relatively dissatisfied and no correlation exists between objective severity of the 
deformity and satisfaction with facial appearance.38
Considering our long-term results, in only  ≤50% of the patients the affected facial 
features (i.e., ears, facial profile, eyelids and chin) were surgically corrected. More at-
tention could be paid to corrections of ears and midface. In addition, there is often a 
discrepancy between satisfaction and the wish for further treatment. This might be 
because the patient's attention was focussed elsewhere, or because some surgical 
corrections were never discussed/suggested in the past. Obviously, optimising specific 
items in the general treatment does not warrant the success of overall treatment as this 
depends on long-term psychological functioning as well.38 In the overall stigma of be-
ing facially deformed, patients have to accept their deformity and the prejudices of the 
society. Therefore, especially in a syndrome such as TCS, a holistic approach covering 
all points of attention is challenging. Acquired data could form a "physical" basis for an 
evidence-based protocol management in which all patients receive the same screening 
at certain ages. Accordingly, the variability (i.e., severity) of the phenotype determines 
the treatment necessary.
Limitations
Facial functions were not objectively measured, but only the patients' own experience. 
Due to the lack of preoperative data on satisfaction we are unable to estimate the iso-
lated effect of surgery. Due to its rarity a relatively small sample size of the patient group 
was available and thus the power of the statistical analysis may be less strong. Consider-
ing the significance of the P values, it is unlikely that results would change dramatically 
with a larger patient group. However, it could still be that by using a patient group with 
a highly variable phenotype, significant differences are less easy to find in features that 
occur seldom.
90 Chapter V
CONCLuSIONS
In patients with TCS, functional deficits of the face are shown to be as important as 
the facial appearance. Particularly nasal patency and hearing are frequently impaired 
and require routine screening and treatment from intake onwards. Furthermore, cor-
rection of ear deformities and midface hypoplasia should be offered and performed 
more frequently. Residual deformity and dissatisfaction remains a problem, especially 
in reconstructed eyelids.
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ABSTRACT
Background In adults with severe congenital facial disfigurement, assessment of 
long-term psychological impact remains limited. This study determines the long-term 
psychological functioning in these patients and evaluates differences compared with 
patients with acquired facial disfigurement and a non–facially disfigured reference 
group. Also explored is the extent to which psychological functioning of the congenital 
group is related to satisfaction with facial appearance, fear of negative appearance 
evaluation by others, self-esteem, and severity of the facial deformity.
Methods Fifty-nine adults with severe congenital facial disfigurement, 59 adults with 
a traumatically acquired facial deformity in adulthood, and 120 non–facially disfigured 
adults completed standardized psychological, physical, and demographic question-
naires, including the Fear of Negative Appearance Evaluation Scale, the Rosenberg 
Self-Esteem Scale, the Hospital Anxiety and Depression Scale, the Achenbach Adult 
Self-Report, the 36-Item Short-Form Health Survey, and a visual analogue scale.
Results Adults with severe congenital facial disfigurement had relatively normal psy-
chological functioning but appeared more prone to internalizing problems than the 
non–facially disfigured adults. Compared with patients with an acquired facial defor-
mity, the congenital group displayed fewer problems on the physical component score 
of quality of life only. Satisfaction with facial appearance, fear of negative appearance 
evaluation, and self-esteem were good predictors of the different aspects of psychologi-
cal functioning, with the exception of the physical component score of quality of life.
Conclusions Improving satisfaction with facial appearance (by surgery), enhancing self-
esteem, or lowering fear of negative appearance evaluation (by psychological support) 
may enhance long-term psychological functioning. Future research should focus on the 
individual patient and risk factors for maladjustment.
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INTRODuCTION
In the literature, a lack of consensus exists concerning the issue of whether individuals 
with congenital facial deformities are more prone to develop psychological problems in 
the long term because of their deformity.1–3 On the one hand, studies report that adults 
with congenital facial deformities have a higher prevalence of psychological problems, 
next to problems with social functioning.4,5 These psychological problems consist of a 
reduced quality of life, more internalizing behavior, lower self esteem, increased depres-
sion and anxiety, and other problems.6–9 On the other hand, several studies report no 
significant increase of these psychological problems in this group.10–12 Moreover, some 
studies even conclude that they adjust psychosocially relatively well.1,10,13
Although psychological adjustment in people with disfigurement has been related to 
physical (visibility) and demographic characteristics,14,15 psychologically based charac-
teristics may be more relevant as predictors.3 The literature points out that it is not the 
“objective” severity of the deformity16,17 but rather the patient's level of satisfaction with 
his or her own appearance that influences psychological problems; greater dissatisfac-
tion with appearance seems to be a predictor for higher rates of anxiety and depression 
and a lower rate of quality of life and self-esteem.7,9,14 Furthermore, self-esteem itself 
and social anxiety are most commonly cited as being central to adjustment to physical 
disfigurement in general; however, results are equivocal, partly because of inconsistency 
in the measures and/or definitions of the constructs used.18 People with facial disfigure-
ment and low self-esteem are thought to be at risk for the development of psychological 
problems.19
In addition to a lack of consensus, assessment of long-term psychological function-
ing of adults with congenital craniofacial deformities also remains limited and studies 
suffer from methodologic issues.15,20,21 Previous studies comprised mostly patients with 
a cleft lip–  cleft palate deformity, had no control groups, used nonstandardized or 
nonvalidated measures, or had small sample sizes. The only available systematic review 
on psychosocial effects of having a cleft lip– cleft palate showed that only 15 of the 64 
included studies were specifically focused on adults.1 Only three of these studies used 
validated measures in combination with a nondisfigured reference group.8,13,22 Studies 
on other, more severe congenital craniofacial deformities suffer from small sample sizes 
because of the rarity of the cases.7
Furthermore, comparison with other relevant groups is limited. The question of 
whether adults with congenital craniofacial deformities suffer less from psychological 
sequelae than patients with a traumatically acquired facial deformity, as suggested in 
the literature, has little empirical support.23 Therefore, the present study was devised 
to (1) determine the impact of severe congenital facial disfigurement on long term 
psychological functioning; (2) evaluate whether patients with severe congenital facial 
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disfigurement differ from patients with acquired facial disfigurement regarding long-
term psychological functioning; and (3) explore the extent to which their psychological 
functioning is related to satisfaction with facial appearance, severity of the facial defor-
mity, fear of negative appearance evaluation by others (an aspect of social anxiety), and 
self-esteem.
PATIENTS AND METhODS
Study populations
Patients with a congenital deformity
Patients with rare facial clefts were chosen because they represent a wide spectrum of 
congenital facial deformities in all facial units in different sequences and with varying 
degrees of severity.24,25 Medical charts of the 123 patients with an extensive rare facial 
cleft (Treacher Collins, oblique/ paramedian/median Tessier clefts)24 who had surgical 
treatment between 1969 and 2009 at the Department of Plastic and Reconstructive 
Surgery of the Erasmus University Medical Center were reviewed. A total of 48 patients 
were excluded because they were dead (n =4), had incomplete data (n=9), were younger 
than 18 years (n=32), were mentally retarded (n =1), were blind (n =1), or had insufficient 
knowledge of the Dutch language (n=1). The remaining 75 patients were invited to 
participate.
Patients with an acquired facial deformity
This group consisted of patients who suffered from facial trauma at an adult age and 
had an operation between 1991 and 2007. Only patients with a minimum follow-up 
of two years after initial reconstruction were selected, because it was more likely that 
physical and/or psychological consequences of the trauma had stabilized. Medical 
charts of these patients were reviewed, and all patients with other visible congenital 
or traumatic disfigurements, or who had suffered from personal assault, were excluded. 
Of the remaining 140 patients, another 36 patients were excluded because they were 
dead (n = 2), had incomplete data (n =4), were younger than 18 years (n =21), or had 
insufficient knowledge of the Dutch language (n =9). As a result, 104 met the inclusion 
criteria.
Reference group without facial disfigurement
This reference group was composed of the patient population from five randomly se-
lected general practitioner practices in Rotterdam and of Erasmus Medical Center staff 
without any congenital or acquired visible deformity. They were recruited by means of 
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posters, and exclusion was based on criteria similar to those applied in the congenital 
group.
Design and procedure
A clinical-empirical cross-sectional design was used. Ethical approval was obtained from 
the local medical ethical committee (MEC-2006-121). A patient information form, ques-
tionnaires, an informed consent form, and a stamped return envelope were sent by mail 
to the home addresses of the patients; current addresses were checked with the mu-
nicipal population registry. Within one month, patients had to decide on participation. 
Patients could withdraw at any time. Patients who did not return their questionnaires 
within one month were contacted again by mail. If a patient declined to participate, his 
or her reason was requested by means of a telephone conversation. The reference group 
completed the same questionnaires at home and returned them by mail.
Assessments
Demographic information
This provided data on age, sex, and educational level.
Fear of negative appearance evaluation
The six-item Fear of Negative Appearance Evaluation Scale is a self-report assessment 
tool measuring apprehension about appearance evaluation on a five-point Likert scale. 
The Fear of Negative Appearance Evaluation Scale has good internal consistency and a 
convergent validity similar to measures of body image in the field of eating disorders.26
Self-esteem
The Rosenberg Self-Esteem Scale is a 10-item self-report inventory measuring self-
esteem on a four-point Likert scale.27 Good reliability and validity have been demon-
strated.28
Severity of facial disfigurement
Objective severity of facial disfigurement was scored independently by two experts in 
each patient of both patient groups based on recent standardized photographs and 
using the scoring list of Versnel et al., with an objective scoring approach for facial 
disfigurement.29
Anxiety and depression
The Hospital Anxiety and Depression Scale is a 14-item self-report measure based on a 
four-point Likert scale. It comprises two internal scales (i.e., Anxiety and Depression) and 
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has been found a robust and effective screening tool.30 A score of 11 and above indicates 
clinically significant levels of anxiety and depression.31
Adaptive functioning/behavioral problems
The Adult Self-Report assesses people's perception of their own functioning (age range, 
18 to 59 years). It consists of 126 items on problem behaviors, using a three-point Likert 
scale, which are categorized into subscales.32 The two broad band scales (i.e., Internal-
izing and Externalizing) and the Total Problem Score were used. Cutoff scores for the 
clinical range per age group and sex for these three total scores are available. Good 
reliability and validity have been demonstrated for the American version, and it has 
been used in Dutch population samples.32,33
Quality of life
The 36-Item Short-Form Health Survey is a 36-item measure of quality of life, including 
physical and mental health. The physical domain subscales are physical functioning, role 
problems, bodily pain, and general health. The mental domain subscales are vitality, 
social functioning, problems with work and daily activities attributable to emotional 
problems, and general mental health. The Physical and Mental Component Summary 
measures were used; they take the correlation among the eight 36-Item Short-Form 
Health Survey subscales into account and are calculated with U.S. norm scores from 1998 
as a reference point.34 With this norm-based scoring (mean (SD)) (50 (10)), an individual 
respondent's score on Physical Component Summary and Mental Component Summary 
below 45 implies a health status below the average range. Because these international 
norm scores were available, the reference group did not complete the 36-Item Short-
Form Health Survey to reduce the number of questionnaires. The 36-Item Short-Form 
Health Survey has good psychometric properties.35
Satisfaction with facial appearance
A visual analogue scale was used as a 100-mm continuous horizontal line anchored at 
the poles, with “very dissatisfied” at the left and “very satisfied” at the right pole, to mea-
sure the degree of satisfaction with the patient's current facial appearance. The visual 
analogue scale has shown reliability and validity in studies on facial appearance.8,10 Mea-
sures for body image36 (e.g., the Multidimensional Body-Self Relations Questionnaire) 
have not yet shown significant differences in studies on facially disfigured persons, not 
even when using the facial subscale.37 Therefore, the visual analogue scale was preferred.
Statistical analysis
The mean and SD were used for metric variables, and percentages were given for 
categorical variables. Fisher's exact test was used to analyze differences in categori-
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cal variables between independent groups. Comparison of means between the three 
groups was performed with analyses of covariance with adjustments for age, sex, and 
education level. The percentage of patients within the clinical range in each group was 
calculated with the raw scores according to the above-mentioned cutoff points for the 
Hospital Anxiety and Depression Scale and the Adult Self-Report. Differences in these 
percentages between groups were analyzed with a logistic regression analysis with two 
groups as outcome variable, and adjustments for age, sex, and education level (Hospi-
tal Anxiety and Depression Scale) or only education level (Adult Self-Report; because 
cutoff scores take age and sex into account). Comparison of the means of the Physical 
Component Summary and Mental Component Summary between the congenital group 
and the U.S. norm scores was performed with an unpaired t test. The predictive value of 
satisfaction with facial appearance, fear of negative appearance evaluation, self-esteem, 
and objective severity of facial disfigurement for the different aspects of psychologi-
cal functioning were analyzed using the method of multiple linear regression analysis 
(procedure Enter) to identify the importance of the predictors jointly. Statistical analysis 
was conducted with version 17.0 of the computer program SPSS (SPSS, Inc., Chicago, Ill.).
RESuLTS
Of the 75 rare facial cleft patients, 59 (79 percent) agreed to participate. The remaining 
16 patients refused: eight did not respond to the letters (four lived abroad), three had 
traumatic experiences with treatment, two refused because they had already talked 
about it to the media in the past, and three patients found it psychologically too difficult.
Of the 104 patients with a traumatically acquired facial disfigurement, 59 (57 percent) 
participated. The average time from injury to the assessments was seven years (range, 2 
to 16 years). The majority of the remaining patients in this group did not respond to the 
letters and could not be contacted; however, they did not differ from the sample studied 
on any demographic or surgical variables.
Demographic characteristics
Because the congenital deformity group showed significant differences compared with 
the acquired deformity patients on sex and age, and compared with the reference group 
on education level, all analyses were adjusted for sex, age, and education level (Table 1).
Differences between groups
There were no significant differences between the congenital and reference groups in 
the mean scores of anxiety and depression; Internalizing, Externalizing, and Total Behav-
ioral Problem scores; and the Physical and Mental Component Summary measures of 
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quality of life (Table 2). Mean scores of anxiety and depression fell within the “normal/
nonclinical” range in all three groups. The percentage of patients with a clinical level of 
anxiety was 11 percent in the congenital group, 11 percent in the acquired group, and 
3 percent in the reference group. After adjustments, the difference between the con-
genital group and the reference group was nonsignificant (p=0.29). Six percent in the 
congenital group, 9 percent in the acquired group, and 4 percent in the reference group 
demonstrated a clinical level of depression. Again, after adjustments, no significant dif-
ference was found between the congenital and reference groups (P = 0.66).
Externalizing and Total Problem Scores showed no significant difference on the 
percentage of patients within the clinical range between the congenital and reference 
groups. The values for Externalizing were as follows: congenital group, 10 percent; 
acquired group, 7 percent; reference group, 5 percent (p=0.56). The values for Total Prob-
lem Scores were as follows: congenital group, 11 percent; acquired group, 9 percent; 
reference group, 6 percent (P = 0.31). However, the congenital group had more patients 
within the clinical range on Internalizing problem scores (25 percent) than the reference 
group (13 percent), although the difference was not significant (P =0.08). In the acquired 
group, 21 percent of the patients had internalizing problems.
The only significant difference between the congenital and the acquired group was 
on the Physical Component Summary. The mean score of the acquired group was lower 
than the U.S. norm population, whereas the congenital group scored better. In the con-
Table 1. Demographic characteristics of the study groups
Groups Differences between groups (p)*
Congenital
(n = 59)
Acquired
(n = 59)
Reference
(n = 120)
Congenital vs. 
acquired
Congenital vs. 
reference
Sex % 0.01 0.73
Male 32.2 41.4 29.4
Age, yr 0.01 0.21
Mean 34.1 43.1 36.7
SD 12.9 14.6 16.4
Minimum/ maximum 18/74 18/84 18/79
Education level % 0.68 0.04
Primary school ** 35.1 27.6 17.2
High school** 47.4 55.2 59.5
Postgraduation** 17.5 17.2 23.3
Severity of facial deformity 0.001 -
Mean score 13.9 6.44 -
SD 7.65 5.0 -
*Corrected for multiple testing, α = 0.025 (two-tailed).
** Represent column percentages.
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genital group, 13 percent scored lower than 45 on the Physical Component Summary 
and 31 percent had a Mental Component Summary score lower than 45, implying a 
health status below the average range. The percentages of patients within the clinical 
range showed no significant difference between the congenital and acquired groups 
regarding anxiety (p=0.70), depression (P = 0.70), internalizing (P =0.73), externalizing 
(P = 0.66), or total behavioral problems (P =0.66).
Predictors of the psychological aspects
Apart from objective severity of the facial disfigurement, they all appear to be significant 
predictors (p value) for the different aspects of psychological functioning, except for the 
Physical Component Summary (Table 3). Self-esteem is the strongest predictor (β) for all 
aspects of psychological functioning; the higher the self-esteem, the better the psycho-
logical functioning. Satisfaction with facial appearance is not a significant predictor for 
externalizing problems.
The scores of the congenital deformity group on fear of negative appearance 
evaluation (18.02 ± 6.38) and satisfaction with facial appearance (4.26 ±2.19) were not 
significantly different from those of the acquired deformity group (fear of negative ap-
pearance evaluation, P = 0.19; satisfaction with facial appearance, P =0.54) but differed 
significantly from those of the reference group (fear of negative appearance evaluation, 
P  =0.001; satisfaction with facial appearance, P  =  0.001). The scores of the congenital 
group on self-esteem (31.81±5.16) did not differ significantly from those of the acquired 
group (P = 0.64) or the reference group (P = 0.07).
Table 2. Differences between groups on psychological aspects
Mean† (SD) Group scores Differences in group scores (p)*
Psychological aspects Congenital
(n = 59)
Acquired
(n = 59)
Reference
(n = 120)
Congenital vs. 
acquired
Congenital vs. 
reference
Anxiety 4.3 (3.9) 5.0 (4.0) 3.8 (3.9) 0.40 0.54
Depression 4.1 (3.7) 5.4 (3.6) 4.4 (3.6) 0.08 0.76
Internalizing 15.3 (10.8) 14.3 (10.9) 12.2 (10.7) 0.99 0.10
Externalizing 9.3 (6.3) 8.5 (6.4) 7.2 (6.3) 0.86 0.08
Total problem** 43.1 (24.5) 39.5 (24.7) 34.3 (24.4) 0.86 0.06
PCS 52.0 (8.4) 47.8 (8.4) - 0.02 0.13***
MCS 51.6 (10.2) 50.6 (10.3) - 0.68 0.23***
† Adjusted for mean values of age, sex and education level.
*Corrected for multiple testing, α = 0.025 (two-tailed).
** Total problem score (Adult Self-Report).
*** Calculated with 1998 U.S. norm scores as the reference group. For PCS, mean (SD) = 50 (10), n = 6742; 
for MCS, mean (SD) = 50 (10), n = 6742
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DISCuSSION
This study demonstrates that adults with severe congenital facial disfigurement appear 
to have rather “normal” psychological functioning. No differences were found on mean 
scores of anxiety, depression, behavioral problems, or quality of life between the three 
groups, with the exception of the Physical Component Summary. Despite the normal 
group scores, it is important not to overgeneralize to the individual.3 This is supported 
by the fact that a subset of patients of the congenital group scored within the clinical 
range on the different psychological aspects: 11 percent had anxiety, 6 percent had 
depression, 10 percent had externalizing problems, and 25 percent had internalizing 
problems. Therefore, although the latter was not significant, adults with congenital 
facial deformities seem prone to internalizing problems. Regarding quality of life, the 
Mental Component Summary was below the average range in 31 percent of the patients 
in the congenital group, and the Physical Component Summary was below the average 
range in 13 percent of the patients. This implies that despite a normal quality of life in 
the congenital group, attention should be paid to the presence of mental distress in 
each individual.
Several studies support positive psychological adjustment in patients with congenital 
craniofacial deformities.1,38 In most studies, little attention is paid to normal results, and 
it seems difficult to accept that people manage to live a relatively normal life with a 
severe disfigurement.39,40 How do we interpret the rather normal psychological function-
ing found in the present study?
First, change in internal standards, values, and meaning of quality of life can cause an 
adaptation process, resulting in a good self-perceived quality of life and psychological 
Table 3. Predictors of psychological aspects
Psychological aspects
Candidate predictors
p β
SFA FNAE SE OS SFA FNAE SE OS
Anxiety 0.01 0.01 0.001 0.64 -0.45 0.35 -0.64 -0.08
Depression 0.001 0.001 0.001 0.94 -0.53 0.50 -0.71 -0.01
Internalizing 0.02 0.01 0.001 0.05 -0.40 0.42 -0.61 0.12
Externalizing 0.06 0.02 0.01 0.69 -0.31 0.36 -0.51 -0.07
Total problem 0.02 0.01 0.001 0.82 -0.38 0.38 -0.57 0.04
PCS 0.17 0.44 0.17 0.48 0.18 -0.10 0.19 -0.09
MCS 0.01 0.01 0.001 0.62 0.48 -0.42 0.71 0.18
β, standardized regression coefficient; SFA, satisfaction with facial appearance; FNAE, fear of negative ap-
pearance evaluation; SE, self-esteem; OS, objective severity of the facial disfigurement; PCS, Physical Com-
ponent Summary; MCS, Mental Component Summary.
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functioning. Mechanisms to achieve this are coping, social comparisons, and adjustment 
of goals and expectations.41
Second, facial deformity is one of many naturally occurring stressors in life that must 
be adapted to.39 People without a facial deformity also have to deal with all types of 
occurring/immanent stressors that can have an impact on psychological functioning 
comparable to a facial deformity.
Third, methodologic issues could explain the lack of differences in psychological 
functioning. Disease- specific questionnaires reveal more differences than generic ques-
tionnaires; therefore, more questions related to facial appearance should be used. In 
addition, as demonstrated above, an individual approach seems important and should 
not be conducted by psychometric tests only.42
Looking at the differences between the congenital deformity and acquired deformity 
populations, the acquired deformity group suffered significantly more from physical 
problems (Physical Component Summary) than the congenital deformity group. This 
implies that adaptation to physical problems might take a long time, or that trau-
matically acquired facial disfigurement could be related to more physical impairment. 
Furthermore, because congenital deformities occur before memory, a patient has no 
knowledge of how life would be without the disfigurement and concomitant physical 
problems.43
The scores on the Mental Component Summary imply that both groups have no 
psychological distress. Thus, the fact that people with a congenital facial deformity 
have had more time to get used to their deformity does not result in better long-term 
psychological functioning.
Previous studies on facial trauma patients report more anxiety, depression, and 
psychological stress compared with the normal population.44,45 However, in contrast to 
the present study, these latter studies were conducted in acute settings and assessed 
patients with concomitant injury and assault; this might explain the better outcome in 
the present study.
Concerning the evaluation of predictive factors, self-esteem appears the strongest 
predictor for all aspects of psychological functioning. Therefore, when low, self-esteem 
should be assessed and ameliorated by psychological support.
Objective severity has no predictive value for psychological distress, but self-perceived 
satisfaction with facial appearance does. Therefore, during treatment, patients' realistic 
wishes and expectations regarding their facial appearance should be taken into account. 
Fear of negative appearance evaluation appeared to be a good predictor of psycho-
logical functioning. Therefore, psychological support should also be focused on training 
patients to rely less on the opinions of others. Physical problems are not influenced by 
the examined predictors.
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One of the limitations of the present study is the possible selection bias, although the 
participation rate in the congenital deformity group (79 percent) and the traumatically 
acquired deformity group (57 percent) can be considered relatively high compared with 
other studies21,38; nevertheless, outcomes in both of these groups may be worse than 
presented here. Also, the reference group consisted of a mixture of people, which might 
bias the outcomes. To enable better comparison, the significant baseline characteristics 
among the three groups were statistically adjusted in all analyses. Furthermore, not all 
aspects of psychological functioning and predicting factors were evaluated. The fact 
that the reference group did not complete the 36-Item Short-Form Health Survey is an 
additional limitation of this study.
CONCLuSIONS
Adults with congenital facial disfigurement have rather normal psychological function-
ing but are more prone to internalizing problems. They differ from patients with an 
acquired facial deformity only on physical problems. Improving the patient's satisfaction 
with his or her facial appearance by surgery, and improving self-esteem or lowering fear 
of negative appearance evaluation by psychological treatment, may enhance long-term 
psychological functioning over the long term. Therefore, future research should focus 
on the individual patient and risk factors for maladjustment rather than on group com-
parisons, also because of the inconsistency of the results published.
Facial deformity psychological sequelae 107
6
REFERENCES
 1.  Hunt O, Burden D, Hepper P, Johnston C. The psychosocial effects of cleft lip and palate: A system-
atic review. Eur J Orthod.2005;27:274–285.
 2.  Wehby GL, Cassell CH. The impact of orofacial clefts on quality of life and healthcare use and 
costs. Oral Dis. 2010; 16:3–10.
 3.  Thompson A, Kent G. Adjusting to disfigurement: Processes involved in dealing with being visibly 
different. Clin Psychol Rev. 2001;21:663–682.
 4.  Clifford E, Crocker EC, Pope BA. Psychological findings in the adulthood of 98 cleft lip-palate 
children. Plast Reconstr Surg. 1972;50:234–237.
 5.  Peter JP, Chinsky RR. Sociological aspects of cleft palate Adults: I. Marriage. Cleft Palate J. 
1974;11:295–309.
 6.  Sinko K, Jagsch R, Prechtl V, Watzinger F, Hollmann K, Baumann A. Evaluation of esthetic, func-
tional, and qualityof- life outcome in adult cleft lip and palate patients. Cleft Palate Craniofac J. 
2005;42:355–361.
 7.  Sarwer DB, Bartlett SP, Whitaker LA, Paige KT, Pertschuk MJ, Wadden TA. Adult psychological func-
tioning of individuals born with craniofacial anomalies. Plast Reconstr Surg. 1999; 103:412–418.
 8.  Marcusson A, List T, Paulin G, Akerlind I. Reliability of a multidimensional questionnaire for adults 
with treated complete cleft lip and palate. Scand J Plast Reconstr Surg Hand Surg. 2001;35:271–278.
 9.  Ramstad T, Ottem E, Shaw WC. Psychosocial adjustment in Norwegian adults who had undergone 
standardised treatment of complete cleft lip and palate: I. Education, employment and marriage. 
Scand J Plast Reconstr Surg Hand Surg. 1995;29:251–257.
 10.  Oosterkamp BC, Dijkstra PU, Remmelink HJ, et al. Satisfaction with treatment outcome in bilateral 
cleft lip and palate patients. Int J Oral Maxillofac Surg. 2007;36:890–895.
 11.  Mani M, Carlsson M, Marcusson A. Editor's Choice: Quality of life varies with gender and age 
among adults treated for unilateral cleft lip and palate. Cleft Palate Craniofac J. 2010; 47:491–498.
 12.  Versnel SL, Duivenvoorden HJ, Passchier J, Mathijssen IM. Satisfaction with facial appearance and 
its determinants in adults with severe congenital facial disfigurement: A casereferent study. J 
Plast Reconstr Aesthet Surg. 2010;63:1642– 1649.
 13.  Marcusson A, Paulin G, Ostrup L. Facial appearance in adults who had cleft lip and palate treated 
in childhood. Scand J Plast Reconstr Surg Hand Surg. 2002;36:16–23.
 14.  Rumsey N, Clarke A, White P, Wyn-Williams M, Garlick W. Altered body image: Appearance-related 
concerns of people with visible disfigurement. J Adv Nurs. 2004;48:443– 453.
 15.  Robinson E. Psychological research on visible differences in adults. In: Lansdown R, Rumsey N, 
Bradbury E, Carr T, Partridge J, eds. Visibly Different: Coping with Disfigurement. Oxford: Butter-
worth-Heinemann; 1997:102–120.
 16.  Love B, Byrne C, Roberts J, Browne G, Brown B. Adult psychosocial adjustment following child-
hood injury: The effect of disfigurement. J Burn Care Rehabil. 1987;8:280–285.
 17.  Malt UF, Ugland OM. A long-term psychosocial follow-up study of burned adults. Acta Psychiatr 
Scand Suppl. 1989;355: 94–102.
 18.  Rumsey N, Harcourt D. Body image and disfigurement: Issues and interventions. Body Image 
2004;1:83–97.
 19.  Lefebvre A, Munro I. The role of psychiatry in a craniofacial team. Plast Reconstr Surg. 1978;61:564–
569.
 20.  De Sousa A. Psychological issues in oral and maxillofacial reconstructive surgery. Br J Oral Maxil-
lofac Surg. 2008;46:661–664.
108 Chapter VI
 21.  Kapp-Simon KA. Craniofacial conditions. In: Sarwer DB, Pruzinsky T, Cash TF, Goldwyn RM, Persing 
JA, Whitaker LA, eds. Psychological Aspects of Reconstructive and Cosmetic Plastic Surgery: Clinical, 
Empirical, and Ethical Perspectives. Philadelphia: Lippincott Williams & Wilkins; 2006:63–81.
 22.  Berk NW, Cooper ME, Liu YE, Marazita ML. Social anxiety in Chinese adults with oral-facial clefts. 
Cleft Palate Craniofac J. 2001;38:126–133.
 23.  Pruzinsky T. Body image adaptation to reconstructive surgery for acquired disfigurement. In: Cash 
T, Pruzinsky T, eds. Body Image: A Handbook of Theory, Research, and Clinical Practice. New York: 
Guilford Press; 2002:440–449.
 24.  Tessier P. Anatomical classification facial, cranio-facial and latero-facial clefts. J Maxillofac Surg. 
1976;4:69–92.
 25.  van der Meulen JC, Mazzola R, Vermey-Keers C, Stricker M, Raphael B. A morphogenetic classifica-
tion of craniofacial malformations. Plast Reconstr Surg. 1983;71:560–572.
 26.  Lundgren JD, Anderson DA, Thompson JK. Fear of negative appearance evaluation: Development 
and evaluation of a new construct for risk factor work in the field of eating disorders. Eat Behav. 
2004;5:75–84.
 27.  Rosenberg M, ed. Society and the Adolescent Self-Image (revised edition). Middletown, Conn: 
Wesleyan University Press; 1989.
 28.  Schmitt DP, Allik J. Simultaneous administration of the Rosenberg Self-Esteem Scale in 53 nations: 
Exploring the universal and culture-specific features of global self-esteem. J Pers Soc Psychol. 
2005;89:623–642.
 29.  Versnel SL, Mulder PG, Hovius SE, Mathijssen IM. Measuring surgical outcomes in congenital 
craniofacial surgery: An objective approach. J Craniofac Surg. 2007;18:120–126.
 30.  Bjelland I, Dahl AA, Haug TT, Neckelmann D. The validity of the Hospital Anxiety and Depression 
Scale: An updated literature review. J Psychosom Res. 2002;52:69–77.
 31.  Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 
1983;67:361–370.
 32.  Achenbach TM, Rescorla LA. Manual for the ASEBA: Adult Forms & Profiles. Burlington, Vt: University 
of Vermont, Research Center for Children, Youth, & Families; 2003.
 33.  Reef J, Diamantopoulou S, van Meurs I, Verhulst F, van der Ende J. Child to adult continuities of 
psychopathology: A 24-year follow-up. Acta Psychiatr Scand. 2009;120:230–238.
 34.  Ware JE Jr, Kosinski M, Gandek B, et al. The factor structure of the SF-36 Health Survey in 10 coun-
tries: Results from the IQOLA Project. International Quality of Life Assessment. J Clin Epidemiol. 
1998;51:1159–1165.
 35.  Ware JE Jr, Snow KK, Kosinski M, Gandek B. SF-36 Health Survey: Manual and Interpretation Guide. 
Boston: Nimrod Press; 1993.
 36.  Ching S, Thoma A, McCabe RE, Antony MM. Measuring outcomes in aesthetic surgery: A compre-
hensive review of the literature. Plast Reconstr Surg. 2003;111:469–480; discussion 481–482.
 37.  Levine E, Degutis L, Pruzinsky T, Shin J, Persing JA. Quality of life and facial trauma: Psychological 
and body image effects. Ann Plast Surg. 2005;54:502–510.
 38.  Lansdown R. Psychological problems of patients with cleft lip and palate: Discussion paper. J R 
Soc Med. 1990;83: 448–450.
 39.  Eiserman W. Unique outcomes and positive contributions associated with facial difference: 
Expanding research and practice. Cleft Palate Craniofac J. 2001;38:236–244.
 40.  Clifford E. Why are they so normal? Cleft Palate J. 1983;20: 83–84.
 41.  Sprangers MA, Schwartz CE. Integrating response shift into health-related quality of life research: 
A theoretical model. Soc Sci Med. 1999;48:1507–1515.
Facial deformity psychological sequelae 109
6
 42.  Broder H, Strauss RP. Self-concept of early primary school age children with visible or invisible 
defects. Cleft Palate J. 1989;26:114–117; discussion 117–118.
 43.  Robinson E, Rumsey N, Partridge J. An evaluation of the impact of social interaction skills training 
for facially disfigured people. Br J Plast Surg. 1996;49:281–289.
 44.  Shepherd JP, Qureshi R, Preston MS, Levers BG. Psychological distress after assaults and accidents. 
BMJ. 1990;301:849–850.
 45.  Bisson JI, Shepherd JP, Dhutia M. Psychological sequelae of facial trauma. J Trauma 1997;43:496–
500.

THE NOSE: ENDONASAL 
AND EXTERNAL 
NASAL DEFORMITY 
AND SATISFACTION 
WITH FUNCTION AND 
APPEARANCE

Chapter VII 
Nasal sequelae of 
Treacher Collins syndrome
Raul G. Plomp
Irene M.J. Mathijssen
Sanne E. Moolenburgh
Kees. A.G.M. van Montfort
Jacques J.N.M. van der Meulen
René M.L. Poublon
J Plast Reconstr Aesthet Surg. 2015 Mar 14. [Epub ahead of print] 
114 Chapter VII
ABSTRACT
Objective This study aimed to determine external and endonasal deformity, and satis-
faction with nasal functioning and appearance, in Treacher Collins syndrome.
Study design Cross-sectional cohort study.
Methods Eleven adult Treacher Collins patients were compared with 151 controls 
regarding satisfaction with nasal functioning and appearance by means of the Nasal 
Appearance and Function Evaluation Questionnaire. In all patients with Treacher Col-
lins external nasal deformities were scored on standardized digital photographs of the 
nose as rated independently by three experienced physicians. Endonasal deformity was 
determined by standardized nasal endoscopy.
Results Patients were relatively satisfied with the various esthetic nasal subunits. The 
most significant functional problems were snoring (P=0.001) and quality of phonation 
(P=0.003). The main external nasal deformities were the dorsal hump (73%), external 
deviation (≤ 55%), the bifid or bulbous nasal tip (55%), and columellar septal luxation 
(55%). In 82% of the patients a septal deviation was found, often associated with spurs.
Conclusion Satisfaction with esthetics of the nose was fair, but these patients suffer 
from the functional problems of snoring and impaired quality of phonation. A struc-
tured nasal ENT physical examination with nasal endoscopy might determine aspects 
requiring more attention during treatment. Septorhinoplasty can be performed at an 
adult age if there is a considerable esthetic wish of the patient and/or nasal obstruction 
combined with septal deviation. Attention should be paid to dorsal hump reduction, 
correction of deviated external osseous framework, septoplasty, and correction of the 
nasal tip shape.
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INTRODuCTION
Treacher Collins syndrome is a rare congenital craniofacial syndrome with an incidence 
of 1 in 50,000 live births and an autosomal dominant inheritance pattern.1-3 In this 
syndrome, craniofacial deformities consist of bilateral defects in the periorbital region, 
mandibular hypoplasia and hypoplasia of zygoma and microtia, and middle-ear defor-
mities.4 Treacher Collins syndrome is mainly caused by mutations in TCOF1 which com-
promise the ability of neuroepithelial cells to proliferate during early embryogenesis, 
leading to neuro-epithelial apoptosis (programmed cell death) and, finally, affecting 
development of the first and second pharyngeal arch. Haploinsufficiency of TCOF1 
causes hypoplasia of the frontonasal and maxillary regions, cleft palate, and mandibular 
hypoplasia.5-6 Other causative mutations for Treacher Collins syndrome can be found in 
POLR1D and PORLR1C.3
Although the nose can be severely affected, as illustrated by a case report of arhinia,7 
the nose is not always mentioned as a craniofacial feature in Treacher Collins syndrome.8 
Only one study in 1989 performed morphometry of the external nose in Treacher Col-
lins (mainly in children), and only one group has reported a possible surgical treatment 
for the deformities as described by Farkas and Posnick in 1989.9-11 In addition, current 
treatment overviews seldom (or never) describe nasal reconstruction or other methods 
of treatment of the nose.12-15 Moreover, these few specific overviews/studies describe 
only the external nose and do not include nasal functioning. However, nasal function-
ing warrants attention because intrinsic nasal problems can have a causal relation with 
obstructive sleep apnea, which is frequently present in Treacher Collins syndrome.16-18 
Although other upper airway deformities have (to some extent) been described in 
Treacher Collins syndrome endonasal deformities have not - even though this is essen-
tial to at least exclude them as a focus of obstructive sleep apnea.19-20 In general, there is 
a lack of literature and data on nasal deformity and nasal functioning in Treacher Collins 
syndrome.
Therefore, in adult patients with Treacher Collins syndrome, the present study aimed 
to determine: 1) patients' problems with nasal functioning, and their satisfaction with 
nasal appearance, using a validated questionnaire compared with controls; physicians' 
assessment of: 2) external nasal deformities using standardized digital photographs, 
and 3) endonasal deformities by means of flexible endoscopy.
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PATIENTS AND METhODS
Patient selection
We conducted a single-center cross-sectional cohort study. Patients in the Treacher 
Collins group were included if they had been diagnosed with Treacher Collins by the 
multidisciplinary craniofacial team of the Erasmus University Medical Center since 1974 
(i.e. during a 37-year period). All adult patients (age ≥ 18 years) were eligible for inclu-
sion. All investigations (described below) took place at our outpatient clinic on the same 
day (per patient) in October 2012.
In addition, data on a control group of 151 adults were obtained from the Nasal Ap-
pearance and Function Evaluation Questionnaire (see below). Exclusion criteria for both 
groups were age < 18 years and, in the control group, any visible facial deformity.
The study was approved by the Medical Ethics Committee of the Erasmus MC (MEC-
2011-135).
Reconstructive surgeries, obstructive sleep apnea, medication and allergies
In the Treacher Collins group, an inventory was made of known allergies and currently 
used medication. An overview was made of all facial reconstructive surgeries performed, 
including endonasal surgeries. The presence of obstructive sleep apnea, as determined 
by polysomnography, was known for all patients.
Satisfaction with nasal functioning and appearance
The Nasal Appearance and Function Evaluation Questionnaire was filled out by both the 
Treacher Collins and the control group. This questionnaire has been validated for pa-
tients with a nasal reconstruction and consists of 14 questions answered on a five-point 
Likert scale.21 The Nasal Appearance and Function Evaluation Questionnaire consists of 
two parts; the first consists of sevenquestions on nasal function, including airway pas-
sage, snoring, olfaction, dry mucosa, epistaxis and phonation; answers can be scored 
ranging from “always” to “never”. The second part consists of seven questions addressing 
satisfaction rated per different subunit of the nose, and overall satisfaction (Figure 1); 
answers can be scored ranging from “very dissatisfied” to “very satisfied”.
External nasal deformity
External nasal deformities were scored in the Treacher Collins group on standardized 
digital photographs of the nose taken by a professional medical photographer of the 
Erasmus MC. Three medical specialists, i.e. two craniofacial surgeons and one otorhi-
nolaryngologist (IMJM, JJNMM and RMLP; all three involved in operating congenital 
craniofacial malformations), evaluated the photographs independently using a detailed 
and structured external nasal deformity scoring assessment (Figure 2). A total of 29 items 
Nasal sequelae of Treacher Collins syndrome 117
7
were scored using standard terminology.22 Nasal deformities were scored by all raters at 
the same angle, in frontal, caudal and/or lateral view on six standardized photographs 
of the nose (available per patient). After filling out the assessment a consensus was 
reached when at least two-thirds of raters scored the specific deformity.
Endonasal deformity
In the Treacher Collins group, an experienced otorhinolaryngologist (RMLP) performed 
anterior rhinoscopy and standardized nasal endoscopy (using a flexible laryngoscope) 
to determine endonasal deformities. In relation to the nasal septum, deviations, spines 
Items of the Nasal Appearance and Function Evaluation Questionnaire
always mostly every now 
and then
hardly ever never
1.  How often do you have trouble 
breathing through your nose?
1 2 3 4 5
2.  How often do you snore? 1 2 3 4 5
3.  How often can you smell odors? 1 2 3 4 5
4.  How often do you have trouble 
with nasal crusts?
1 2 3 4 5
5.  How often do you have a bloody 
nose?
1 2 3 4 5
very poor poor moderately good excellent
6.  How do you assess your quality 
of speech?
1 2 3 4 5
very dissatisfied dissatisfied moderately satisfied very satisfied
7.  How satisfied are you with your 
total nasal functioning?
1 2 3 4 5
8.  How satisfied are you with your 
nasal tip appearance?
1 2 3 4 5
9.  How satisfied are you with your 
nasal wing(s) appearance?
1 2 3 4 5
10.  How satisfied are you with your 
nasal dorsum appearance?
1 2 3 4 5
11.  How satisfied are you with the 
size of your nostril(s)?
1 2 3 4 5
12.  How satisfied are you with the 
color of your nasal skin?
1 2 3 4 5
13.  How satisfied are you with your 
nasal position?
1 2 3 4 5
14.  How satisfied are you with your 
total nasal appearance?
1 2 3 4 5
Figure 1. Nasal Appearance and Function Evaluation Questionnaire
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External nasal deformity assessment form
Patient identification number:
Nose: assess in frontal view only:
Upper 1/3 of the nose
Deviation None Left Right
No in/outfraction Infraction
left
Outfraction  
left
Infraction
right
Outfraction 
right
Width Normal Tight Broad
Middle 1/3 of the nose
Deviation None Left Right
Shape Normal Inverted V
Lower 1/3 of the nose
Nasal tip
Deviation None Left Right
Shape Normal Bulbous Bifid Prominent
Basis
Width Normal Tight Broad
Alar flaring left None Present
Alar flaring right None Present
Nose: assess in caudal view only:
Basis
Width Normal Tight Broad
Nares left Normal (oval) Slit-shaped Round
Nares right Normal (oval) Slit-shaped Round
Columella
Septal luxation None Left Right
Width Normal Tight Broad
Length Normal Short Long
Nose: assess in lateral view only:
Nasofrontal angle Normal Deep Flat
Length Normal Short Long
Height
Hump None Present (n.f.s.)
Saddle None Present (n.f.s.)
Nasal tip
Projection Normal Under projection Over projection
Rotation Normal Under rotated Over rotated
Columella Normal Retracted Columellar show
Alar region (left) Normal High Low
Alar region (right) Normal High Low
Nasolabial fold (left)$ Normal (sharp) Blunt
Nasolabial fold (right)$ Normal (sharp) Blunt
Other Double break 
present (normal)
Double break not 
present
Figure 2. Standardized external nasal deformity assessment
N.f.s. : Not further specified
$ Assess in both lateral and frontal view
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and spurs were described. Deformities of the turbinates, aspect of the choanae and 
nasal floor, and signs of rhinitis were noted.
Statistical analysis
Analyses were performed with SPSS 21.0 for Windows (SPSS, Inc., Chicago, IL, USA). All 
statistical tests were two-tailed with P <0.05 designated as statistically significant. For 
categorical data the Chi-squared test was used and for continuous data the Wilcoxon 
signed rank test was used in case of non-normally distributed data. For all outcome 
variables of the Nasal Appearance and Function Evaluation Questionnaire, three candi-
date covariates ("gender", "age" and "clustered education level") were tested separately. 
Education level was found to be a confounder of importance. Multivariate linear regres-
sion (with bootstrapping in case of non-normally distributed data) was conducted to 
compare means between the Treacher Collins and control group for separate items of 
the Nasal Appearance and Function Evaluation Questionnaire by adjusting for clustered 
education level. Measured values are reported as mean ± 1 standard deviation or me-
dian (range/interquartile range), as appropriate.
RESuLTS
Demographic characteristics
In the period 1974 to 2010, 57 patients were diagnosed with Treacher Collins syndrome 
and, during this period, four patients died. In 2012 (when this research started), of the 
53 available patients 40 were aged ≥ 18 years, and two lacked a current address. Of the 
Table 1. Demographic characteristics of the study participants.
Treacher Collins group 
(n=11)
Control group  
(n=151) †
P-value for differences 
between patients and 
controlsMedian (range) Median (range)
Age (years) 41 (20-61) 40 (19-93) 0.931
Gender
Male 27.3% 40.4% 0.390
Female 72.7% 59.6%
Education level
Primary school & 10th grade 27.3% 14.6% 0.156
High school & Community college 27.3% 57.0%
Postgraduation 45.5% 28.5%
Categorical data for gender and education are displayed as frequency counts.
† The control group was used to compare outcomes from the Nasal Appearance and Functional Evaluation 
Questionnaire.
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remaining 38 adult patients who were approached by letter, 11 participated (29%) and 
27 were unwilling to participate; this patient group included three males (27%) and all 
were (pale-skinned) Caucasian. There were no significant differences in age, gender and 
clustered education level between the patients and controls (Table 1).
Reconstructive surgeries, obstructive sleep apnea, medication and allergies
Of the 11 included patients, five had previously undergone nasal surgery of which two 
external rhinoplasties and four endonasal procedures (Table 2). Three of the 11 patients 
suffered from obstructive sleep apnea (two mild; one severe who used continuous posi-
tive airway pressure). Two of these patients suffered from dust mite allergy (both from 
hay fever, and one had contact allergy for adhesive plasters and nickel). One of these 
latter patients used (long-term) oral antihistamine, and two used nasal steroid sprays 
Table 2. Previous nasal surgery, obstructive sleep apnea and endonasal deformities found in 11 adult pa-
tients with Treacher Collins syndrome
Cases Previous nasal surgery
Severity of 
obstructive 
sleep apnea
Anatomic site of deformity
Turbinates Nasal septum Nasal 
floor
Choana
Deviated Other
No. 1 - - Bullous 
middle 
turbinate
Convex Spur - -
No. 2 - - - - Broad divergent 
perpendicular 
plate
- -
No. 3 -  Surgically assisted rapid 
maxillary expansion
- Le Fort I osteotomy
- Dacryocystorhinostomy
Mild - Dorsal Spur
Septal spine
- -
No. 4 - Trauma††
- Choanal reconstruction
- Le Fort I osteotomy
- Inferior 
turbinates
reduced †
Dorsal
vomer
Septal spina Higher -
No. 5 - Septoplasty
- Turbinectomy
- - - Spur - -
No. 6 - - - Dorsal Spur - -
No. 7 - Nasal hump reduction Severe - Dorsal Spur - -
No. 8 -  Restoring tip projection 
with cartilage graft and 
lateral osteotomy of the 
nasal bones.
- - Dorsal - - -
No. 9 - - - Dorsal Spur - -
No. 10 - - - Caudal Septal spine - -
No. 11 - Mild - Dorsal Spur - -
† After bilateral surgical inferior turbinate reduction
†† No nasal surgery performed related to this trauma.
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incidentally during spring time. Another patient used sodium chloride nasal flushes and 
a nasal steroid spray; she also used continuous positive airway pressure for her obstruc-
tive sleep apnea and was not known to have an allergy.
Satisfaction with nasal functioning and appearance
All patients filled out the Nasal Appearance and Function Evaluation Questionnaire. The 
following complaint/function was scored most frequently: “snoring” median two (i.e. 
“mostly”), (interquartile range 1-3) (Table 3). All patients snored, of whom 46% (5/11) 
“every now and then” and the remainder “mostly” (18%, 2/11) or “always” (36%, 4/11); 
this item showed a significant difference between patients and controls (P=0.001). The 
quality of phonation was scored “moderately” in 27% (3/11) of patients and showed a 
significant difference compared with controls (P=0.003). Of the 11 patients, five (45%) 
scored “trouble breathing through the nose” as “every now and then” or more frequently 
(i.e. “mostly” or “always”); this score was not significantly different compared with con-
trols. For all items regarding satisfaction with nasal appearance  ≥  81% (9/11) scored 
“satisfied” or “very satisfied” with a similar interquartile range (4-4). 
Table 3. Satisfaction with nasal functioning and appearance in Treacher Collins syndrome: outcomes of the 
Nasal Appearance and Function Evaluation Questionnaire
Treacher Collins group
(n=11)
Control group
(n=151)
Differences between 
groups
Median  
(interquartile range)
 Median
(interquartile range) P-value
1. Trouble breathing through nose 4 (3-4) 4 (3-4) 0.506
2. Snoring 2 (1-3) 4 (3-5) 0.001
3. Olfaction 2 (1-3) 2 (1-2) 0.202
4. Dry mucosa 4 (3-5) 4 (3-5) 0.361
5. Epistaxis 5 (4-5) 5 (4-5) 0.298
6. Quality phonation † 4 (3-4) 4 (4-5) 0.003
Satisfaction with
7. Overall function 4 (4-4) 5 (4-5) 0.184
8. Nasal tip 4 (4-4) 5 (4-5) 0.391
9. Ala nasi 4 (4-4) 5 (4-5) 0.083
10. Nasal dorsum 4 (4-4) 5 (4-5) 0.067
11. Nostril size 4 (4-4) 5 (4-5) 0.031
12. Color 4 (4-4) 5 (4-5) 0.005
13. Nasal position 4 (4-4) 5 (4-5) 0.014
14. Total nasal appearance 4 (4-4) 5 (4-5) 0.025
Multivariate analysis was applied with adjustment for clustered education level.
† Regarding this item one value was missing
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The item “total nasal appearance” was scored as “satisfied” in 81% (9/11); the two patients 
who previously underwent external rhinoplasty were the only dissatisfied patients. 
Compared with controls, satisfaction was significantly lower in the Treacher Collins 
group for the items nostril size (P=0.031), color of the nose (P=0.005), nasal position 
(P=0.014), and total nasal appearance (P=0.025) (Table 3).
External nasal deformity
The nasal items of all Treacher Collins patients were scored by the three independent 
raters. Median consensus rate of these three raters per patient was 96.6% (89.7-100%). 
Median consensus rate for all patients per nasal item was 100% (81.8-100%) (Table 4). 
Overall, the dorsal hump (cartilaginous and/or bony) was the most frequently found de-
formity (73%). Deviation was found most frequently in the upper 1/3 of the nose (55%). 
The aspect of the nasal tip was scored as bifid or bulbous in 55% and was underrotated 
in 36% of the patients (Table 4; Figure 3).
Endonasal deformity
Endonasal deformities were found concerning the following constituents: turbinates, 
nasal septum, and nasal floor. In one of the two patients, turbinate deformity was 
directly related to previous surgery, whereas deformities related to the nasal septum 
(spurs, septal spines and/or deviations) were found in 100% (11/11) of the patients. Of 
all deformities, 82% (9/11) consisted of septal deviations which were dorsal (seven), 
caudal (one) and convex (one) deviations. The nine patients with septal deviations 
perceived their nasal obstruction to have the following frequency: “always” (one patient 
with severe obstructive sleep apnea), “mostly” (one patient with mild obstructive sleep 
apnea), “every now and then” (three), and “hardly ever” (four; of which one patient had 
mild obstructive sleep apnea). All these patients snored with the following frequency: 
“always” (four), “mostly” (one) and “now and then” (four). No current signs of rhinitis were 
A B C
Figure 3. Most prominent external nasal deformities found in Treacher Collins syndrome
a-c: a: dorsal hump deformity, b: bifid tip, c: bulbous tip and septal luxation
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found in any of the patients. One of the two patients without septal deviation had previ-
ously undergone septoplasty. Spurs and septal spines were found in 7/11 patients and 
4/11 patients, respectively (Table 2). One patient underwent choanal surgery; however, 
at the time of investigation this patient no longer showed choanal stenosis.
A B
D E
C
Figure 4. Bilateral clefting of the lateral alar cartilages in a patient with Treacher Collins syndrome. Preop-
erative (a-b), intra-operative (c ) and postoperative photographs (d-e).
Preoperatively a bifid tip, a deviated osseous framework and a cartilaginous hump were found. The domes 
were not defined adequately and the tip was underrotated caused by low "hanging" medial crura. Intra-
operatively, a hypoplastic alar rim and bilateral defect of the lateral alar cartilage suggested a bilateral 
cleft contributing to the deformed nasal tip and alar region; subsequently, this was corrected with alar rim 
grafts. The deviated osseous framework was corrected and the cartilaginous hump based on a septal ridge 
reduced, new domes were formed, interdomal sutures were placed, and a tongue in groove technique was 
used to reshape the region of the upper laterals.
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Other congenital deformities included a broad divergent perpendicular plate of the eth-
moid and a partial aplasia of the vomer. After the present study, one patient underwent 
a revision septorhinoplasty and, intraoperatively, a remarkable "clefting" of the bilateral 
alar cartilages was found (Figure 4).
DISCuSSION
This cross-sectional cohort study in patients with Treacher Collins shows that the main 
problems with nasal functioning were frequent snoring and diminished quality of pho-
nation, as compared with controls. Although patients were less satisfied with nostril size, 
color, nasal position and total nasal appearance as compared with controls, they nev-
ertheless reported to be “satisfied”. The main external nasal deformities are the dorsal 
nasal hump, a deviated nose, and an abnormally shaped nasal tip. In addition, the main 
endonasal deformities are nasal septum deviations frequently associated with spurs.
External nasal deformity and satisfaction with nasal appearance
The most distinct external nasal deformities were the dorsal hump, an abnormally 
shaped nasal tip, and deviation of the upper to the lower one-third of the nose. Although 
Farkas et al. did not describe aspects of the tip, they found a protruded proximal part 
of the nose (possibly resembling the dorsal hump), and a relatively deep nasal root.11 
In the limited descriptive Treacher Collins literature, the nose is sometimes referred to 
as “prominent”, and the facial profile as “convex” with a “droopy” tip.10, 23 Probably called 
“prominent” due to a combination of the dorsal hump, exaggerated by a (usually) 
hypoplastic maxilla and orbitozygomatic complex, and a relatively deep nasal root. In 
addition, the posteriorly situated mandible and reduced cranial base angle give these 
patients a more convex facial profile.23
Underrotation was found in about one-third of the cases and possibly explained the 
“droopy” aspect in Treacher Collins. In addition, the nasal tip was frequently found to be 
bifid (subtle) and bulbous. This might suggest an embryological developmental origin 
in which the intermaxillary segment from the nasomedial processes forms structures 
including the primary palate, the nasal tip, crest of the nose and a portion of the nasal 
septum.24 A cleft of the lateral alar cartilage (found in one of our patients), may con-
tribute to the deformed lobule/nasal tip. In the present study, deformities (except for 
cleft palate) were found in all structures. The cartilaginous septal deviations found could 
cause deviations of the middle one-third and lower one-third of the nose.
Analysis of patient satisfaction showed that patients were significantly less satisfied 
compared with controls regarding nostril size, color of the nasal skin, nasal positioning 
and total nasal appearance. Nostril size, for example, was often scored as "slit like". All 
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patients were white skinned Caucasians and skin color was not scored by the panel. 
Therefore, there is no plausible explanation for the significant difference between the 
groups for this item. Moreover, taking into account that the medians/frequencies caus-
ing the statistically significant difference between the two groups are both high (cor-
responding with “satisfied” vs. “very satisfied” in the controls), this indicates that clinically 
the patients were in fact fairly (acceptably) satisfied. It is possible that patients focus 
less on specific nasal subunits and their relatively subtle deformities and much more 
on severe deformities (such as the eyelids and ears). Also, the perceived severity of the 
deformity generally correlates with a patient's level of acceptance/satisfaction with their 
facial appearance and this is largely determined by, e.g., education level, fear of negative 
evaluation of appearance, and self-esteem.25-27
We suggest performing –on indication- a rhinoplasty that includes osteotomies with 
in-fracture reduction of the skeletal and cartilaginous dorsal hump and removal of 
the cephalic portions of the lower laterals and on indication a septal cartilage graft to 
improve tip projection. In case of a significant septal deviation causing snoring or nasal 
obstruction this can be reconstructed at the same time.
Endonasal deformity and satisfaction with nasal functioning
The most frequently found deformity was the cartilaginous dorsal septal deviation 
(often accompanied by spurs and columellar septal luxation). Our detected prevalence 
of septal deviation is relatively high; however, in a "normal" population this prevalence 
is also high.28-29 Results of the Nasal Appearance and Function Evaluation Questionnaire 
revealed that all patients with a septal deviation suffered from some degree of nasal 
obstruction; however, only two patients reported this to be “mostly” or “always”. Dorsal 
septal deviations can cause the perceived nasal obstructions and may contribute to 
incompetence of the internal nasal valve area; also, caudal deviations can affect the ex-
ternal nasal valve area.30 Compared with controls, patients scored snoring significantly 
more frequently. Explanations for nasal obstruction (other than septal deviation) were 
ruled out. In our adult patients, outcomes of snoring are similar to those in children with 
Treacher Collins and suggest that this is a consistent complaint for all ages; our results 
also match snoring frequencies in children with syndromic and complex craniosynos-
tosis.17, 31 Because snoring in Treacher Collins does not allow to distinguish between 
having/not having obstructive sleep apnea, a polysomnography is indicated.17
Although our patients frequently complained about the olfactory function, it was not 
different from the “standard” in our control group.32 However, this was subjective deter-
mination of olfactory functioning. On the other hand, anosmia or hyposmia in Treacher 
Collins originating from a congenital sensorineural olfactory dysfunction is unlikely, as 
the olfactory placodes are derived from the neural plate and not from the neural crest.
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In our patient group, only one was known with a choanal atresia/stenosis and, prior to 
the study, this patient underwent choanal surgery. In Treacher Collins syndrome, unilat-
eral or bilateral choanal atresia is a rarely found and the exact prevalence is unknown.33 
However, one study estimated the prevalence to be about 11%.12 Choanal atresia can 
be caused by a persistence of the nasobuccal membrane during embryologic develop-
ment. However, a hypoplastic maxilla or affected surrounding structures of the choanae 
(e.g. vomer, palatal bone, medial pterygoid lamina) can also lead to stenosis/atresia of 
the choanae.24 Interestingly, these structures can be affected due to a misdirection of 
neural crest migration with subsequent mesodermal flow; this mechanism might be 
involved in the etiology of Treacher Collins syndrome.34
In the present study, the quality of phonation was a considerable functional issue. It is 
known that speech problems (e.g., hyponasality, hypernasality and articulation errors) 
are important and can occur in ≤ 74% of patients with Treacher Collins syndrome.12, 32
Limitations
The main limitation of the present study is the low participation rate. Moreover, no ob-
jective external nasal measurements were performed; however, the nose was assessed 
by three independent raters. In addition, the nose was approached in a structured way, 
rather than measurements alone.
CONCLuSION
In this study group, although satisfaction with nasal esthetics is relatively good, the 
patients still suffer from the functional problems of snoring and impaired quality of 
phonation. A structured nasal ENT physical examination with nasal endoscopy could de-
termine those aspects that require more attention during treatment. Septorhinoplasty 
can be performed at an adult age if the patient has a considerable esthetic wish and/or 
nasal obstruction combined with septal deviation. Special attention should be paid to 
dorsal hump reduction, correction of deviated external osseous framework, septoplasty, 
and correction of the shape of the nasal tip.
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ABSTRACT
Background No reviews or guidelines are available on evidence-based treatment for 
the multidisciplinary approach in Treacher Collins syndrome (TCS). Aim is to provide an 
evidence-based review of multidisciplinary treatment of TCS based on levels of evidence 
and supported with graded recommendations.
Methods A systematic search was performed in PubMed, Web-of-Science, EMBASE, 
Cochrane Central (1985-January 2014). Included were clinical studies (with ≥5 TCS pa-
tients) related to therapy, diagnosis, or risk of concomitant diseases. Level of evidence 
of the selected articles was rated according to the American Society of Plastic Surgeons 
for Evidence-based Clinical Practice Guidelines. After two panelists had reviewed each 
abstract separately, a consensus method was used to solve any disagreements concern-
ing article inclusion.
Results Of the 2433 identified articles, 63 studies [level of evidence (2-5)] were included. 
Conclusions and recommendations were consecutively extracted for the items: upper 
airway; the ear, hearing and speech; the eye, eyelashes and lacrimal system; growth, 
feeding and swallowing; the nose; psychosocial factors, and craniofacial reconstruction.
Conclusions This systematic review provides current evidence for the multidisciplinary 
treatment of TCS and makes recommendations for treatment. Although some topics are 
well supported, especially ocular, nasal, speech, feeding and swallowing problems lack 
sufficient evidence. In addition, craniofacial surgical reconstruction lacks a sufficient 
level of evidence to provide a sound basis for a full treatment protocol. Despite the rar-
ity of the syndrome, more research is needed to compare outcomes of several surgical 
treatments, especially in orbitozygomatic/maxillary regions.
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INTRODuCTION
Treacher Collins syndrome (TCS) is a rare congenital craniofacial condition.1 TCS is an 
autosomal dominant disorder of craniofacial development with an estimated incidence 
of 1 in 50,000 live births.2-4 Mutations in TCOF1, and in a smaller subset of TCS patients 
in POLR1D and POLR1C, are held responsible for the resulting phenotype; neverthe-
less, in some TCS patients no mutations within these three genes are detected.4-6 The 
subsequent craniofacial morphogenesis has a wide range of inter- and intra-familial 
phenotypic variability.7-8 Craniofacial deformities mostly consist of defects in the peri-
orbital region and hypoplasia of the mandible and zygoma, microtia and middle-ear 
deformities.
The rarity of the syndrome and the variety of the phenotypic expression, make the 
multidisciplinary treatment challenging. Treatment nowadays is based on low levels of 
evidence consisting of mainly expert opinions (publishing their experience), case series 
or retrospective cohort studies.9-12 Although some authors present narrative reviews (i.e. 
overviews), generally these are not systematic and are opinion based, thereby suffering 
from the same limitations as an expert opinion.13-19 Since there is no clinical guideline 
or systematic review available, this study summarizes the current best-quality evidence 
and presents graded levels of recommendations with the aim to assist physicians in 
their clinical decision-making and to explore the need for a multidisciplinary treatment 
approach in patients with TCS.
PATIENTS AND METhODS
A systematic search was performed in PubMed, Web of Science, EMBASE, Cochrane 
Central (1985- January 2014). The search term ‘Treacher Collins’, ‘Mandibulofacial dys-
ostosis’ and ‘Treacher Collins Francescetti’ and all possible combinations, truncations 
and abbreviations were used. Databases were systematically searched consecutively 
and duplicates were omitted (Figure 1). For PubMed the following terms were used: 
(Treacher col*[tw] OR Franceschetti’s syndrom*[tw] OR Franceschetti syndrom*[tw] OR 
Mandibulofacial Dysostos*[tw]). For Embase ((Treacher* NEXT/1 col*) OR (Franceschett* 
NEXT/1 syndrome* ) OR (dysostos* NEAR/3 mandibul* )):de,ab,ti
For scopus: ((“Treacher col*” OR “Franceschetti syndrom*”) OR (dysostos* NEAR/3 man-
dibul* )).
Level of evidence of the selected articles was rated according to the American Society 
of Plastic Surgeons for Evidence-Based Clinical Practice Guidelines (Table 1 and 2).20-21 
Two panelists (RGP and MJSvL) reviewed each abstract separately. Lists of abstracts 
found per topic of interest (the overview studies and the seven topics as described 
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below) were critically reviewed between these two authors. Afterwards, a consensus 
method between the panelists was used to solve disagreements concerning the inclu-
sion.
Included were: clinical studies related to therapy, diagnosis or risk of concomitant 
diseases, with ≥ 5 TCS patients. Overview studies and seven topics were investigated: 
upper airway; the ear, hearing and speech; the eye, eyelashes and lacrimal system; 
growth, feeding and swallowing; the nose; psychosocial factors; and craniofacial recon-
struction. Tables were drawn up with all the studies included per topic of interest and a 
level of evidence was assigned. All authors of any specialty agreed on the assigned level 
of evidence.
Excluded were: case reports < 5 TCS patients, book chapters, proceedings, studies 
not related to clinical practice, no abstract available, or inaccessibility of full text and/or 
non-English language texts.
Conclusions and recommendations were developed through a consensus process 
(all authors) and graded on the same levels of evidence by taking appropriate grades 
Systematic search:*
- Embase (n = 1838)
- Medline (OvidSP) (n = 1726)
- Web-of-Science (n = 730)
- PubMed publisher (n = 7)
- Cochrane (n = 1)
- Google Scholar (n = 200)
Search results:
n = 4502 studies
n = 2433 studies
Excluded:
double hits: 
n = 2069
Potentially relevant 
studies identified:
n = 146 studies
Excluded:
studies excluded 
based on abstract: 
n = 2287
Relevant studies 
identified:
n = 63 studies
Excluded:
studies excluded 
based on full text: 
n = 83
Duplicates per database:*
- Embase (n = 11)
- Medline (OvidSP) (n = 1383)
- Web-of-Science (n = 515)
- PubMed publisher (n = 4)
- Cochrane (n = 1)
- Google Scholar (n = 155)
Figure 1. Flowchart of the systematic literature search for the present review.
*Databases searched consecutively
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(A-D), according to the American Society of Plastic Surgeons. The consensus process 
consisted of a critical review for all topics of interest by all authors and conclusions and 
recommendations were revised until all authors agreed.
Table 1. Level of Evidenced-Based Medicine according to the American Society of Plastic Surgeons
Evidence rating scale for therapeutic studies
Level of evidence Qualifying studies
I High-quality, multi-centered or single-centered, randomized controlled trial with adequate 
power; or systematic review of these studies
II Lesser-quality, randomized controlled trial; prospective cohort or comparative study; or 
systematic review of these studies
III Retrospective cohort or comparative study; case-control study; or systematic review of 
these studies
IV Case series with pre/post test; or only post test
V Expert opinion developed via consensus process; case report or clinical example; or 
evidence based on physiology, bench research or “first principles”
Evidence rating scale for diagnostic studies
I High-quality, multi-centered or single-centered, cohort study validating a diagnostic test 
(with “gold” standard as reference) in a series of consecutive patients; or a systematic review 
of these studies
II Exploratory cohort study developing diagnostic criteria (with “gold” standard as reference) 
in a series of consecutive patient; or a systematic review of these studies
III Diagnostic study in nonconsecutive patients (without consistently applied “gold” standard
as reference); or a systematic review of these studies
IV Case-control study; or any of the above diagnostic studies in the absence of a universally
accepted “gold” standard
V Expert opinion developed via consensus process; case report or clinical example; or 
evidence based on physiology, bench research or “first principles”
Evidence rating scale for prognostic/risk studies
I High-quality, multi-centered or single-centered, prospective cohort or comparative study 
with adequate power; or a systematic review of these studies
II Lesser-quality prospective cohort or comparative study; retrospective cohort or 
comparative study; untreated controls from a randomized controlled trial; or a systematic 
review of these studies
III Case-control study; or systematic review of these studies
IV Case series with pre/post test; or only post test
V Expert opinion developed via consensus process; case report or clinical example; or 
evidence based on physiology, bench research or “first principles”
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RESuLTS
The literature search (after deduplication) yielded 2433 articles (Figure 1). Finally, 
63 studies with different levels of evidence (range 2-5) were included. These results 
compiled "overview studies" addressing more than one topic and the seven topics of 
treatment (Table 3). No randomized controlled trials were found.
DISCuSSION
upper airway
Obstructive sleep apnea (OSA) is a known frequent finding in congenital craniofacial 
syndromes. Also TCS patients suffer frequently from OSA. Only three papers report on 
the prevalence of OSA in TCS, each using different criteria (including a wide age range, 
and patients who already received treatment to improve breathing).22-24 The reported 
prevalences were 25%,25 95% (11% tracheotomies)23 and 46% (n=35; 6% tracheoto-
mies),22 respectively, despite several craniofacial surgeries related to the upper airway. 
OSA occurs in TCS children and adults22 and there is no evidence for diminishing or 
changing prevalence and severity in the natural course of OSA with aging. The level 
of severity ranged from mild to severe; severe OSA syndrome was found in 25-41%.22-24
Table 2. Grades of recommendation according to the according to the American Society of Plastic Sur-
geons
Scale for grading recommendations
Grade Descriptor Qualifying evidence Implications for practice
A Strong Recommendation Level I evidence or 
consistent findings 
from multiple studies 
of levels II, III, or IV
Clinicians should follow a strong recommendation 
unless a clear and compelling rationale for an 
alternative approach is present.
B Recommendation Levels II, III, or 
IV evidence and 
findings are generally 
consistent
Generally, clinicians should follow a 
recommendation but should remain alert to new 
information and sensitive to patient preferences.
C Option Levels II, III, or 
IV evidence, 
but findings are 
inconsistent
Clinicians should be flexible in their decision-
making regarding appropriate practice, although 
they may set bounds on alternatives; patient 
preference should have a substantial influencing 
role.
D Option Level V: Little or no 
systematic empirical 
evidence
Clinicians should consider all options in their 
decision-making and be alert to new published 
evidence that clarifies the balance of benefit versus 
harm; patient preference should have a substantial 
influencing role.
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Obstructions responsible for OSA are found in the whole upper respiratory tract, i.e. 
from nasopharyngeal to laryngeal level as observed through (sleep) endoscopy.22, 26
Screening for OSA in TCS based on the Epworth Sleepiness Scale in adults and the 
Brouillette score in children is unreliable; partially because a substantial part of the pa-
tients snore.27-28 In general, questionnaires are unable to discriminate between snoring 
vs. OSA, or determine the severity of OSA.29 In other studies the results were unclear, 
due to including several syndromes and/or not reporting syndrome-specific results 
(bronchoscopy30 and screening questionnaires).31
Incidence of cleft palate is estimated at 23%.32 There is no specific evidence that timing 
of cleft repair should be different from other cleft palate syndromes or non-syndromic 
cleft palate repair. A higher risk of palatal fistula is mentioned, although not much 
evidence is provided.32 In a study researching several congenital craniofacial syndromes 
(including TCS) it is thought that the presence of a cleft palate reduces the probability 
of a tracheotomy.24 Another study reported delayed palatal repair in some cases due to 
complicated airway management in TCS.9 Although it is assumed that closure of the cleft 
palate narrows the airway, the exact effect on OSA of palate closure in TCS is unreported. 
However, it is advisable to precede palatal reconstruction by polysomnography with 
imitated closure to rule out potential severe respiratory distress. In case of respiratory 
problems the palatal reconstruction should be delayed.33-34
In general, a tracheotomy necessary to secure the airway is reported in ≤ 41%.22, 24, 35 
Other options are CPAP or in selected cases a mandibular distraction osteogenesis. In 
mild OSA prone positioning could be considered as respiratory treatment (as in Pierre 
Robin sequence).36
Although one study showed a correlation between OSA severity and diminished 
health-related quality of life, it included few participants and facial deformity was an 
important confounding factor.28
The ear, hearing and speech
Although patients with TCS (and other craniofacial syndromes) can suffer from hear-
ing loss, delay of appropriate treatment and, thus, hearing rehabilitation is still often 
encountered.37-38
Around 93-96% of TCS patients suffer from a unilateral or bilateral conductive hear-
ing loss. Seven percent suffer from a mixed hearing loss.35, 39 Hearing loss is moderate 
(41-55 dBHL) to moderately severe (56-70 dBHL),35 the latter being reported in up to 
65%.9 Patients themselves often report hearing impairment (95%) and about 50% report 
communication difficulties.40
CT findings reveal complex, often combined deformities to both external auditory 
canal, middle ear cavity and inner ear. The external auditory canal is shown to be normal 
(0-15%), stenotic (28-31%) and atretic (54-72%). Middle ear cavity deformities are usually 
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symmetric and constitute of hypoplastic, ankylosed ossicles (33-82%) or missing ossicles 
(22-67%), particularly the malleus and incus.39, 41-43 The inner ear is developed normally 
in most cases (78-100%),39, 41, 43 the mastoid rarely shows pneumatisation.41-43 The facial 
nerve sometimes runs a deviant course, complicating middle ear surgery.40, 42-43
Unfortunately, the outcome of reconstructive ear surgery is often disappointing and 
effective hearing improvement is achieved in only a minority.42, 44
The bone-anchored hearing aid (BAHA) offers significant hearing improvement 
compared with conventional bone-conduction hearing aids (in total 39 dB vs. 29 dB); 
also, its insertion has a low complication rate.45 In addition, one study showed improved 
quality of life related to behavior, concentration, learning and development.46 A banded 
hearing aid is an option for the first few years of life. In general, a BAHA should not be 
placed before 3 years of age.47
Speech development is frequently impeded in patient with TCS, although reported 
evidence is scarce.9, 35, 48 One study showed that speech errors often consist of overlap-
ping causes, related (in about 60%) to malocclusion, palatopharyngeal imcompetence 
(30%) and errors in the general articulatory/phonologic category or hearing loss(50%).35 
Hypernasality (palatopharyngeal imcompetence), hyponasality (restricted nasal cavities 
and/or choanal atresia), but also mixed resonance patterns, are found.35 Patients are dis-
satisfied with their speech/quality of phonation compared to controls.49
Autologous external ear reconstruction could start at 9 years and prosthetic devices 
are an option. However, the results of both are found to be dissatisfying in one study.49 
Moreover, the autologous reconstruction is impeded by a low hair implant and the 
limited options of reconstruction caused by unavailability of the temporofascial flap, if 
used earlier in pedicled bone grafts for the zygoma.
The eye, eyelashes and lacrimal system
Although periorbital soft tissue defects are well known, true ophthalmologic sequelae 
are seldom mentioned.9, 13-14
However, there is evidence for vision loss (37%), amblyopia (33%), significant refrac-
tive errors (58%) and anisometropia (17%).50 Another study found bilateral absence of 
the inferior lacrimal puncta (36%), cilia (50%), scleral show (50%), refractive errors (86%), 
regular astigmatism (36%) and absent lateral canthal tendon (64%).51 Absent inferior 
lacrimal puncta, normal superior lacrimal puncta and intermittent or constant tearing 
were found in 71%.52 One overview reported downslanting palpebral fissures in all and 
"visual disability" in around one third.9 Although TCS patients are dissatisfied with the es-
thetic appearance of their eyelids, they are not dissatisfied with their vision compared to 
controls.49 Musculocutaneous transposition flaps, z-plasties and lateral canthopexy9-17, 19 
can be used to reconstruct the periorbital soft tissue deformities; they are frequently 
applied but often lead to scarring, contour deformities and low patient satisfaction of 
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the residual deformity.49 Colobomas need special attention at an early age from birth on 
because they form a potential threat to vision through corneal drying. A defect larger 
than one third of the eyelid margin indicates timely surgery.53
Growth, feeding and swallowing
Feeding issues are common in patients with craniofacial syndromes. However, direct 
evidence of orofacial dysfunctioning in TCS is scarce. TCS patients are generally rather 
thin, suggestion a feeding problem.22 One study found reduced jaw opening (63%), 
malocclusion (94%), narrow hypopharynx (84%) and eating difficulties as reported by 
patients (68%) as well as dry oral mucosa (42%).40 The latter may be partially explained 
by the salivary gland pathology, found in 48%. Dysplasia of the parotid and the subman-
dibular gland was found in 29% and total aplasia in 19% of TCS patients. Over 50% had 
no parotid gland secretion and the orifice of Stenson’s duct was often not detectable.54
The nose
Currently, there is limited evidence for endonasal and external nasal deformities and as-
sociated dysfunctional and esthetic sequelae. The clinical picture suggests a pollybeak 
deformity and a dorsal hump deformity.9-11, 55 Main external nasal deformities were the 
dorsal hump (73%), external deviation (≤55%), bifid or bulbous tip (55%) and columellar 
septal luxation (55%).56 In 82% a septal deviation was found, sometimes contributing to 
nasal obstruction.56 A septorhinoplasty is advised from aged 17 years onwards.13-14, 57 One 
study showed a prevalence of 11% of choanal atresia.9 In 1989, Farkas et al. performed 
measurements (age range 6-21 years); in most patients the nose height and width was 
optimal, although a protruded proximal part of the nose and a relatively wide/deep 
nasal root was also found.58 Another study reports patients who are relatively satisfied 
with the various esthetic subunits of the nose compared to a control group. The most 
significant functional problem was snoring.27
Psychosocial factors
Evidence for psychosocial problems is very limited.59 Adults with congenital rare facial 
clefts appear to have a relatively "normal" long-term psychological functioning. How-
ever, stigmatization and insecurity about possible negative reactions of others can elicit 
stress and avoidance behavior.60-61 Important predictors for long-term psychological 
functioning are fear of negative appearance evaluation, self-esteem and patients’ sat-
isfaction with facial appearance.62 In addition, self-esteem is an important predictor to 
differentiate between "mature" (recognition of a threat and dealing with it) and "im-
mature" (denial and externalization) psychological defense mechanisms.63 Interestingly, 
objective severity of the deformity is not a predictor for patients’ acceptance of the 
deformity or for long-term psychological functioning. However, compared to a non-
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affected population, TCS patients remain less satisfied about several facial subunits (i.e. 
ears, facial profile, eyelids and chin).49 Congenital craniofacial patients less frequently 
have a partner or children and are prone to internalizing behavior problems.62 Risk 
factors for not accepting the final surgical result are self-perceived visibility of the 
deformity, a troublesome puberty, an emotional coping style, and facial functional 
problems.64 Importantly, especially these functional problems frequently occur in TCS.49 
In mixed craniofacial groups, surgery seems to positively affect patients’ attractiveness,65 
satisfaction with facial appearance59 and reactions of their surroundings.65
Craniofacial reconstruction
Craniofacial reconstruction is the most challenging part of treatment in TCS. Many 
experts have published their opinion/narrative review, including the Tessier integral 
procedure.9-18
Upper face and midface
Calvarial bone grafts are generally used for zygomatic reconstruction and orbital floor 
and lower rim repair, either as free grafts or as pedicled flaps.66-67 Disadvantage is resorp-
tion of calvarial bone grafts for zygomatic reconstruction, which occurs in almost all 
patients.68
The hypoplastic maxilla is positioned posteriorly in relation to the cranial base.69 
Techniques for correcting the midface hypoplasia are the Le Fort I (age > 16 years), 
Le Fort II with cranial bone grafts (described at several ages12), augmentation with rib 
grafts,19 or the malar osteotomy18 with or without onlay autologous grafts70 or lipofilling. 
Although limited, there is some evidence for a safe and reliable malar reconstruction 
using parascapular free flap transfer.71-72 However, microvascular free flaps can be bulky, 
have a tendency to sag, and may require multiple revisions for thinning and resuspen-
sion as in, e.g. progressive hemifacial atrophy. Lipofilling can be a treatment of choice in 
these syndromes.73 Inorganic implants might be an option, but may be as with inorganic 
implants in general, more prone to infection and dislocation.74
Lower face
The mandible in TCS is retrognathic: the ramus is short, the ramus body angle is more 
obtuse and the mandibular plane angle more steep, and a deep antegonial notch is of-
ten present.75-76 There is evidence for safe mandibular lengthening at age 1-4 years with 
distraction osteogenensis77 to correct the pediatric compromised airway resulting from 
the congenitally retrognathic mandible.78-79 A small study (n=5) reported that genioplasty 
distraction osteogenesis combined with hyoid advancement might also be favorable in 
TCS, in case mandibular distraction fails to reduce the upper airway obstruction.80 Patients 
cannot always be decannulated after mandibular distraction, probably due to multi-level 
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obstructions.26 Throughout the years a thorough dental/orthodontic screening is neces-
sary to monitor malocclusion and dental crowding. Orthodontic treatment may be indi-
cated pre- and/or postoperatively regarding mandibular and/or maxillary surgery.9, 13-14
Grading systems
Some subjective grading systems have been described to grade TCS. Hayashi et al de-
scribed a scoring system with eight criteria (facial features and the TCOF1 mutation).81 The 
second is the O.M.E.N.S. classification, as initially proposed for craniofacial microsomia 
indicating five major facial features.82 A third, more recently proposed expert opinion 
based orbitozygomatic classification system indicates four types of severity and their 
advised reconstruction.70 Although all these classification systems illustrate the variety 
and severity of the deformities, these classifications have never shown a predictive value 
with regards to functional problems and/or timing and type of treatment; therefore they 
are rarely used in clinical practice.
All together, main targets of the multidisciplinary treatment of TCS should be early 
recognition of OSA through a polysomnography and a thorough ENT physical exami-
nation to determine the level of upper airway obstruction. (Table 4 and figure 2) The 
results of these examinations should determine the next steps in treatment. In severe 
respiratory distress a nasopharyngeal tube could be temporarily an option followed by 
a tracheotomy. Prior to closure of a cleft palate a sleep study should be performed with 
imitated closure to rule out potential severe respiratory distress. Weight gain and feed-
ing need close monitoring and require the help of a dietician and (prelingual) linguist.
Specific attention should be paid to hearing and speech at an early stage to start treat-
ment as soon as possible.
In addition, an ophthalmologist should be consulted to identify and treat (intra-) 
ocular deformities. There exist a considerable dissatisfaction with (residual) deformity 
after craniofacial surgery. Counseling of psychological sequelae and creating realistic 
expectations for the patient seems essential. Sufficient evidence on surgical reconstruc-
tions lacks to provide an evidence-based treatment protocol, but a proposed treatment 
algorithm was made for respiratory care. (Figure 2)
Because of the rarity of the syndrome it is recommended to centralize medical care of 
these patients in a craniofacial center nation/ statewide. This provides conjoined exper-
tise of physicians and more possibilities for research to compare outcomes of different 
treatment modalities.
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Limitations
This systematic review is limited by the low evidence provided for treatment of TCS 
until now. Current (recommendation for) treatment is based on an interpretation of the 
evidence together with good clinical practice.
Figure 2.
Algorithm for respiratory care in Treacher Collins syndrome
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Conclusions
This systematic review provides current evidence for the multidisciplinary treatment 
of TCS and makes recommendations for treatment. Although some topics are well 
supported, especially ocular, nasal, speech, feeding and swallowing problems lack suf-
ficient evidence. In addition, craniofacial surgical reconstruction lacks a sufficient level 
of evidence to provide a sound basis for a full treatment protocol. Despite the rarity of 
the syndrome, more research is needed to compare outcomes of several surgical treat-
ments, especially in orbitozygomatic/maxillary regions.
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ENGLISh SuMMARy OF ThE ThESIS:
CLINICAL IMPLICATIONS OF TREAChER COLLINS SyNDROME
General introduction
In the general introduction (chapter I) of the thesis entitled "Clinical implications of 
Treacher Collins syndrome", the history, background, outline and aims of the thesis are 
described.
Treacher Collins syndrome (TCS) is a congenital craniofacial condition. It is estimated 
that four to five children with this syndrome are born every year in the Netherlands 
(estimated incidence 1:50,000). Little scientific attention has been paid to TCS due to 
the rarity of the syndrome. The severity and clinical consequences of the facial deformi-
ties can vary per patient. Deformities range from mild periorbital soft tissue defects, 
hypoplastic ears (both the auricle and the middle ear) to severe facial deformities of the 
mandible and zygoma leading to a severely compromised upper airway and obstructive 
sleep apnea (OSA). The assortment of deformities found in TCS lead to severe esthetic 
problems, but also to functional deficits, for example upper airway, hearing and feed-
ing problems. The facial features of TCS are symmetric and it is assumed that men and 
women are affected equally.
This thesis aims to answer four clinical questions in TCS:
1) To determine the prevalence, severity, cause and screening of OSA and potential 
effects of OSA on oxidative stress and inflammation (chapter II, III and IV)
2) To determine which facial features, functions and psychosocial aspects need more 
attention during treatment in the long-term (chapter V and VI)
3) To determine external and endonasal deformity, and satisfaction with nasal func-
tioning and appearance (chapter VII)
4) To provide recommendations for treatment by a systematic evidence-based review 
of multi-disciplinary treatment based on levels of evidence (chapter VIII)
Obstructive sleep apnea
Congenital craniofacial syndromes are associated with upper airway problems lead-
ing to OSA. Prevalence and severity of OSA vary between craniofacial syndromes. It is 
known that OSA occurs in TCS to a certain extent. However, scientific clinical evidence 
has been limited and difficult to obtain in this group, due to the rarity of the cases and 
the varying range in severity of phenotypic presentation of the disorder. In chapter 
II of the thesis the prevalence, severity and anatomical cause of OSA was determined 
in a cross-sectional cohort of 35 TCS patients (13 children). To determine prevalence 
and severity of OSA, an ambulatory polysomnography was used. In addition all upper 
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airway related surgical interventions were evaluated. In 11 patients an endoscopy of 
the upper airway was performed. OSA was diagnosed in TCS in 46% (41% in adults, 54% 
in children). Despite the fact that multiple TCS patients had undergone one or more 
upper airway related surgeries (38 surgical interventions in 17 patients), the prevalence 
of OSA was still high in children and adults. Endoscopic examination of the upper airway 
revealed obstruction at various anatomical levels. The most significant obstruction was 
found at the level of the oro/hypopharynx. OSA has shown to be an important problem 
in TCS patients considering the high prevalence and severity, which can persist even 
after upper airway surgery. Therefore polysomnography is recommended for screening 
for the presence and severity of OSA. In case of OSA, additional endoscopy of the upper 
airway is advised for determining the level(s) of obstruction and to guide treatment. 
This proposed work-up for OSA provides a base for individualized multilevel treatment, 
and will result in more adequate treatment of OSA in this population. When there are 
no surgical options for severe OSA in for example a multilevel severe obstructed airway 
and in young children, a non-invasive ventilation or continuous positive airway pressure 
should be considered as a treatment modality. In case of severe OSA and respiratory 
support fails, a tracheotomy is necessary.
The gold standard for screening for OSA is the poly(somno)graphy. This can be 
performed in hospital or in an ambulatory setting at home. To determine whether 
other tools for screening for OSA in TCS patients are useful, the value of other screening 
methods was explored. Therefore the aim of chapter III was to evaluate the accuracy 
of two established OSA questionnaires in children and adults with TCS. In children the 
Brouillette score was used. The Brouillete score is composed of three questions: the 
presence of apneas, breathing during sleep, and snoring. The total score is calculated 
using a formula (range of score -3.83  –  6.79) with the following classification: a score 
below -1 is defined as no OSA, a score between -1 and 3.5 as suggestive for OSA and a 
score > 3.5 as suspect for OSA. As cutoff for the classification OSA was -1 used. In adults 
the Epworth Sleepiness Scale was used. The Epworth Sleepiness Scale provides eight 
questions regarding hypersomnolence. The total score (range from 0 to 24) indicates 
significant hypersomnolence in eight individual situations during the day. A score ≥ 10, 
a score ≥ 16 indicates a high level of hypersomnolence. As cutoff for the classification 
OSA was used a score ≥ 10. Outcomes of the questionnaires were compared with the 
polysomnography results as described in chapter II. The total Brouillette score showed a 
low sensitivity (50%), specificity of 71%, and a low positive and negative predictive value 
(60% and 63% respectively). The Epworth Sleepiness Scale showed a low sensitivity (0%), 
a high specificity of 92% and a low positive and negative predictive value of 0% and 57% 
respectively. It can be concluded that these specific questionnaires are not useful for 
screening for OSA in TCS. By using these questionnaires the diagnosis OSA in TCS will 
be missed in a lot of patients. Possibly due to habituation to the nocturnal respiratory 
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pattern this questionnaire is not reliable. It is therefore recommended that all (newly) 
referred pediatric and adult TCS patients are screened for OSA with a polysomnography.
OSA is associated with additional oxidative stress and systemic inflammation. Oxida-
tive stress can contribute to the initiation of atherosclerosis and vascular dysfunction; 
systemic inflammation is a predictor for future cardiovascular comorbidity and hyper-
somnolence. Until now it is unknown what the effect of OSA on oxidative stress and 
systemic inflammation is in congenital craniofacial deformities, this is the reason this 
was further explored in chapter IV. A cross-sectional cohort study was performed in pa-
tients in with TCS and syndromic craniosynostosis. Laboratory analyses were performed 
including malondialdehyde, tumor necrosis factor α (TNF-α), interleukine 6 (IL-6) and 
high sensitivity C-reactive protein (hCRP). Forty-eight patients were included. De Body 
Mass Indexes of the patients were normal (median (SD) 0,7 (-1.82 tot 2.48)) in children 
and 20.5 (15.2-29.4) in adults. OSA was diagnosed in 23 of the 48 patients; mild OSA in 
16 and moderate/severe in seven patients. Neither oxidative stress nor systemic inflam-
mation had a correlation with the severity of OSA. Only TNF-α was found significantly 
higher in both the OSA and non OSA group compared with the reference values of a 
normal population, median 15,1 pg/mL en 12,3 pg/mL respectively versus 4,05 (0,0- 8,1 
pg/mL). The increased levels of TNF-α in both the OSA and non OSA group, cannot be 
explained by OSA; it might be possible that an unknown genetic origin is responsible 
for this finding. It can be concluded that no elevated levels were found for oxidative 
stress and systemic inflammation. This could be explained by a relative high prevalence 
of mild OSA in this group and the absence of an associated comorbidity in a “normal” 
population: obesity.
Long-term results of treatment
Patients with TCS are operated frequently for several facial deformities. One of the aims 
of treatment is satisfaction with the result of the operation. But do we reach our goals? 
How satisfied are patients with their facial features and functions after (surgical) treat-
ment on the long term? Is there still a desire for further treatment? Not much is known 
about the answers to these questions in TCS, therefore this was explored (chapter V). A 
cross-sectional cohort study was performed in adults (23 TCS patients and 206 controls, 
all ≥ 18 years). A standardized questionnaire (adjusted Body Cathexis Scale) was used 
to detect differences between satisfaction with facial appearance and functions. Desire 
for further treatment of these items was questioned in TCS patients. For each patient 
an overview was made of all facial surgical interventions performed, the affected facial 
features and objective severity of the facial deformities. Patients were least satisfied 
with the appearance of the ears, facial profile and eyelids. Regarding functioning, 
patients were least satisfied with hearing and nasal patency. Residual deformity of the 
reconstructed facial areas remained a problem in mainly the periorbital area. The desire 
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for further treatment and dissatisfaction was high, predominantly for eyelid reconstruc-
tions. Another significant wish for further treatment existed for hearing improvement.
On the long term TCS adults are moderately satisfied regarding their facial appear-
ance. Functional deficits of the face are shown to be as important as facial appearance. 
Particularly nasal patency and hearing are frequently impaired and require routine 
screening and treatment from intake onwards. Furthermore, correction of ear deformi-
ties and midface hypoplasia should be included in regular screening and the treatment 
protocol.
It is plausible that severe congenital craniofacial conditions are associated with psycho-
logical issues. Moreover, it can be questioned if so, whether differences exist between 
an acquired and a congenital facial deformity. In literature this is poorly understood. To 
determine the impact of these psychological issues in our patient group a study is per-
formed as described in chapter VI. In this chapter long-term psychological functioning 
was assessed in three groups: a group with a severe congenital craniofacial deformity 
including TCS, a group with an acquired facial deformity and as comparison a non-fa-
cially disfigured control group. Differences between these groups regarding long-term 
psychological functioning were determined. Fifty-nine adults with severe congenital 
facial disfigurement, 59 adults with an acquired facial deformity in adulthood and 120 
non-facially disfigured adults participated. Six questionnaires were filled out regarding 
long-term psychological functioning the Fear of Negative Appearance Evaluation Scale, 
Achenbach Adult Self-Report, Short-Form Health Survey, Rosenberg Self-Esteem Scale, 
Hospital Anxiety and Depression Scale and a visual analogue scale. Adults with severe 
congenital facial disfigurement had a relatively normal psychological functioning but 
appeared to be more prone to internalizing problems (over-control regarding emotions, 
emotions are focused inwards, for example social anxiety, anxiety in general and depres-
sion) than the control group. Compared with patients with an acquired facial deformity, 
the congenital group displayed fewer problems on the physical component summary 
(physical quality of life only, for example physical activity, work related problems and 
physical pain). Satisfaction with facial appearance, fear of negative appearance evalu-
ation and self-esteem showed to be good predictors for several aspects of long-term 
psychological functioning with the exception of the physical component summary of 
quality of life. Improving satisfaction with facial appearance (by craniofacial surgery), 
enhancing self-esteem by early psychological support, or lowering fear of negative ap-
pearance evaluation may ameliorate the treatment of these patients.
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The nose: endonasal and external nasal deformity and satisfaction with 
function and appearance
As described in chapter V, TCS patients are dissatisfied with their facial profile and 
complain about nasal obstruction. Although the nose is not the most prominent facial 
feature of TCS, it is generally considered a feature of TCS when deformed. In chapter 
VII external and endonasal deformity and satisfaction with nasal functioning and ap-
pearance was assessed. A cross-sectional cohort study was performed with 11 adult TCS 
patients and 151 controls. The Nasal Appearance and Function Evaluation Question-
naire as used earlier for assessing oncological resection and trauma, was filled out by 
the patients to determine satisfaction with nasal functioning and appearance. In all TCS 
patients external nasal deformities were scored on a predetermined scoring list by three 
experienced physicians in craniofacial surgery. Endonasal deformity was determined by 
standardized nasal endoscopy. Patients were relatively satisfied with the various esthetic 
nasal subunits. The most significant nose related functional problems were snoring and 
quality of phonation. The main external nasal deformities as scored by physicians were 
the dorsal hump (73%), external deviation (≤ 55%), the bifid or bulbous nasal tip (55%), 
and columellar luxation (55%). In 82% of the patients a septal deviation was found, often 
associated with spurs. The nose appeared to be frequently deformed and is considered 
a facial feature of TCS. Although the nose appears to be an underexposed feature of 
TCS to both patient and physician, possibly other more prominent facial features attract 
more attention. In summary, satisfaction with esthetics of the nose was fair, however, 
these patients suffer from the functional problems snoring and impaired quality of 
phonation. A structured nasal ENT physical examination with nasal endoscopy could 
determine aspects requiring more attention during treatment. Regarding the external 
nose, attention should be paid to dorsal hump reduction, correction of the deviated 
external osseous framework, a septoplasty and correction of the nasal tip shape.
Evidence-based medicine: the treatment of Treacher Collins syndrome
One of the aims of the thesis was to make recommendations for treatment of TCS. Until 
now no systematic review or clinical guideline is available based on sufficient level of 
evidence to make funded recommendations. Therefore chapter VIII was written, as last 
part of this thesis. This chapter is a systematic review with the aim to summarize the cur-
rent evidence-based medicine for multidisciplinary treatment of TCS. In addition graded 
levels of recommendation were presented for treatment based on what nowadays is 
known.
A systematic search was performed in PubMed, Web-of-Science, EMBASE, Cochrane 
Central (1985-January 2014). Included were clinical studies (with ≥5 TCS patients) related 
to therapy, diagnosis, or risk of concomitant diseases. Level of evidence of the selected 
articles was rated according to the American Society of Plastic Surgeons for Evidence-
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based Clinical Practice Guidelines. Two panelists had reviewed each abstract separately 
and consensus was reached concerning article inclusion. Of the 2433 identified articles, 
63 studies [level of evidence (2-5)] were included. Conclusions and recommendations 
were consecutively extracted for the items: upper airway; the ear, hearing and speech; 
the eye, eyelashes and lacrimal system; growth, feeding and swallowing; deformities of 
the nose; psychosocial factors and craniofacial reconstruction. Although some topics 
are well supported, especially the eye, eyelashes and lacrimal system speech, growth, 
feeding and swallowing and deformities of the nose lack sufficient evidence.
Main targets are early recognition of OSA through a polysomnography and a thorough 
ENT physical examination of the nose to determine the level of upper airway obstruc-
tion. The results of these examinations should determine the next steps in treatment. 
Moreover, more attention should be paid for the limited functions hearing and speech, 
these deficits should be recognized early.
In addition, an ophthalmologist should be consulted more often to identify and treat 
(intra-)ocular deformities. Feeding problems can be encountered early and followed up 
by a dietician and/or (prelingual) linguist. A structured ENT examination of the nose can 
determine deformed subunits of the nose and a wish for further nasal reconstruction 
can be evaluated. An nasal endoscopy could establish endonasal deformities leading 
to upper airway obstruction. There exist a considerable dissatisfaction with (residual) 
deformity after craniofacial surgery. Counseling of psychological sequelae and creating 
realistic expectations for the patient seems essential. Also on the topic of surgical recon-
struction lacks sufficient evidence to provide in a full evidence-based treatment protocol.
Therefore, more research is necessary to compare outcomes of craniofacial surgical 
reconstruction, especially in the orbitozygomatic/ maxillary region. Because of the rarity 
of the syndrome it is recommended to centralize medical care of these patients in a cra-
niofacial center nationwide. This provides conjoined expertise of physicians and more 
possibilities for research to compare outcomes of different treatment modalities. Until 
now, the most important limitation of craniofacial research is the low number patients 
available.
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NEDERLANDSE SAMENVATTING PROEFSChRIFT:
kLINISChE IMPLICATIES VAN hET TREAChER COLLINS SyNDROOM
Algemene introductie
In de algemene introductie (hoofdstuk I) van dit proefschrift getiteld “Klinische im-
plicaties van het Treacher Collins syndroom” worden de geschiedenis, achtergrond, en 
doelen van dit proefschrift beschreven.
Treacher Collins syndroom (TCS) is een aangeboren aangezichtsafwijking. Per jaar 
worden ongeveer vier tot vijf kinderen met dit syndroom geboren (geschatte incidentie 
1:50.000) in Nederland. Door de zeldzaamheid van het syndroom is er relatief weinig 
medisch wetenschappelijke aandacht voor geweest. De ernst en de klinische conse-
quenties van de aangezichtsafwijkingen verschillen per patiënt. Afwijkingen kunnen 
variëren van milde ooglidafwijkingen, hypoplasie van de oren (zowel externe oorschelp 
als middenoor) en zeer ernstige afwijkingen van mandibula en zygomata hetgeen kan 
leiden tot een ernstig bedreigde bovenste luchtweg en obstructief slaap apneu (OSA). 
Dit scala aan afwijkingen leidt tot esthetische maar ook functionele problemen, waar-
onder luchtweg- gehoor- en voedingsproblematiek. De aandoening is symmetrisch en 
komt bij mannen en vrouwen evenveel voor.
Doelen van dit proefschrift waren om in TCS:
1) Prevalentie, ernst, oorzaak en screening van OSA alsmede gerelateerde potentiële 
neveneffecten hiervan op oxidatieve stress en inflammatie vast te stellen (hoofdstuk 
II,III en IV).
2) Lange termijn resultaten van behandeling te onderzoeken en daardoor vast te stel-
len welke kenmerken en functies van het aangezicht alsmede welke psychosociale 
aspecten meer aandacht behoeven in de behandeling (hoofdstuk V en VI).
3) Uitwendige en endonasale afwijkingen van de neus vast te stellen, alsmede tevre-
denheid met functie en esthetiek (hoofdstuk VII).
4) Aanbevelingen voor multidisciplinaire behandeling te doen door middel van een 
systematic review gebaseerd op level of evidence (hoofdstuk VIII).
Obstructief slaap apneu
Congenitale craniofaciale syndromen zijn geassocieerd met bovenste luchtweg proble-
matiek in de vorm van OSA. Prevalentie en ernst kunnen verschillen per syndroom. Het 
is bekend dat OSA in een bepaalde mate en ernst voorkomt in TCS. Echter, wetenschap-
pelijk klinisch bewijs is beperkt en moeilijk te verkrijgen in deze groep vanwege de 
zeldzaamheid van de casus en de variërende ernst van de fenotypische presentatie van 
de aandoening. In hoofdstuk II is in een cohort van 35 patiënten met TCS (13 kinderen) 
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de prevalentie, ernst en anatomische oorzaak van obstructief slaap apneu (OSA) on-
derzocht. Een ambulante polysomnografie werd in een cross-sectionele studie verricht 
om de prevalentie en ernst van OSA te bepalen. Daarnaast werden alle soorten van chi-
rurgie met betrekking tot de bovenste luchtwegen geëvalueerd. In 11 patiënten werd 
endoscopie van de luchtwegen verricht. OSA werd gediagnosticeerd in 46% van de TCS 
patiënten (41% in volwassenen en 54% in kinderen). Ondanks het feit dat veel patiënten 
al meerdere chirurgische ingrepen gerelateerd aan de bovenste luchtwegen hadden 
ondergaan (38 ingrepen bij 17 patienten) bleek in zowel kinderen als volwassenen de 
prevalentie van OSA nog hoog te zijn. Het endoscopisch onderzoek liet verschillende 
anatomische niveaus van obstructie zien. Het meest belangrijke obstructieniveau werd 
gevonden op het niveau van de oro/hypofarynx. OSA is een belangrijk probleem gezien 
de hoge prevalentie en ernst en wat kan persisteren ondanks chirurgie van de bovenste 
luchtwegen. Aanbevolen wordt om alle patiënten met TCS te screenen op aanwezig-
heid en ernst van OSA middels polysomnografie. In geval van OSA wordt aanvullende 
endoscopie van de bovenste luchtweg geadviseerd om het niveau van de luchtwegob-
structie vast te stellen en om de behandeling te bepalen. Deze voorgestelde work-up 
voor OSA voorziet in een basis voor geïndividualiseerde multi-level behandeling en zal 
zorgen voor een adequatere behandeling van OSA in deze populatie. Indien er geen 
chirurgische behandelopties zijn voor ernstig OSA in bijvoorbeeld een multi-level ern-
stig geobstrueerde luchtweg en bij jonge kinderen, dan zal ademhalingsondersteuning 
met non-invasieve beademing of continue positieve druk ondersteuning noodzakelijk 
zijn. Bij zeer ernstige OSA waarbij het niet mogelijk is ademhalingsondersteuning toe te 
passen is een tracheotomie de behandeling.
De gouden standaard voor OSA screening is de poly(somno)grafie. Deze meting 
kan gedaan worden in het ziekenhuis of in de thuissituatie. Om te bepalen of er alter-
natieven zijn voor OSA screening werd ook het nut van andere screeningsmethoden 
bepaald. Derhalve was het doel van hoofdstuk III om vast te stellen in hoeverre twee 
veel gebruikte vragenlijsten ontworpen voor screening op OSA bruikbaar zijn bij 
kinderen en volwassenen met TCS. Bij kinderen werd de Brouillette score gebruikt. De 
Brouillette score bestaat uit een drietal vragen: de aanwezigheid van ademstilstanden, 
moeilijkheden met ademhalen tijdens het slapen en snurken. De antwoorden op de vra-
gen leveren middels een formule een score op (range: -3.83 tot 6.79) met de volgende 
normering voor risico op OSA: een score van <-1 geen OSA, een score tussen -1 en 3.5 
suggestief voor OSA, een score > 3.5 verdacht voor OSA. Als afkappunt voor classificatie 
op OSA werd -1 aangehouden. Voor volwassenen werd de Epworth Sleepiness Scale 
toegepast. De Epworth Sleepiness Scale bevat acht vragen die betrekking hebben op 
hypersomnolentie. De totaalscore van de vragen (range 0 tot 24) geeft een mate van 
hypersomnolentie in acht verschillende situaties gedurende de dag aan. Een score ≥ 10 
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geeft belangrijke hypersomnolentie aan, een score ≥ 16 ernstige hypersomnolentie. Als 
afkappunt voor classificatie op OSA werd een score ≥ 10 aangehouden.
De vragenlijsten werden vergeleken met de uitkomsten van polysomnografie zoals 
beschreven in hoofdstuk II. De Brouillette score toonde een lage sensitiviteit (50%), spe-
cificiteit 71%, en lage positief voorspellende waarde (60%) en negatief voorspellende 
waarde (63%). De Epworth Sleepiness scale toonde een lage sensitiviteit (0%), hoge 
specificiteit (92%) en lage positief voorspellende waarde (0%) en negatief voorspel-
lende waarde 57%. Geconcludeerd kon worden dat specifieke vragenlijsten voor OSA 
screening niet zinvol zijn voor screening in patiënten met TCS. Bij veel patienten zal de 
diagnose OSA gemist worden als enkel deze vragenlijsten gebruikt zouden worden. Mo-
gelijk speelt gewenning aan het ademhalingspatroon 's nachts hierin een oorzakelijke 
rol. Derhalve wordt aanbevolen om alle (nieuwe) verwezen kinderen en volwassenen 
met TCS op OSA te screenen middels een polysomnografie.
OSA is geassocieerd met een toename van oxidatieve stress en systemische inflam-
matie. Oxidatieve stress draagt bij aan de initiatie van atherosclerose en vasculaire dys-
functie; systemische inflammatie is een voorspeller voor toekomstige cardiovasculaire 
comorbiditeit en hypersomnolentie. Tot nu toe is nog onbekend wat het effect van OSA 
op oxidatieve stress en systemische inflammatie is in congenitale craniofaciale afwij-
kingen, derhalve werd dit in hoofdstuk IV onderzocht. Er werd een cross-sectionele 
cohort studie gedaan bij patiënten met TCS en syndromale craniosynostose. Diverse 
laboratorium bepalingen werden verricht om markers van oxidatieve stress en systemi-
sche inflammatie te bepalen (malondialdehyde (MDA), tumor necrosis factor α (TNF-α), 
interleukine 6 (IL-6) en high sensivity C-reactive protein (hCRP)). Er werden 48 patiënten 
onderzocht. De Body Mass Index van de patiënten waren normaal met een mediaan (SD) 
van 0,7 (-1.82 tot 2.48) in kinderen en 20.5 (15.2-29.4) in volwassenen. In 23 van de 48 
patiënten werd OSA gediagnosticeerd; milde OSA bij 16 patiënten en matig/ernstig OSA 
bij zeven patiënten. De markers voor oxidatieve stress en systemische inflammatoire 
hadden geen correlatie met de ernst van OSA. Er werd enkel voor TNF-α een significant 
hogere waarde dan de referentiewaarden van de “normale populatie” gevonden, zowel 
in de OSA groep als de non OSA groep (mediaan respectievelijk 15,1 pg/mL en 12,3 pg/
mL versus 4,05 (0,0- 8,1 pg/mL). De verhoogde TNF-α waarde in zowel de non OSA als 
OSA groep kan vooralsnog niet door OSA direct verklaard worden, mogelijk ligt hier een 
nog niet onderzochte genetische origine aan ten grondslag.
Geconcludeerd werd dat er geen verhoogde waarden werden gevonden voor de mar-
kers van oxidatieve stress en systemische inflammatie. Redenen hiervoor kunnen zijn de 
relatief hoge prevalentie van met name mild OSA in deze groep en de afwezigheid van 
een belangrijke geassocieerde comorbiditeit in de “normale” OSA populatie: obesitas.
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Lange termijn resultaten van behandeling
Patiënten met TCS worden frequent geopereerd aan verschillende afwijkingen van het 
aangezicht. Doel van behandeling is onder andere dat de patiënt tevreden is met het re-
sultaat van de operatie. Maar in hoeverre slagen we hier daadwerkelijk in? Hoe tevreden 
zijn patiënten nu precies op de lange termijn met welke uiterlijke kenmerken en functies 
van het aangezicht? En bestaat er nog een behandelwens? Omdat op het antwoord van 
deze vragen weinig bekend is werd dit onderzocht (hoofdstuk V). Er werd een cross-
sectionele cohort studie verricht bij volwassenen (23 TCS patienten en 206 controles, 
allen  ≥  18 jaar) waarin door middel van een gestandaardiseerde vragenlijst (adjusted 
Body Cathexis Scale) is gekeken naar verschillen qua tevredenheid met uiterlijk en func-
ties van het aangezicht. Verder is er gekeken naar wensen voor verdere behandeling 
binnen het patiënten cohort. Voor elke patiënt werd een overzicht van alle aangezichts-
operaties gemaakt, de aangedane aangezichtsdelen en ernst van de afwijking gescoord. 
TCS patiënten waren het meest ontevreden over het uiterlijk van de oren, profiel van 
het gezicht en oogleden. Qua functie waren ze het meest ontevreden over de functie 
van het gehoor en de neuspassage. Restafwijkingen van de aangezichtsreconstructies 
werden met name genoemd in de peri-orbitale regio. Er was een aanzienlijke wens voor 
verdere behandeling en de ontevredenheid was groot aangaande de ooglidcorrecties. 
Er was ook duidelijk de wens om het gehoor te verbeteren.
Op lange termijn zijn TCS volwassenen matig tevreden over hun uiterlijk van het 
aangezicht en staan met name ook functionele problemen op de voorgrond; vooral 
neuspassage- en gehoorklachten zijn hierbij frequent aanwezig en vereisen een routine 
screening en behandeling vanaf de eerste poliklinische intake. Verder zullen correctie 
van afwijkingen van de oorschelp en midface hypoplasie opgenomen moeten worden 
in de reguliere screening en het behandelschema.
Het is aannemelijk dat ernstige congenitale afwijkingen vaker geassocieerd zijn met 
het ontstaan van psychologische problemen. Daarnaast is het de vraag of er een verschil 
in psychologisch functioneren is tussen een verworven of een congenitale aandoening 
van het gezicht. In de literatuur echter is dit weinig onderzocht. Om de impact van deze 
problemen te bepalen in onze patiëntencategorie is een onderzoek verricht wat wordt 
beschreven in hoofdstuk VI. In dit hoofdstuk werd lange termijn psychologisch functi-
oneren bepaald in drie groepen: een groep met ernstige congenitale aangezichtsafwij-
kingen inclusief TCS, een groep met verworven aangezichtsafwijkingen en ter vergelijk 
een controle cohort zonder aangezichtsafwijkingen. Er is gekeken naar verschillen qua 
lange termijn psychologisch functioneren tussen deze groepen. Negenenvijftig volwas-
senen met een ernstige aangeboren afwijking, 59 met een verworven afwijking en 120 
controle patiënten participeerden. Zes vragenlijsten werden ingevuld met betrekking 
tot het psychologisch functioneren: de Fear of Negative Appearance Evaluation Scale, 
Achenbach Adult Self-Report, Short-Form Health Survey, Rosenberg Self-Esteem Scale, 
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Hospital Anxiety and Depression Scale en een visual analogue scale. Volwassenen met 
een ernstige aangeboren afwijking hadden een relatief “normaal” psychologisch func-
tioneren maar bleken meer vatbaar voor internaliserende problemen (overcontrole 
over emoties waardoor dezen naar binnen worden gericht, bijvoorbeeld sociale terug-
getrokkenheid, angst en depressie) dan het niet aangedane controle cohort. Vergeleken 
met patiënten met een verworven aangezichtsafwijking, liet de congenitale groep 
minder problemen zien op de physical component summary (fysieke kwaliteit van 
leven, bijvoorbeeld lichamelijke activiteit, fysieke werkgerelateerde problemen en pijn). 
Tevredenheid met het uiterlijk, angst om negatief beoordeeld te worden door anderen 
en zelfvertrouwen bleken goede voorspellers voor verschillende aspecten van lange 
termijn psychologisch functioneren met als uitzondering de physical component sum-
mary van kwaliteit van leven.
Verbetering van tevredenheid van het uiterlijk (door craniofaciale chirurgie), vergro-
ten van het zelfvertrouwen door vroegtijdige psychologische hulp en verminderen 
van angst om negatief beoordeeld te worden anderen, kan de behandeling van deze 
patiënten met ernstige aangeboren afwijkingen verbeteren.
De neus: endonasale en uitwendige afwijking en tevredenheid met functie en 
esthetiek
Zoals in hoofdstuk V beschreven staat zijn TCS patiënten ontevreden over het profiel 
van aangezicht en de neuspassage. Hoewel de neus niet tot de meest karakteristieke 
afwijking binnen TCS wordt gerekend, is er wel sprake over het algemeen van een ken-
merkende afwijkende vorm van de neus.
In hoofdstuk VII worden zowel de uitwendige als ook de endonasale afwijkingen be-
studeerd en daarnaast de tevredenheid met functie en uiterlijk van de neus onderzocht. 
Er werd een cross-sectionele cohort studie uitgevoerd bij 11 volwassen TCS patiënten 
en een controle groep van 151 patiënten. De Nasal Appearance and Function Evaluation 
Questionnaire zoals ontwikkeld en gebruikt bij neusreconstructies na oncologische 
resectie en trauma, werd door het patiënten cohort ingevuld om tevredenheid met 
uiterlijk en functie van de neus vast te stellen. In alle TCS patiënten werden uitwendige 
afwijkingen van de neus gescoord door drie ervaren specialisten op het gebied van 
craniofaciale chirurgie volgens een vaste scoringslijst. Endonasale afwijkingen werden 
vastgesteld door middel van een gestandaardiseerde nasendoscopie van de neus. 
Patiënten waren relatief tevreden met de verschillende esthetische kenmerken van de 
uitwendige neus. De belangrijkste aan de neus gerelateerde functionele klachten waren 
snurken en kwaliteit van de stem. De belangrijkste afwijkingen die gevonden werden 
door de specialisten: de dorsale hump (73%), uitwendige deviatie (≤55%), een bifide of 
plompe neuspunt (55%) en luxatie in de columella (55%). In 82% van de patiënten werd 
een septum deviatie gevonden vaak samengaand met een basale crista. De neus bleek 
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vaak afwijkend te zijn en behoort dan ook tot een karakteristieke afwijking voor TCS. De 
neus blijkt tot nu toe een relatief onderbelichte afwijking bij patiënt en behandelaar, 
mogelijk doordat de opvallendere andere aangezichtsafwijkingen meer de aandacht 
trekken. Samenvattend is de patiënttevredenheid met de esthetiek van de neus redelijk, 
maar patiënten ervaren met name problemen met snurken en beperkte kwaliteit van de 
stem. Een gestructureerd KNO onderzoek van de neus met nasendoscopie kan bepalen 
welke endonasale afwijkingen meer aandacht behoeven in de behandeling van TCS. 
Qua uitwendige neus zou er aandacht moeten zijn voor reductie van de dorsale hump, 
correctie van de uitwendige deviatie van de neus, een septumplastiek en correctie van 
de vaak afwijkende neustip.
Evidence-based medicine: de behandeling van Treacher Collins syndroom
Een van de doelen van dit proefschrift was om aanbevelingen te doen voor behande-
ling van TCS. Tot op heden zijn er geen systematische reviews of richtlijnen beschikbaar 
gebaseerd op voldoende wetenschappelijk bewijs om tot gegronde aanbevelingen 
te komen. Daarom werd als laatste onderdeel van dit proefschrift hoofdstuk VIII ge-
schreven. Dit hoofdstuk is een systematische review met als de doel weer te geven wat 
de huidige evidence-based medicine is voor de multidisciplinaire behandeling van TCS. 
Tevens werden er gegradeerde aanbevelingen gedaan voor behandeling gebaseerd op 
datgene wat er tot nu toe bekend is.
Een systematische zoekactie werd uitgevoerd op PubMed, Web-of-Science, EMBASE, 
Cochrane Central (1985 tot januari 2014). Geïncludeerd werden klinische studies 
(met ≥ 5 TCS patiënten) gerelateerd aan therapie, diagnose of risico van gerelateerde 
comorbiditeit. Level of evidence werd gescoord van alle geïncludeerde studies volgens 
het systeem van de American Society of Plastic Surgeons for Evidence-based Clinical 
Practice Guidelines. Twee auteurs hebben alle abstracts beoordeeld en er werd consen-
sus bereikt over de geïncludeerde studies.
Van de 2433 geïdentificeerde artikelen werden 63 studies (level of evidence 2-5) 
geïncludeerd in de studie. Conclusies en aanbevelingen werden vervolgens opgesteld 
voor de volgende onderwerpen: bovenste luchtweg; het oor, horen en spraak; het oog, 
oogleden en traanwegsysteem; groei, voeding en slikken; de neus; psychosociale facto-
ren en craniofaciale reconstructie.
Er kan geconcludeerd worden dat voor sommige onderwerpen redelijk bewijs is, ech-
ter ontbreekt er met name voldoende bewijs voor de volgende onderwerpen: het oog, 
oogleden en traanwegsysteem; groei, voeding en slikken en afwijkingen van de neus.
Kernpunten zijn vroege herkenning van OSA middels een polysomnografie en een 
gedegen KNO onderzoek waarin de niveaus van de bovenste luchtweg obstructie 
worden bepaald. Deze onderzoeken dienen bepalend te zijn voor de behandelingsop-
ties in het vervolgtraject. Daarnaast zal er meer vroegtijdige herkenning en aandacht 
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voor de beperkte functies van het gehoor en spraak moeten zijn. Ook zal een oogarts 
vaker geconsulteerd dienen te worden om oogafwijkingen vast te stellen en te kunnen 
behandelen. Voedingsproblemen kunnen vroegtijdig samen met een diëtist en/of (pre-
verbale) logopedist behandeld en vervolgd worden. Een gestructureerd uitwendig KNO 
onderzoek van de neus kan bepalen wat afwijkend is aan de vorm van de neus en er kan 
geïnventariseerd worden of er een wens bestaat tot reconstructie. Een nasendoscopie 
kan endonasale afwijkingen vaststellen die tot luchtwegobstructie kunnen leiden. Er 
bestaat nog steeds een aanzienlijke ontevredenheid over de (rest) afwijkingen na 
aangezichtschirurgie. De gevolgen hiervan op psychologisch gebied alsmede het goed 
counselen van patiënten en reële verwachtingen creëren lijkt essentieel. Ook bij het 
onderdeel chirurgische reconstructies ontbreekt voldoende bewijs voor een volledig 
evidence-based behandelprotocol.
Derhalve is er meer onderzoek nodig om uitkomsten te vergelijken van craniofaciale 
chirurgische reconstructie, met name in de orbitozygoma/ maxilla regio. Omdat het 
een zeer zeldzame aandoening betreft verdient het aanbeveling om de behandeling 
landelijk te centraliseren in een nationaal craniofaciaal centrum. Dit biedt bundeling van 
expertise maar ook betere mogelijkheden voor wetenschappelijk onderzoek waarmee 
bijvoorbeeld verschillende behandelmodaliteiten en de resultaten daarvan onderzocht 
kunnen worden. Tot nu toe zijn met name de patiëntenaantallen de beperkende factor 
binnen craniofaciaal onderzoek.
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prevalence, severity, cause and screening 
2012 20/0.7 
-  X World Congress on Sleep Apnea Sleep Respiratory Disorders and Snoring, 
Rome, Italy: Abstract: Oxidative stress, systemic inflammation and sympathic 
inflammation in patients with craniofacial anomalies 
2012 20/0.7 
-  Bi-annual Scientific Meeting Dutch Society of Otorhinolaryngology (KNO) 
Groningen: Oral: Obstructive sleep apnea in Treacher Collins syndrome: 
prevalence, severity, cause and screening 
2011 20/0.7 
-  Craniofacial Scientific Meeting Sophia Erasmus MC Rotterdam: Oral: 
Inflammatory parameters and oxidative stress in Treacher Collins syndrome and 
syndromic craniosynostosis 
2011 20/0.7 
-  Annual Scientific Meeting Dutch Society of Plastic Surgery (NVPC): Oral: Long-
term results satisfaction with facial appearance and functioning 
2011 20/0.7 
-  Scientific Meeting department of Plastic and Reconstructive Surgery, Erasmus 
MC Rotterdam: Oral: Clinical implications of Treacher Collins syndrome 
2011 20/0.7 
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-  International Society of Craniofacial Surgery (ISCFS) XIV Biennial International 
Congress, Livingstone, Zambia: Abstract: Long-term results satisfaction with 
facial appearance and functioning 
2009 20/0.7 
-  Annual Meeting Dutch Society of Cleft Palate and Congenital Deformities 
(NVSCA), Tilburg: Oral: Treacher Collins syndrome and obstructive sleep apnea: 
prevalence and severity 
2009 20/0.7 
-  International Society of Craniofacial Surgery (ISCFS) XIII Biennial International 
Congress, Oxford: Abstract: Treacher Collins and obstructive sleep apnea 
2009 20/0.7 
-  Bi-annual Scientific Meeting Dutch Society of Plastic Surgery (NVPC) Utrecht: 
Oral: Treacher Collins syndrome and obstructive sleep apnea 
2009 20/0.7 
Seminars and workshops
-  Bi-annual Scientific Meeting Dutch Society of Plastic Surgery (NVPC), Utrecht 2012 8/0.3 
-  Bi-annual Scientific Meeting Dutch Society of Plastic Surgery (NVPC), Haarlem 2011 8/0.3 
-  Bi-annual Scientific Meeting for General Surgery (NVVH), Ede 2010 8/0.3 
-  Bi-annual Scientific Meeting Dutch Society of Plastic Surgery (NVPC), 
Maastricht 
2009 8/0.3 
-  Annual Meeting Dutch Society of Cleft Palate and Congenital Deformities 
(NVSCA), Nijmegen 
2008 8/0.3 
-  Benelux Meeting for Plastic, Reconstructive and Aesthetic Surgery 2008 2008 8/0.3 
-  Congress Wound Healing and Wound Treatment, Rotterdam 2007 8/0.3 
-  Bi-annual Scientific Meeting Dutch Society of Plastic Surgery (NVPC) Utrecht 2007 8/0.3 
Organised conferences
-  Scientific meeting General Surgery, Region IV, Rotterdam 2014 56/2 
-  Congress wound healing and wound treatment, Rotterdam 2007 8/0.3 
Grants
-  Nuts Ohra Foundation Grant: Treacher Collins syndrome 2010 112/4 
-  Stichting Hoofdzaak (former Carolien Bijl Foundation) 2010 
Other
-  MEC-2012-135 Approval Paper METC, Erasmus MC 2012 112/4 
-  MEC-2008-402 Approval Paper METC, Erasmus MC 2008 112/4 
2. Teaching activities
Lecturing
-  3rd year minor “From head to hands” practicum: suture techniques 2011 14/0.5 
-  3rd year minor “From head to hands”: Hand anatomy, introduction to plastic 
surgery 
2011 14/0.5 
-  2nd year medicine students practicum anatomy: clinical implications of hand 
anatomy 
2011 14/0.5 
-  3rd year college Craniofacial surgery: Treacher Collins syndrome 2010 7/0.3 
-  3rd year minor Craniofacial surgery: author study assignment 
“zelfstudieopdracht”: Treacher Collins syndrome 
2010 14/0.5 
Supervising practicals and excursions
-  Supervision microsurgery course: skills lab Erasmus MC 2011-2012 28/1 
Supervising Master's theses
-  None   
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